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Porcine reproductive and respiratory syndrome virus (PRRSV) is an infectious agent of 
significant concern to the global swine industry. PRRSV infection of pigs is initiated by a 
long viremia after which the virus enters in an extended persistent phase of 3-4 months 
that ultimately is resolved by the immune system. The delayed and weak host adaptive 
response is responsible for the protracted convalescence period. An initial sub-optimal 
innate immune response is postulated to be the reason behind such meager adaptive 
immune response. A major focus of the studies undertaken in this dissertation was to 
identify the viral non-structural proteins (nsps) involved in antagonizing cellular 
interferon (IFN) production, a principal component of host innate defense system. 
Among the four different nsps identified from initial cursory screening, nsp1 exhibited 
the strongest suppression of IFN induction. Nsp1α and nsp1β, the proteolytic products of 
nsp1 were both found to down-regulate dsRNA-induced activation of interferon 
regulatory factor 3 (IRF3). Furthermore, Nsp1β specifically antagonized IRF3 
phosphorylation and nuclear translocation. In order to determine the amino acid residues 
responsible for the anti-IFN property of nsp1α and nsp1β, we prepared alanine-scanning 
mutants of both proteins. These mutants were probed for their ability to alleviate the IFN-
suppression in reporter assays. Several candidates with variable degrees of relief were 
 
 
identified. A recombinant PRRSV with the respective mutations incorporated in nsp1β 
induced higher level of type I IFN and was attenuated in vitro. However, in infected 
swine the mutant virus quickly reverted to acquire the wild type IFN-suppression 
phenotype. To further understand the role of nsp1β in PRRSV life cycle, we employed 
co-immunoprecipitation coupled with mass spectrometry analysis to identify host cellular 
factors that interact with nsp1β. Here, we characterized nsp1β‟s interaction with cellular 
poly(C) binding protein (PCBP)-1 and 2. Both PCBP1 and PCBP2 associated with 
several components of viral replication and transcription apparatus. Using various 
biochemical assays, I demonstrated that both PCBP1 and PCBP2 are important for 
transcription and/or replication of the viral genome. 
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CHAPTER I 
LITERATURE REVIEW 
 
History 
In the late 1980s, swine herds in the United States experienced a serious outbreak of a 
“mystery swine disease” of unknown etiology (84). Clinical manifestations of the disease 
included reproductive failure, pneumonia and reduced growth performances (70). Similar 
outbreaks were also reported in Germany in 1990 and the disease quickly spread to the 
rest of the Europe (8, 18). Researchers at Central Veterinary Institute (Lelystad, The 
Netherlands) were the first to establish the causative organism to be an RNA virus (193, 
223). A similar virus was also isolated in North America shortly thereafter and now has 
been identified in the Asian continent (32, 71). The name “porcine reproductive and 
respiratory syndrome” (PRRS) was introduced in 1991 and signifies the major clinical 
symptoms associated with the disease. At present, PRRS is endemic in most swine 
producing countries.  
Etiology of PRRS 
PRRS is caused by PRRS virus (PRRSV), a single strand positive-sense RNA virus that 
belongs to the family Arteriviridae (24).  The other members of this family are equine 
arteritis virus (EAV), lactate dehydrogenase elevating virus (LDV) and simian 
hemorrhagic fever virus (SHFV). The Arteriviridae family along with Coronaviridae and 
Roniviridae families form the order Nidovirales (24, 35). PRRSV virion is enveloped and 
its genome is ~15 Kb in length. PRRSV strains are divided into two distinct genotypes, 
which are type I (European) and type II (North American), based on their genetic 
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differences as well as geographical distribution, but at present strains of both genotypes 
may co-circulate in the same region and even in the same farm (60). The virus strains 
Lelystad and VR2332 are considered as the prototypes of type I and type II genotypes 
respectively (15, 223). Both genotypes share only 60% genetic identity and can be 
serologically distinguished (4, 119, 129). The genetic differences observed are dispersed 
throughout the genome rather being concentrated in a particular location (125, 129). The 
isolates within single genotypes are also highly divergent, with sequence heterogeneity 
close to 20% (66, 119, 129, 144). At present PRRSV is considered as “one of the most 
significant swine pathogens” worldwide. The annual economic loss was estimated to be 
$560 million to the US swine producers alone (132).    
Virion morphology 
The virions are pleomorphic with shapes varying from oval to spherical. As per the recent 
cryoelectron tomography study by Spilman et al. (182), the viral particle measures 50-65 
nm (avg. 55 nm) in diameter with the nucleocapsid core width measuring 40 nm. The 
virion outer surface is smooth with few protrusions, which are proposed to be formed by 
ectodomains of minor envelope glycoproteins. The bilayer lipid envelope is separated by 
a 3 nm gap from virion core, which is suggested to be hollow (low electron density) 
(182). The nucleocapsid core arrangement is suggested to be asymmetric and helical but 
details of the organization of viral RNA and nucleocapsid (N) protein are unknown (46).  
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Fig.1.1 Schematic representation of PRRSV genomic organization. The top figure 
depicts the entire PRRSV genome from 5‟ to 3‟ direction. Different ORFs are shown in 
separate rectangles and their identities are indicated inside the rectangle or by an arrow. 
The 5‟ 7-methylguanosine cap and 3‟ poly (A) tail along with 5‟ and 3‟ UTRs are shown 
on both ends of the genome. The bottom panel depicts the 14 different nsps produced by 
processing of the pp1a and pp1ab polyprotein translated from ORF1a and ORF1b. The 
proteases that carries out processing are nsp1α, nsp1β, nsp2 and nsp4 (shown in grey and 
their protease family is also denoted). The two known proteins that are part of the viral 
replicase complex are nsp9 (polymerase) and nsp10 (helicase) are shown in red. PRRSV 
nsps for which no function has been described are in white. 
 
 
PRRSV genomic organization 
The linear single stranded RNA genome of PRRSV has a 5‟ cap structure and the 3‟ tail 
is polyadenylated (Fig. 1.1) (48). The genome consists of 10 known open reading frames 
(ORFs) (33, 48, 51, 80). ORF1a and ORF1b are comprised of 75% of the total genome 
and code for 14 different non-structural proteins (nsps).The nsps are synthesized as 
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polyprotein and are co- and post-translationally processed to produce the 14 different 
nsps- nsp1α, nsp1β, nsp2-6, nsp7α, nsp7β, nsp8-12 (175, 203). Four virus encoded 
proteases- nsp1α, nsp1β, nsp2 and nsp4 are responsible for this proteolytic processing 
(175). Besides their role in polyprotein processing, the nsps are essential for viral RNA 
replication, subgenomic (sg) mRNA transcription, and translation. The PRRSV structural 
proteins encoded by ORF2-7 are expressed from a set of six nested sg mRNAs through a 
process of discontinuous RNA transcription (138, 162). These sg mRNAs are 
polycistronic except for the last sg mRNA (sg mRNA7) but only the 5‟ proximal ORF is 
translated to generate a structural protein. The sg mRNAs are 3‟ co-terminal and also 
share a common leader sequence at their 5‟ end with the genomic RNA, a property 
unique to both Coronaviruses and Arteriviruses (49, 127).  
Viral non-structural proteins 
Upon virus entry and uncoating, PRRSV ORF1a is translated to produce polyprotein 1a 
(pp1a). In some cases, however, the pp1a is further extended in the c-terminus resulting 
in synthesis of pp1ab polyprotein. This occurs due to a -1 ribosomal frame shift just 
upstream of the ORF1a termination codon resulting in a read-through during ribosomal 
scanning (20). Both pp1a and pp1ab are processed by the three N-terminal viral accessory 
proteases (nsp1α, nsp1β and nsp2) and the main protease (nsp4) to produce 14 different 
nsps (48, 175, 242). The processing scheme of the polyprotein is complex and might 
involve a major and a minor pathway giving rise to different polyprotein intermediates 
(175, 219). Information regarding most PRRSV nsps is scarce and for several of the nsps, 
there are no assigned functions. Below is a summary of the known functions of several 
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proteins. In some cases presumed functions of certain nsps were described in light of 
their EAV counterparts.  
Nsp1α: It is the N-terminal papain-like cysteine protease (PCP) and is responsible for 
cleavage of the nsp1α-nsp1β junction resulting in release of the nsp1α protein from the 
polyprotein (44, 177). In North American strains this junction site is located at Met180-
Ala181 making the nsp1α protein of 180 amino acid (aa) long (29, 187). This protein has 
an amino-terminal zinc-finger (ZF) domain, the cysteine protease (PCPα) domain and a 
C-terminal extension (CTE) (175, 187). Recently the nsp1α crystal structure was solved 
and this study identified a second ZF, with the zinc bound to the PCPα protease active 
site (187). PRRSV nsp1α exists as a dimer in solution and its protease activity is only 
observed in cis configuration. The self-processed nsp1α was found to have the CTE 
peptide tightly bound to the protease active sites suggesting that once released from the 
polyprotein nsp1α does not have any proteolytic function. Mutations in the cysteine 
residues of the N-terminal ZF resulted in viruses with different degrees of deficiency in 
sg mRNA synthesis without any adverse effect on replication (198, 201). Mutations of 
several charged aa residues of PCPα also prevented sg mRNA synthesis implying this 
domain‟s involvement in viral transcription (128). The counterpart of PRRSV nsp1α in 
EAV has a mutation in the protease active site rendering the later proteolytically inactive 
(44). Research in EAV nsp1 has found that the protein is involved in three important 
processes- viral polyprotein synthesis, viral sg RNA transcription and virion biogenesis 
(198). 
Nsp1β: This is the second accessory protease, which auto-cleaves itself from the 
pp1a/pp1ab polyprotein via its cysteine protease activity. The protease processes the 
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nsp1β-nsp2 junction at amino acid position Gly383-Ala384, which is conserved in both 
genotypes of PRRSV. The resulting 203 aa protein‟s crystal structure has also been 
determined (233). The protein has 3 known domains- (i) N-terminal nuclease domain 
(NTD), (ii) middle linker domain and (iii) C-terminal PCPβ domain. Besides these 
domains, the 22 amino acids at extreme C-terminus forms a CTE (C-terminal extension) 
peptide that occupies the substrate binding groove of the protease domain after release of 
nsp1β from the polyprotein (233). Based on this information nsp1β was also suggested to 
be a cis acting protease just like nsp1α. The nsp1β also forms homodimer in solution and 
disruption of dimerization resulted in insoluble proteins in Escherichia Coli (E. coli) 
expression system (233). Dimerization is most likely not a requirement for nsp1β‟s 
protease activity, but might be important for other non-proteolytic role. The NTD domain 
has nuclease activity towards dsDNA and ssRNA (233). But this enzyme activity is not 
sequence specific and the biological role of this nuclease in the context of virus infection 
is not known. Mutation of the protease active site residues (Cys, His) resulted in a 
replication-incompetent virus presumably due to non-processing of nsp1β-nsp2 junction 
as correct processing of nsp2 is required for virus viability (90). Nedialkova et al. (128) 
have recently shown that EAV virus with mutant PCPβ (mutations in certain charged 
residues) is also deficient in sg mRNA synthesis. The EAV nsp1 also interacts with 
cellular transactivator p100, which is speculated to be important for viral and/or cellular 
transcription (199). Both nsp1α and nsp1β translocate to the nucleus shortly after PRRSV 
infection, but both proteins lack consensus nuclear localization signal (NLS) (29). Similar 
observations have been made for the EAV orthologue nsp1, but the actual function of this 
nsp1 in the nucleus is unknown (200). 
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Nsp2: PRRSV nsp2 is a multidomain protein and its principal role appears to mediate the 
processing of nsp2-nsp3 junction. The various domains are- (i) N-terminal cysteine 
protease domain, (ii) middle hypervariable domain of unknown function, (iii) 
transmembrane domain and (iv) C-terminal tail (65). The cysteine protease belongs to the 
mammalian ovarian tumor domain (OTU)-containing protein superfamily and the 
protease activity is essential for viable virus recovery (65, 112). The protease domain is 
capable of both cis and trans cleavage activity (65). PRRSV full-length sequence analysis 
has shown that nsp2 is the most variable among nsps with most sequence heterogeneity 
concentrated in the middle hypervariable region. In PRRSV-infected cells, nsp2 localizes 
to the perinuclear region, where it associates with intracellular membrane most likely 
derived from endoplasmic reticulum (ER) to form double membrane vesicles (DMV) 
which are sites for virus replication and transcription (141, 146, 206). In EAV, expression 
of nsp2 and nsp3 is sufficient to drive formation of these DMV structures in the absence 
of viral replication (176). Biochemical and electron microscopic studies of EAV 
replication has revealed that nsps with transmembrane domains (nsp2, nsp3 and nsp5) are 
part of these DMV and it has been suggested that these proteins help in recruiting other 
members of replicase complex to the DMV which lack the membrane spanning regions 
(206).  
Nsp9: Arterivirus nsp9 encodes the RNA-dependent RNA polymerase (RdRp) (45). The 
RdRp domain is located in the C-terminal part of nsp9 and the function of the upstream 
N-terminal domain is not known. Enzymatically active RdRp can be purified from E. coli 
expressing EAV nsp9 and is capable of de novo RNA synthesis (14). 
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Nsp10: This protein codes for the viral helicase. The protein can be putatively divided 
into three domains i.e. N-terminal zinc-binding domain, a linker domain and the helicase 
domain. Both EAV and PRRSV nsp10 possesses ATPase activity and are capable of 
unwinding dsRNA and dsDNA in a 5‟-3‟ direction in vitro (10, 49). The zinc-binding 
domain is important for the ATPase and helicase activity (164). EAV nsp10 has been 
implicated in viral sg mRNA synthesis (207). 
Nsp11: Arterivirus nsp11 contains the nidovirus endoribonuclease (NendoU) domain, 
which is considered as the genetic marker of Nidovirales order, as it is absent in other 
RNA viruses (62, 173). Nsp11 endoribonuclease is capable of cleaving ssRNA and 
dsRNA substrates 3‟ of pyrimidines, however its target molecules in virus infected cells 
is not known. Mutations in the EAV endoribonuclease active sites are not lethal for virus 
rather the mutants show defect in sg mRNA synthesis (147).  
No specific functions have been attributed to PRRSV nsp5, nsp6, nsp7α, nsp7β, 
nsp8 and nsp12. 
Viral structural proteins 
PRRSV encodes seven structural proteins from as many ORFs. The ORFs and the 
corresponding proteins are: ORF2a-Glycoprotein (GP)2a, ORF2b-E, ORF3-GP3, ORF4-
GP4, ORF5-GP5, ORF6-membrane (M) protein and ORF7-Nucleocapsid (N) protein. 
Out of these GP2a, GP3, GP4 and GP5 are glycosylated and along with E and M protein 
are present on the viral envelope. Based on their abundance on the envelope GP5 and M 
are considered as the major envelope proteins and GP2a, E, GP3 and GP4 are minor 
envelope proteins. All major and minor proteins are required for infectious virus 
production but GP5, M and N alone can produce virus like particles (227). Recently a 
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short ORF (ORF5a) was identified that overlaps with the 5‟ end of ORF5, but whether 
the protein product of ORF5a is a structural component of the virion is not known (51, 
80).   
GP2a and E: PRRSV GP2a and E proteins are translated from the same sub genomic 
mRNA-2 with the latter being translated from an internal ORF inside ORF2. GP2a has 
two glycosylation sites and glycan addition at aa position 184 is essential for viable virus 
recovery in type II strains (36, 40). GP2a also interacts with the cellular receptor CD163 
and hence may be a target for neutralizing antibodies (36). The E protein is a small (73 
aa) hydrophobic protein, which has been suggested to contain ion channel activity (96). 
Viruses deficient in E protein are capable of entering susceptible cells but could not 
undergo the subsequent stages of viral replication and transcription. It has been 
speculated that E protein‟s ion channel activity helps in disassembling the virion 
nucleocapsid and release of viral RNA to the cytoplasm (96). 
GP3: This glycoprotein is heavily glycosylated with 7 predicted N-glycosylation sites 
(40) but only six of these sites are used for glycan addition (36, 37). These glycans on 
virion surface prevent recognition of epitopes by neutralizing antibodies, a phenomenon 
described as “glycan shielding”. Vu et al.(215) has recently showed that a North 
American strain naturally lacking glycosylation at position 131 is highly susceptible to 
neutralizing antibodies and swine infected with this mutant virus also induces robust 
neutralizing antibody response.  A subset of the GP3 protein is secreted from the cell as a 
non-membrane anchored soluble form (114).  
GP4: This glycoprotein has four N-glycosylation sites. It was also found to interact with 
the cellular receptor CD163 along with GP2 (36). The GP4 protein of Lelystad virus has 
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been shown to contain a neutralizing epitope located in the hypervariable region (from 
aa40-79) (122). The minor structural component of virion (GP2a, E, GP3 and GP4) might 
associate with each other through non-covalent interaction (225, 227).  
GP5: It is the most abundant glycoprotein. GP5 is a triple membrane spanning protein 
with a short ectodomain of 40 aa and its cytoplasmic endodomain is 50 to 70 aa long 
(115, 121). This protein exists as a disulfide-linked heterodimer with the M protein in the 
virion (115). In the case of EAV, such heterodimerization is essential for viral envelope 
assembly and infectivity (174). Both European and North American strains of PRRSV 
contain a major neutralizing epitope in the ectodomain of GP5. GP5 of the North 
American strains has three glycosylation sites, whereas European strains possess only 2 
N-glycosylation sites (6, 228). Ansari et al. (6) has shown that GP5 glycans also 
participate in the glycan shielding process. Mutant viruses carrying glycosylation 
deletions in GP5 are highly susceptible to antibody neutralization when compared to fully 
glycosylated wild type virus. 
M: This is the most conserved structural protein and is un-glycosylated. Similar to GP5 
the membrane protein also has a short ectodomain and spans the membrane three times 
(40). The M protein is suggested to be involved in virus assembly and budding. 
N: The nucleocapsid protein is the most abundant structural protein of the virion and is 
translated from a monocistronic sg RNA (sg RNA7) (40, 116, 121). The N protein is a 
serine phosphoprotein that exists as a dimer. The protein is highly immunogenic but 
antibodies directed against this protein are non-neutralizing. Because of the strong 
immune response against this protein, this protein is incorporated in routine diagnostic 
assays evaluating PRRSV infection. In infected macrophages, PRRSV N protein is 
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distributed in the cytoplasm as well as nucleolus (153).  The reason behind N protein‟s 
nucleolar localization is not clear. Several hypotheses have been proposed, including: a 
cellular defense mechanism to sequester viral N protein from sites of virus replication, 
disruption of nucleolar proteome, recruitment of nucleolar proteins for viral propagation 
(153, 240). 
PRRSV life cycle inside the cell 
PRRSV exhibits a very narrow cell tropism typical of other arteriviruses. In infected 
animals, the virus preferentially infects highly differentiated macrophages in lungs, 
lymph nodes and placenta (47, 94, 145). The peripheral blood monocytes and peritoneal 
macrophages are refractory to infection. The in vitro studies involving PRRSV are mostly 
conducted in primary porcine alveolar macrophages (PAMs), which are also a major in 
vivo target. Besides PAM, monocyte derived macrophages, monocyte derived dendritic 
cells (DCs) and bone-marrow derived DCs are also susceptible to PRRSV infection in 
vitro. The monkey kidney epithelial cell MA-104 and its derivative (MARC-145) are the 
only continuous cell line available for propagation of PRRSV (85). This stringent cell 
tropism is most likely determined at the level of cellular entry mediator (receptors) level 
as several cell lines have the ability to support virus replication and assembly when the 
PRRSV genomic RNA is transfected into them. Several PRRSV cellular receptors have 
been identified suggesting different cells might use different receptors for virus entry. 
The receptors are- heparan sulfate, sialoadhesin, CD163, vimentin and CD151 (41-43, 86, 
165). Van Breedam et al.(204) in a recent review have proposed a working model of 
PRRSV entry by incorporating the major findings about PRRSV entry into macrophages. 
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Fig.1.2. Schematic representation of PRRSV replicative cycle inside the cell. After 
entry by receptor mediated endocytosis and uncoating (step 1), the (+) sense genomic 
RNA acts as mRNA for polyprotein translation (step 2). The polyprotein is processed into 
several nsps which are recruited to the membranous structures to form complexes for 
viral replication and transcription. The viral genomic RNA is replicated to form (–) sense 
genome (step 3) as well as transcribed to form (–) sense sg RNAs (step 4). The later then 
give rise to (+) sense sg RNAs which when translated form the different viral structural 
proteins (GP2a, GP3, GP4, GP5, M and N). The N protein and viral genomic RNA are 
assembled together with the different structural proteins in the ER and golgi complex 
(step 5). Budding of progeny virus occurs in intra cellular membranes in ER and Golgi 
complex (step 6) followed by release of virus by exocytosis. 
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As per the model the virus first comes in contact with the heparan sulfate glycans on the 
macrophage surface. Then this weak interaction is strengthened by interaction of viral 
GP5/M heterodimer with sialoadhesin molecule on macrophage. This is followed by 
internalization of the virus-receptor complex by clathrin-mediated endocytosis. 
Subsequently, virus is released into the cytoplasm, which requires CD163 and endosomal 
acidification by cytosolic enzymes. The CD163-GP2/GP4 interaction might be critical for 
this process. Once inside the cytoplasm the linear viral (+) strand RNA genome 
undergoes translation by the host translational machinery (Fig.1.2). This gives rise to 
pp1a or pp1ab polyprotein which are processed to form the mature nsps. These nsps 
include the viral RdRP, the helicase among others and are targeted to the modified 
membranous structures derived from ER, which are the site of PRRSV replication and 
transcription. The viral replicase complex then synthesizes genome length (-) strand RNA 
intermediates using the genomic (+) RNA as the template, a process named as 
replication. The (-) strand RNA template is further replicated to form more (+) strand 
RNA genomes. The (+) strand RNA is also used as a template by the polymerase to 
produce six nested set of sg RNAs, a process termed as transcription. These sub genomic  
RNAs contain a common 5‟ “leader” sequence (same as genomic leader, 191 nt in case of 
type II PRRSV) linked to different “body” segments from the 3‟ part of the genome (138, 
162). A number of models have been proposed to explain the generation of these sub 
genome length RNAs, which are common throughout Nidovirales order. Amongst those 
models, the one proposed by Sawicki and Sawicki (161) is widely supported and is 
described here (Fig.1.3). According to this model, the sg RNAs are derived from minus 
strand sg RNAs, which are produced through a process of discontinuous RNA synthesis 
14 
 
during replication process. The arterivirus genome has several conserved transcription 
regulatory sequences (TRSs), which precede each of the structural protein ORFs, termed 
“body TRSs” (139, 209). The 5‟ UTR of arterivirus also contains the same TRS labeled 
“leader TRS”. During transcription, when the replicase complex comes across a body 
TRS, the replication process is attenuated. Subsequently, the resulting (-) strand, which 
has the body TRS complement at its 3‟ end, is transferred to the 5‟UTR of the genome 
(Fig. 1.3). There, the body TRS complement forms a base pair with the leader TRS and 
then the polymerase restarts RNA synthesis finishing the complement of the 5‟UTR. The 
resulting minus sense sg RNA can then be used as a template for synthesis of various sg 
RNAs. During replication, there is no attenuation and a full-length (-) strand genomic 
RNA is produced. The sg RNAs are translated to form various structural proteins. Most 
envelope proteins are retained in the intracellular membranes after their synthesis. The N 
protein interacts with viral genomic RNA to form nucleocapsid complexes. Preformed 
nucleocapsid then buds through the smooth ER/Golgi complex and in the process 
acquires the lipid envelope. The exact mechanistic details of viral assembly are not 
known but GP5-M heterodimerization has been suggested as a trigger to initiate the 
process. Through a process of budding, the viral particles accumulate in intracellular 
vesicles, which are then released from the cell by exocytosis.  
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Fig.1.3. Model for arterivirus replication and sg RNA transcription. The top 
figure (replication) indicates the continuous synthesis of genomic (–) sense RNA from 
the genomic (+) sense RNA by viral polymerase complex. The leader TRS is indicated 
in blue rectangle and the various body TRSs are in green rectangles. The bottom 
figure (transcription) depicts the process of discontinuous transcription. In this process 
the viral replicase complex is halted at one of the body TRS. The exact signal (viral 
and cellular factors) that leads to this attenuation is not known. Subsequently the 
complementary element of body TRS (anti-body TRS, yellow rectangle) along with 
the nascent – sense RNA and replicase complex is transferred to the 5‟ UTR. There 
the anti-body TRS form complementary base pairs with leader TRS (in blue) followed 
by resumption of RNA synthesis and release of – sense sg RNAs. Adapted from (128). 
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Host factors in coronavirus (CoV) and arterivirus replicative cycle 
The limited genome coding capacity of viruses has forced them to develop sophisticated 
mechanisms for successful propagation. These mechanisms manipulate the host factors 
for their own benefits. There is an extensive body of literature about involvement of host 
factors in viral life cycle. The following is a brief overview of those host factors that have 
been implicated in viral replication among members of the Nidovirales order. The various 
methodologies used for identification of host factors involved in virus replication include 
genome-wide two-hybrid screenings, proteomic analyses etc. The host polypyrimidine-
tract binding (PTB) protein binds the leader TRS (TRS-L) and the N protein of mouse 
hepatitis virus (MHV) and is an important regulator of transcription (31, 101). Recently 
genomic and sg RNAs of another CoV, transmissible gastroenteritis virus (TGEV), were 
also found to interact with PTB and were relocalized to stress granules (178). This 
indicates a CoV-wide conserved role of PTB in viral transcription. The cellular 
heterogeneous ribonucleoprotein (hnRNP) A1 binds to the MHV TRS-L and TRS-B 
complementary sequences and has been suggested as a transcription factor in CoV RNA 
synthesis (102, 241). The hnRNP A1 also interacts with MHV 3‟UTR and participates in 
the formation of viral replication transcription complexes (76, 167). Other members of 
the hnRNP A2/B1 family can functionally substitute A1 in this process (168). The TGEV 
and bovine CoV 3‟ poly (A) tail interacts with cellular poly (A) binding proteins and 
positively contributes towards RNA replication (179, 181). The EAV nsp1 protein binds 
to the cellular transcriptional co-activator p100 which is speculated to be important for 
nsp1‟s role in sg mRNA synthesis (199). Same p100 also binds to the 3‟UTR of TGEV 
but the functional significance of this interaction is not known (55). The SARS-CoV 
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helicase (nsp13) interacts with a cellular helicase DDX5 and is important for viral RNA 
replication (28). Another helicase DDX1 interacts with exonuclease (nsp14) of SARS-
CoV and infectious bronchitis virus, and is a co-factor in viral transcription and 
replication (231). Altogether this list suggests the wide exploitation of cellular factors in 
viral life cycle.  
Viral pathogenesis in infected pigs 
Following exposure to PRRSV, virus replicates in local macrophages, from which it 
quickly spreads to lymphoid organs and lungs. Regardless of the route of infection (oro-
nasal, intransal or intramuscular), PRRSV primarily replicates in alveolar macrophages of 
lungs. Lungs and lymph nodes are the sites of highest viral load. Viremia generally lasts 
for 4 weeks with peak virus titers occurring between day 7-14 post infections.  The peak 
viral titer usually corresponds to the phase of clinical disease. PRRS presents a wide 
variety of clinical symptoms ranging from asymptomatic infection to lethal outcome [ 
reviewed in (243)]. Factors that influence clinical outcome are dependent on virus strain, 
host immune status, coexisting infections, and management of practice. After the viremic 
period, PRRSV persists in several tissues of lymphoid origin e.g. tonsils, lymph nodes for 
157days post infection (dpi) (3). Viral RNA has been detected up to 250 dpi (226). In 
most cases, the infection is cleared by 3 to 4 months. This infection does not bear the 
characteristics of true persistent infection but it is referred to as a smoldering infection 
(3). PRRSV infection in pregnant sows (primarily in third trimester of gestation) leads to 
late term reproductive failure. This is characterized by abortions with litters composed of 
fresh stillborn fetuses, partially or completely mummified fetuses, live but weak pigs 
(74). Acute infection in young or grower pigs is characterized by anorexia, lethargy, 
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cutaneous hyperemia, reduced weight gain and respiratory distress (dyspnea, hyperpnea, 
pneumonia). Infected boars show signs of anorexia, lethargy, lack of libido, respiratory 
clinical signs and have reduced semen quality.  
The molecular mechanisms behind the pathogenic outcome of PRRSV infection 
are not clearly understood. PRRSV replication induces both apoptosis of infected cells as 
well as of non-infected bystander cells. Such apoptosis can be detected in infected PAMs, 
pulmonary intravascular macrophages (PIMs) and other mononuclear cells in lungs and 
lymph nodes (171, 190). Apoptosis of infected testicular germ cells lead to severe 
depletion in their number and might result in reduced semen quality (189). PRRSV 
induction of apoptosis has also been verified in vitro in MARC-145 cells in which the 
intrinsic apoptosis pathway is activated late in viral infection cycle (98). At the same, 
time PRRSV also induces anti-apoptotic molecules early in infection (34). This is 
probably a mechanism to maximize viral growth before being released by apoptosis late 
in the infection. Induction of proinflammatory cytokines in infected cells can also result 
in a pathogenic outcome. Another possible pathogenic mechanism is PRRSV mediated 
killing of PAMs and PIMs. Besides direct killing, PRRSV infection also compromises the 
macrophage‟s ability to fight an infection. Both of these mechanisms can predispose the 
animal to secondary infections like Bordetella bronchiseptica, Streptococcus suis and 
porcine circovirus (2, 21, 50).  
Host immune response against PRRSV 
PRRSV infection of pigs involves a long period of acute infection (~ 1 month) followed 
by an extended persistent phase (~ at least 3-4 months or longer). Nevertheless, most 
infected pigs recover from infection at the end of the persistent phase. Moreover these 
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recovered pig exhibit solid protection against subsequent infection with the same 
(homologous) virus strain. This suggests that there is a delayed development of host 
adaptive immune response but once it is achieved in the convalescent animal, it confers 
solid homologous protection. However until now the correlates of protection have not 
been clearly identified. 
Innate immune response- 
One of the most notable features of PRRSV is its failure to up regulate inflammatory 
cytokine (IL-1, interferon (IFN)-γ and TNF-α) production during infection (196, 210). 
The type I IFN response is particularly meager. There is minimal IFN-α production after 
PRRSV infection of PAM cells in vitro as well as in the BAL fluid of infected pigs (1). 
Transcriptional profiling of PAM cells and monocyte-derived DCs infected with PRRSV 
showed higher level of IFN-β mRNA but not IFN-α mRNA (58, 110). Considering that 
IFN-β is the immediate early IFN, which subsequently drives IFN-α expression, PRRSV 
might be employing a post-transcriptional mechanism to inhibit IFN-α mRNA synthesis 
(58, 110). Such post-transcriptional blockage should be specific to IFN-α as PRRSV, 
unlike several other viruses, is not a generalized suppressor of host protein synthesis. The 
active suppression of type-I IFN by PRRSV appears to be mediated by its nsps (16, 29, 
140). These nsps seem to target different steps of the IFN induction and signaling 
pathways (described in detail in chapter 2 and 3). At the same time, PRRSV is highly 
susceptible to external IFN treatment (treatment of IFN-α/β of cells prior to PRRSV 
infection greatly reduces viral yield) (99, 136). The sensitivity of PRRSV to IFN effects 
vary among different virus isolates and some subtypes of IFN might be more effective in 
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controlling virus growth than others (99, 157). The next section briefly describes the IFN 
signaling after pathogen infection and its subversion by viruses.  
Several in vitro studies have shown that infection of porcine DCs (monocyte-
derived or bone marrow-derived) with PRRSV compromises many of their functions (26, 
52, 110, 217). For example, PRRSV infection induces apoptosis of DCs, down-regulates 
the expression of CD11b/c, CD14, CD80/86 co-stimulatory molecule, and MHC class I/II 
molecules (137, 217). Interleukin (IL)-10 levels ( mRNA and protein) in the infected DCs 
as well as in BAL fluids are increased after infection (195). Up-regulation of IL-10 may 
contribute to the reduced production of inflammatory cytokines as well as a weak Th1 
response. Based on these observations, IL-10 may be a component of PRRSV mediated 
pathogenesis. However, Subramaniam et al. (185) recently demonstrated that a virulent 
PRRSV strain (FL12) did not induce IL-10 in vitro and in vivo, suggesting IL-10 might 
not be a major factor in PRRSV virulence. PRRSV infection of lung DCs did not lead to 
productive infection, but caused down-regulation of MHC class I expression. Treatment 
of infected cells with exogenous IFN-α actually restored the MHC class I expression and 
enhanced CD80/86 expression (110). Thus, a better IFN response might lead to optimal 
functioning of the DCs in PRRSV infection. However, it is not clear whether PRRSV 
directly infects DCs in vivo. 
Host type I interferon response  
The innate immune response constitutes the first line of host defense against pathogen 
infection. Its primary objective is to limit pathogen spread until the development of 
specific adaptive immune response. Type I IFNs are key innate immune molecules that 
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help in establishment of an antiviral state that has the potential to severely limit viral 
replication. In addition, IFNs promote adaptive immune responses as mentioned below. 
Nucleic acids or proteins from the pathogens, defined as pathogen associated 
molecular patterns (PAMPs), are recognized by Toll-like receptors (TLRs) present on the 
plasma membrane or endosomal membrane of specific cell types (mostly antigen 
presenting cells, APCs). Besides TLRs, two other group of sensors: Retinoic acid-
inducible gene-I (RIG-I) like receptors (RLRs) and nucleotide-binding oligomerization 
domain (NOD)-like receptors (NLRs) also exist in the cytoplasm of most cell types. The 
three members of the RLR family are- RIG-I, melanoma differentiation-associated gene 5 
(MDA5), laboratory of genetics and physiology 2 (LGP2) and all of them recognize viral 
RNAs. Most NLR family members are involved in sensing of bacterial products. These 
receptors, upon ligation of the different PAMPs, initiate a complex signaling cascade 
which leads to transcription of IFN-β. Below is a brief outline of the signaling pathway 
ensued after TLR3/RIG-I receptor activation, as these two are common sensors for viral 
dsRNA, a molecule produced during replication of positive sense RNA viruses like 
arteriviruses (Fig.1.4). Various signaling pathways involved in type I IFN synthesis have 
been reviewed recently (82, 149) 
TLR3, which resides in the endosome, upon recognizing dsRNA recruits an 
adaptor protein called TRIF (Fig.1.4). TRIF subsequently recruits two different kinase 
complexes that ultimately activate two transcription factors, interferon regulatory factor 3 
(IRF3) and nuclear factor -κ B (NF-κB). The first kinase complex includes TNF receptor 
associated factor 3 (TRAF-3), TRAF family member associated NF-kB activator 
(TANK), TANK-binding kinase-1 (TBK-1) and inhibitor of kB kinase (IkB) ε (IKKε). 
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TRAF3 helps in activation of the two kinases TBK-1 and IKKε which in turn 
phosphorylate and activate IRF3. The members of the second kinase complex are: TRAF-
6, receptor interacting protein 1(RIP-1), NF-kB essential modulator (NEMO), TGF-β 
activated kinase 1 (TAK-1), IKKα, and IKKβ. TAK1 activates the IKK complex 
composed of IKKα, IKKβ and NEMO (IKKγ), which consequently phosphorylates IκB 
proteins. Phosphorylated IκB proteins are degraded by proteasome, allowing release of 
NF-κB from the complex. RIG-I upon activation recruits mitochondrial antiviral 
signaling adapter (MAVS) (fig.1.4). Then MAVS engages the TRAF3 kinase complex as 
described above for TLR3. Activated IRF3 and NF-κB translocate to the nucleus where 
they bind to the IFN-β promoter and became a part of the multiprotein “enhanceosome” 
complex that drives IFN-β transcription. The mRNAs of the immediate early IFN (IFN-β 
and α4) are translated and the proteins are secreted. The secreted IFNβ/α4 then binds to 
the homodimeric IFN-α receptor (IFNAR) present on the surface of same or adjacent 
cells. This leads to recruitment of janus kinase 1 (JAK-1) and tyrosine kinase 2 (TYK-2) 
to the cytoplasmic domain of IFNAR. These kinases in turn phosphorylate the key 
transcription factors signal transducers and activators of transcription (STAT) 1 and 2, 
which together with IRF-9 form the IFN-stimulated gene factor 3 (ISGF3) complex.  
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Fig.1.4. Schematic of the signaling pathway triggered by dsRNA. TLR3 present in 
the endosome recognizes viral dsRNA. This leads to TLR3 dimerization and 
recruitment of the TRIF adaptor through TIR domain. TRIF then assembles two 
different groups of kinases. The first group involving TRAF6, RIP1, TAK1, NEMO, 
IKK α/β helps in phosphorylation of IκB, which leads to its proteasomal degradation. 
Then NF-κB subunits are released and translocate to the nucleus to induce IFN-β 
transcription. Members of the other kinase family are- TRAF3, TBK1 and IKKε 
which phosphorylate IRF3 resulting in its dimerization and nuclear translocation to 
drive IFN-β transcription. RIG-I/ MDA-5 present in cytosol recognizes dsRNA 
through their CARD domains. This leads to recruitment of a mitochondria-associated 
adaptor MAVS which then triggers the TRAF3 dependent IRF3 activation.  
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This complex then translocates to the nucleus, where it drives expression of other 
IFN sub-types and hundreds of interferon stimulated genes (ISGs). These ISGs employ a 
variety of mechanisms (inhibition of protein synthesis, ISGylation, RNA degradation etc) 
to enforce an antiviral state and limit viral replication. Type I IFNs have strong 
immunomodulatory roles that affect development of adaptive immune response (95). 
These effects include: stimulation of MHC class I molecule expression, activation of 
natural killer cells, maturation of dendritic cells, sustaining proliferation of antigen-
specific CD8+ T-cells, and induction of  IL-15 production by APCs. Considering their 
broad roles in host immune response, it would be ideal to have a functional IFN response 
to induce a robust pathogen-specific adaptive immune response.  
To face this highly effective antiviral response, most viruses encode genes that 
deactivate specific arms of the innate immune response. Mostly these mechanisms 
involve one or more viral proteins actively suppressing IFN response. Versteeg et al. 
(214) has recently categorized these strategies into four different categories: (i) general 
inhibition of cellular gene expression (as found in vesicular stomatitis virus, polio virus 
and bunyaviruses), (ii) sequestration of molecules in the IFN circuit (sequestration of 
dsRNA by vaccinia virus E3L, influenza NS1, ebola virus VP35 etc) (iii) proteolytic 
cleavage of innate immune components (MAVS cleavage by hepatitis C virus), (iv) 
proteasomal degradation of signaling components (degradation of IRF3 by bovine viral 
diarrhea virus and BHV-1). The viral antagonism of type I IFN response has been 
extensively reviewed in following references (149, 214). 
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Humoral immune response- 
Pigs infected with PRRSV develop a rapid antibody response against the virus, which can 
be detected as early as 5 days post infection (PI) (130, 236, 238). Most animals 
seroconvert by 14 days PI. The acute viral load has been proposed to dictate the 
magnitude of this antibody response. However, most of these antibodies are non-
neutralizing and are directed against viral N and M proteins. The ineffectiveness of these 
antibodies is further demonstrated by co-existence of antibody and virus in the serum of 
infected pigs. The neutralizing antibodies (NAbs) appear at about 4 weeks PI (109). The 
time of their appearance and titer vary among animals and also depends on the PRRSV 
strain used for infection (238). There is also some evidence that PRRSV-specific 
antibodies (directed against GP5, M, and N proteins) may enhance viral infection, a 
phenomenon termed as antibody-dependent enhancement (ADE) (23, 237). In ADE, sub-
neutralizing concentrations of virus-specific antibodies deliver the virus to APCs, which 
results in further amplification of virus replication. It is not clear whether ADE is a 
relevant mechanism for PRRSV virulence. 
 Whether NAbs confer protection was initially questioned, however subsequent 
works have validated the importance of these in PRRSV clearance. Osorio et al. 
demonstrated that passive transfer of NAbs to PRRSV-free pregnant sows could protect 
against an abortifacient PRRSV strain (134). More importantly, the NAbs can be 
transferred from sows to their offspring through milk and can confer sterilizing 
immunity. A NAb titer of 1:8 in the peripheral blood protects piglets against viremia 
while a circulating NAb titer of 1:32 is required to confer sterile immunity to at least 50% 
of pigs after challenge (108). Most structural components of the virion produce 
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antibodies. The N-specific antibodies are non-neutralizing. Antibodies against GP3, GP4, 
GP5 and M protein possess the neutralizing activity (122, 135). GP4 of Lelystad virus 
(the prototypic genotype I strain) contains a neutralizing epitope, but the core sequence is 
not well conserved (122). Vanhee et al (212) has recently identified an antigenic region in 
GP3 that induces NAbs at least in three different type I strains including Lelystad virus. 
GP5-neutralizing epitopes of both European and North American PRRSV have been 
identified in the N-terminal ectodomain of GP5 (61, 143, 222, 228). Two epitopes (A and 
B) within the ectodomain of GP5 of type II strain have been well characterized (135). 
Epitope A is highly immunogenic but antibodies against it are non-neutralizing. In 
contrast, epitope B is located 7 aa downstream of epitope A and is neutralizing: but 
epitope A is not immunodominant. It is possible that epitope A may function as a “decoy 
epitope” that interferes with the immune response to epitope B. This phenomenon might 
explain the delayed NAb response. However the prolonged persistence of virus even after 
induction of NAbs suggests that PRSSV has developed other evasion measures. One such 
measure might be “glycan shielding”, a phenomenon well described in human 
immunodeficiency virus infection (221). PRRSV GP5 and GP3 use their N-linked glycan 
residues to prevent neutralization by glycan shielding (6, 215). 
Cellular immune response- 
The area of “cell-mediated response against PRRSV” is not very well explored. The total 
CD8+ T cell numbers in the lung either remain low or increase substantially following 
peak in viral replication (93, 156). This antigen-specific proliferation response was first 
detected in peripheral blood at 4 weeks PI, peaked at 7 weeks, but then declined to 
undetectable levels at 11 weeks PI (11, 107). T-cell proliferation measured by IFN-γ and 
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IL-2 expression has been detected between 4 to 12 weeks after infection. However the 
IFN-γ produced is ineffective in reducing the infection, although in vitro, pre-treatment of 
IFN-γ in susceptible cells results in significant lower levels of virus yield (12, 152). 
Meier et al. (118) reported that IFN-γ- secreting cells were not detected until 8-10 weeks 
PI and the frequency of these cells gradually increased until 48 weeks PI and remains 
stable until 690 days PI. When compared to a pseudorabies virus infection, levels of IFN-
γ secreting cells are lower and their development is delayed in PRRSV infection. The T-
cell responses are directed against GP2, GP3, GP4, GP5, M and N protein (these are the 
only proteins tested) (13). The response against M protein was most potent. For most 
proteins, T-cell epitopes have not been characterized. Recently. Vashisht et al. (213) and 
Wang et al. (218) have identified immunodominant T-cell epitopes in GP5 and M 
proteins, which are conserved across type II genotypes. 
In summary, PRRSV employs diverse mechanisms to down regulate the host‟s 
innate immune response, which interfere with the development of adaptive immune 
responses. Consequently, the virus is not efficiently cleared. Even when a humoral 
response is developed, PRRSV targets the host neutralizing antibody response by glycan 
shielding of potential neutralizing epitope and diverts the antibody response towards a 
decoy epitope. Though all of these constitute the viral survival strategies, PRRSV is 
ultimately eliminated from the body. However, what factors contribute to this eventual 
elimination of virus is not known 
Scope and outline of this dissertation 
Type I IFNs are central to the innate immune response following infection by an 
intracellular pathogen. Virtually all viruses identified to date encode for one or more IFN 
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antagonists to circumvent this antiviral response. These molecules not only contribute to 
the pathogenesis of the virus but also are important for efficient replication in the natural 
host. PRRSV infection displays all the hallmarks of active suppression of host innate 
immune response. Chapter 2 explores the role of PRRSV nsps in antagonizing host type I 
IFN production. At least five nsps were identified to exhibit measurable suppression of 
IFN-β transcription. The IFN-inhibitory effect of nsp1β was the strongest and hence was 
characterized in greater detail. These studies were carried out in an over-expression 
system and hence are open to the questions of whether IFN-suppression activity of nsp1 
is relevant in the context of virus infection. The availability of a reverse genetics system 
for PRRSV allowed us to answer that. Chapter 3 establishes the anti-IFN property of 
nsp1β in the framework of PRRSV infection. The amino acid residues important for 
nsp1α and nsp1β‟s anti-IFN activity were identified by alanine mutagenesis. Selected 
mutations were incorporated into the PRRSV full length infectious clone and viruses 
were recovered. A more detailed analysis of a mutant displaying growth attenuation and 
increased type I IFN synthesis in infected macrophages is presented. While our results 
from chapter 2 informed us about the precise step of IFN synthesis that is targeted by 
nsp1β (IRF3 phosphorylation and nuclear translocation), we were unable to find out the 
exact mechanistic details of this inhibition. This led us to perform a co-
immunoprecipitation coupled mass spectrometry experiment with nsp1β as bait to 
identify its cellular interaction partners. The aim was to focus on any cellular interaction 
partner of nsp1β, which is part of the IFN circuit. While we did not identify any such 
protein, we detected several interesting proteins involved in RNA metabolism. The nsp1β 
of PRRSV and nsp1 of EAV were known to be important for viral RNA transcription. 
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Consequently, we focused on two cellular RNA-binding proteins- poly (C) binding 
protein 1 and 2 (PCBP1 and PCBP2), which were known to be important for the 
replication of other RNA viruses. Chapter 4 describes the characterization of nsp1β‟s 
interaction with PCBP1 and PCBP2, their association with viral replication-transcription 
complex (RTC) and importance of both proteins in viral replication. Besides nsp1β, the 
PRRSV RdRp (nsp9) was found to interact with PCBP1 and PCBP2. In virus-infected 
cells, both PCBPs relocalize to the viral RTC and moreover they both bind to the viral 
5‟UTR in vitro. Finally, we show that both PCBP1 and PCBP2 are important for viral 
genome replication but do not affect viral protein synthesis. 
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CHAPTER II 
 
Porcine reproductive and respiratory syndrome virus non-structural 
protein 1β modulates host innate immune response by antagonizing 
IRF3 activation  
 
 
This work was published in Journal of Virology, 2010, Vol. 84 No.3, p 1574-1584 
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Abstract 
Porcine reproductive and respiratory syndrome virus (PRRSV) infection of swine leads to 
a serious disease characterized by delayed and defective adaptive immune response. It is 
hypothesized that a suboptimal innate immune response is responsible for the disease 
pathogenesis. In the study presented here we tested this hypothesis and identified several 
non-structural proteins (nsps) with innate immune evasion properties encoded by the 
PRRS viral genome. Four out of the total 10 PRRSV nsps tested were found to have 
strong to moderate inhibitory effects on IFN-β promoter activation. The strongest 
inhibitory effect was exhibited by nsp1 followed by, nsp2, nsp11 and nsp4. We focused 
on nsp1α and nsp1β (self-cleavage products of nsp1 during virus infection) and nsp11, 
three of the nsps with strong inhibitory activity. All three proteins, when expressed stably 
in cell lines, strongly inhibited dsRNA signaling pathways. Nsp1β was found to inhibit 
both IRF3 and NF-κB dependent gene induction by dsRNA and Sendai virus. 
Mechanistically, the dsRNA-induced phopshorylation and nuclear translocation of IRF3 
was strongly inhibited by nsp1β. Moreover, when tested in a porcine myelomonocytic 
cell line, nsp1β inhibited Sendai virus mediated activation of porcine IFN-β promoter 
activity. We propose that this nsp1β-mediated subversion of the host innate immune 
response plays an important role in PRRSV pathogenesis. 
 
Key words: PRRSV, Arteriviruses, PRRSV nsps, innate immunity, IRF3 
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Introduction 
Porcine reproductive and respiratory syndrome virus (PRRSV) is a member of 
family Arteriviridae which, along with the Coronaviridae, are classified in the order 
Nidovirales (24). PRRSV is an enveloped, single stranded RNA virus with positive-sense 
genome of approximately 15 Kb. The genome has 10 open reading frames (ORFs), 
namely, ORF1a, ORF1b, ORF2a, ORF2b, ORF3-7 and the newly identified ORF5a. 
ORF1a and ORF1b are synthesized as a single polyprotein and later processed to 14 
different non-structural proteins (nsps) e.g. nsp1α, nsp1β, nsp2 to nsp12 by the viral 
proteases. Nsp1α, nsp1β, nsp2 and nsp4 are the viral proteases which carry out this 
function.  The viral genome replication and transcription is carried out by nsp9 which 
encodes the viral RNA-dependent RNA polymerase, and nsp10 which encodes a helicase 
(10, 175).  
The ailment caused by PRRSV is considered to be the most economically 
significant infectious disease of swine worldwide. It causes an annual loss of 
approximately $560 million in the US (132). The clinical signs of PRRSV infection 
include late-term reproductive failure in sows and respiratory illness in growing pigs. 
Most cases of PRRSV infection in pigs are complicated by secondary opportunistic 
bacterial infections, which have been attributed to the immunosuppressive nature of the 
virus (50). Upon initial virus infection, viremia lasts for a few weeks after which it gets 
resolved. However, the virus can be detected in secondary lymphoid organs for several 
months indicating failure of host immune response to clear the virus (3).  
The immune response to PRRSV infection is characterized by delayed appearance 
of neutralizing antibodies (109), short duration of cell-mediated immune response (117, 
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230) and slow development of virus-specific interferon γ (IFNγ) response (118). We and 
others have identified various factors which are likely to play multiple roles in delayed 
clearance of PRRSV from the host. These include weak innate immune response (1), 
presence of decoy epitopes (135) and glycan shielding of envelope proteins (6). Previous 
studies have shown that very low or negligible levels of IFN-α are produced upon 
PRRSV infection in pulmonary alveolar macrophages (PAMs) and PRRSV permissive 
monkey kidney cells (MARC-145) in vitro(1, 123). IFN-α production in the lungs of pigs 
acutely infected with PRRSV was either almost undetectable or 100 to 200 fold lower 
than that induced by porcine respiratory coronavirus (PRCV) (22, 210). PRRSV has also 
been found to suppress IFN-α production by transmissible gastroenteritis corona virus 
(TGEV) – a known inducer of IFNs in infected alveolar macrophages (1).  At the same 
time, externally provided IFN-α or IFN-β have been able to reduce viral replication in 
cultured alveolar macrophages (1, 136). The virus was also found to inhibit the dsRNA-
mediated up-regulation of IFN-β gene transcription (123). A microarray analysis of 
PAMs infected with Lelystad virus (European type PRRSV) showed no significant 
change in the IFN-α from the control at 12 h post infection (58). Considering the broad 
role of IFNs in establishing an effective adaptive immune response, we hypothesize that 
the suboptimal induction of type I IFN may be one of the determining factors in deficient 
development of acquired immunity.  
In the constant struggle to outsmart the host, viruses have developed strategies to 
evade and/or inhibit key elements of host immune response. Sometimes a substantial part 
of the viral genome is dedicated to suppress IFN signaling pathways, IFN stimulated 
genes (ISG) functions or pathways for RNA processing and translation (19, 57). In this 
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study we sought to identify the PRRSV proteins that are responsible for mediating the 
inhibition of IFN production. We observed that several PRRSV nsps inhibit IRF3 
mediated activation of IFN-β promoter. Detailed investigation of the mechanism of 
inhibition of one of those viral proteins, nsp1β, that it inhibits dsRNA-mediated IRF3 
phosphorylation and nuclear translocation.  
Materials and methods 
Cells and viruses-HEK293-TLR3 (Invivogen), Hela (ATCC), HT1080 (ATCC), MARC-
145 (obtained from Dr. Will Laegreid, USMARC, USDA/ARS)(85), ST (ATCC), cells 
were maintained in DMEM containing 10 % fetal bovine serum and 50 μg/ml of 
gentamicin (Sigma). HEK293-TLR3 and HT1080 cells stably expressing PRRSV nsp1α, 
nsp1β and nsp11 were established by co-transfecting them with corresponding PRRSV 
protein expression plasmid and pBabePuro. Following selection with 1 μg/ml of 
Puromycin (Mediatech), individual colonies were picked and screened for stable 
expression of PRRSV nsps. For swine macrophage experiments mononuclear cells were 
isolated from blood of donor pigs by Ficoll density centrifugation using Lymphocyte 
separation medium (110) (Mediatech). These cells were then plated in a glass petridish 
for one day followed by washing with PBS to enrich the monocytes.  The attached 
monocytes were cultured in RPMI 1640 medium supplemented with 10% BVDV-free 
fetal bovine serum in presence of growth factor macrophage colony stimulating factor  (5 
ng/ml) (Sigma) for 7 days for maturation into macrophages. These monocyte derived 
macrophages were then harvested by cell dissociation buffer (Gibco) and plated in 
appropriate tissue culture plate with RPMI 1640 and 10% FBS for virus infection. 
Porcine monocytic cell line 3D4/31 (ATCC) was maintained in RPMI 1640 medium 
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supplemented with 10% BVDV-free fetal bovine serum and 50 μg/ml of gentamicin 
(Sigma). Highly virulent North American PRRSV strain FL12 (202) was propagated in 
MARC-145 cells to prepare the virus stocks for this study. TGEV (Purdue strain)(1) was 
obtained from Veterinary Diagnostic Center (University of Nebraska, Lincoln) and 
propagated in ST cells to prepare the virus stocks for infection in macrophages. Sendai 
virus (Cantell strain) was obtained from Charles River Laboratories and was used as 
described below. 
Reporter assays- IFN-β-CAT assays were performed in Hela cells transfected with 1 μg 
of IFN-β-CAT reporter plasmid, 0.5 μg of IRF3 plasmid (Dr. Luwen Zhang, Univ. of 
Nebraska) and 1 μg of indicated viral protein coding plasmid using Lipofectamine-2000 
(Invitrogen) as per the manufacturer‟s instructions. Forty hours post-transfection, cells 
were lysed by freeze thawing and Chloramphenicol Acetyl Transferase (CAT) assay was 
performed as described earlier (155). CAT activity is expressed as fold induction relative 
to the empty vector control. A minimum of three independent experiments were 
performed to confirm the results. For ISG56-Luciferase reporter assays, HEK293-TLR3 
cells were transfected with 0.4 μg of ISG56-Luciferase reporter plasmid and 10 ng of 
pRL-TK (Promega) along with indicated protein expression vectors using Fugene 6 
(Roche Applied Science) as per manufacturer‟s protocol. For NF-κB Luciferase assays 
HEK293-TLR3 cells were transfected with 0.5 μg of 5X-NF-κB-Luciferase reporter 
plasmid (172) and 25 ng of pRL-TK (Promega) along with indicated protein expression 
vector using Fugene 6 as described above. Twenty four hour post transfection the media 
was replaced with fresh media. At 40 h post transfection, cells were either treated with 10 
μg/ml of poly (I): poly (C) (GE Health Care) or PBS for 6 h and Luciferase assays were 
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performed (Dual Luciferase assay kit, Promega). For Porcine IFN-β-Luciferase assay 
3D4/31 cells were transfected with 0.4 μg of porcine IFN-β-luc plasmid and 10 ng of 
pRL-TK (Promega) along with indicated protein expression vectors using Ingenio 
electroporation solution (Miru Bio) in an Amaxa Nucleofector (Lonza) as per 
manufacturer‟s instruction. Then 40 h post transfection cells were either mock infected or 
infected with Sendai virus (Cantell strain) for 8 h, after which cells were lysed and 
luciferase assay was performed. Firefly Luciferase activities were expressed in terms of 
fold change with respect to controls after normalizing with Renilla Luciferase activities.  
Real time PCR and ELISA- Total RNA was isolated from cells using Trizol 
(Invitrogen) reagent and complementary DNA (cDNA) was prepared by using M-MLV 
reverse transcriptase (Invitrogen). This cDNA was used for quantification of the indicated 
mRNA copy number by using Smartcycler (Cepheid). Porcine IFN-α, β and β-actin 
(internal control) real time PCR was performed using a TaqMan probe based method. 
Human interleukin-8 (IL-8) and human ribosomal protein L32 (RPL32, internal control) 
copy numbers were calculated by SYBR-green based quantitative PCR (qPCR). 
Following primer sets, and where indicated, probes were used in the real-time PCR 
reactions. For porcine IFN-α, forward-5‟ AGAGCCTCCTGCACCAGTTCT3‟, reverse-
5‟CTGCATGACACAGGCTTCCA3‟,probe- 
5‟ACTGGACTGGATCAGCAGCTCAGGGA3‟; for porcine β-actin, forward-
5‟CTCCTTCCTGGGCATGGA3‟, reverse-5‟CCACGTCGCACTTCATGATC3‟, probe-
5‟TGCGGCATCCACGAGACCACCT3‟; for human IL-8, forward- 
5‟TAGCCAGGATCCACAAGTCC3‟, reverse-5‟GCTTCCACATGTCCTCACAA3‟. 
Primer and probe sequences for swine IFN-β (58) and human RPL-32 (111) were 
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mentioned earlier.  IFN-α, IFN-β and IL-8 mRNA levels in virus-infected or poly 
(I):poly(C) stimulated cells were expressed in copy numbers relative to mock infected or 
un-stimulated cells as per the method described earlier (184). The porcine IFN and 
human IL-8 mRNA levels were normalized across the experiments using porcine β-actin 
and human RPL-32 levels respectively. Porcine IFN-α protein levels were measured by 
ELISA using F17 monoclonal antibody (mAb) (PBL Biomedical Labs) and peroxidase-
conjugated K9 mAb (PBL Biomedical Labs) as coating and detection antibody 
respectively as described previously (99). Briefly, Flat-bottomed 96-well plates were 
coated overnight at 4 °C with F17 at a concentration of 2 µg/µl in bicarbonate coating-
buffer (pH 9.6). After blocking with 1% BSA, for 1 h at 37 °C, the plates were washed 
three times with 0.05% Tween 20 in PBS. Samples (100 µl) were added into each well 
and incubated for 4 h at 37 °C. Following three washes, 100 µl of peroxidase-conjugated 
K9 at a concentration of 0.5μg/ml, was added to each well. After 2 h incubation and three 
washes, 100 µl of tetramethylbenzidine (TMB) substrate solution was added for 30 min, 
the reaction was stopped with 1 N HCl and the optical density was measured at 450 nm 
wavelength by an ELISA plate reader (Bio-Tek). Quantified recombinant porcine IFN-α 
(R&D systems) was used as a standard, and IFN-α concentrations were calculated based 
upon a standard curve. 
Immunoblotting- For immunoblotting, cells were washed twice with PBS and then 
pelleted by centrifugation. In case of isolation of nuclear fraction, these pellets were 
processed as described previously (159). For whole cell protein extraction, PBS washed 
cell pellets were resuspended in lysis buffer (20 mMTris (pH7.5), 150 mMNaCl, 1 mM 
EDTA, 1 mM EGTA, 1% Triton X-100, 2.5mM sodium pyrophosphate, 1 mM β-
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glycerophosphate, 1 mM sodium orthovanadate and complete protease inhibitor 
(Roche)). The Cell suspension was incubated on ice for 15 min followed by clarification 
by centrifugation at 17000 G at 4°C for 10 min. Total Protein concentrations in the 
supernatants were quantified by using Bradford Assay kit (BioRad). Equal amounts of 
total protein were separated by SDS-PAGE, transferred to PVDF membrane and probed 
with appropriate antibodies. Protein bands were detected using ECL detection system 
(Pierce).  
Plasmids and Antibodies-All PRRSV (FL-12 strain) nsps were amplified by using 
pFL12 (Truong et al., 2004) as template and the primers as listed in Table 1. Since the 
exact site of cleavage between nsp1α and nsp1β is not known, the putative cleavage site 
(nucleotide (nt) 678-692) was included in both expression constructs. Nsp1α and nsp1β 
expression constructs contain FL12 (GenBank accession number AY545985) coding 
sequence from nt 192 to 710 and nt 651 to 1340 respectively. They were cloned into a 
mammalian expression vector pIHA-FLAG, which was derived from pHyg-EGFP 
(clontech) by removing the Hygro-EGFP part and inserting an oligo containing 5‟ FLAG 
epitope tag and few restriction enzyme sites to enable expression of N-terminal FLAG-
tagged gene. Nsp1β was cloned in the same vector but with an N-terminal HA tag.  
Porcine IFN-β-luciferase plasmid was constructed by placing porcine IFN-β promoter 
(from nt -281 to +19, the +1 position refers to the transcription start site of swine IFN-β 
gene GenBank accession number M86762.1) upstream of the firefly luciferase gene in 
pGL3 basic vector (Promega). pIFN-β-CAT(155), pISG56-luc (159), p5X- NF-κB-
Luciferase,  pEFBOS-N-RIG-I (186), pmyc-IKKε(192), pHA-TRIF (79), pCMV2C-
bICP0 (155) were described previously. Immunoblotting and indirect 
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immunofluorescence were performed using the following antibodies: Anti-FLAG M2 
mAB (Sigma), anti-HA mAb (Covance), anti-β-actin mAb (Santa Cruz Biotech), rabbit 
anti IRF3 polyclonal antibody (pAb) (obtained from Dr Michael David, UCSD), rabbit 
anti-ISG56 pAb(63), anti-IRF3-p396 mAb (Cell Signaling), rabbit anti-DRBP76 (159), 
anti-tubulin mAb (Santa-Cruz Biotech), Peroxidase-conjugated goat anti- mouse and goat 
anti-rabbit pAbs (KPL). Protein bands were visualized by ECL plus western blotting 
detection reagent (Pierce), followed by exposure to X-ray film. 
Indirect Immunofluorescence- Cells grown in coverslips were treated as indicated, 
washed with PBS twice and then fixed with 4% paraformaldehyde for 20 min at room 
temperature. After two washes in PBS cells were then permeabilized with 0.2% Triton X-
100 for 15 min and blocked in PBS containing 3% bovine serum albumin (BSA), 5% 
Glycine, 10% non-immune horse serum and 0.05% Tween 20 for 2 hrs at room 
temperature. Then the coverslips were incubated with a rabbit polyclonal antiserum 
against human IRF3 (1:500), or with anti-HA tag mAb (1:1000), in the same blocking 
buffer at 4°C overnight. Following three PBS washes, cover slips were incubated with 
Alexa-Fluor 568 Donkey anti-mouse (Invitrogen) and Alexa-Fluor 488 Goat anti-rabbit 
(Invitrogen) antibodies at room temperature for 1 hr. Coverslips were washed and 
treataed with  4, 6-diamidino-2- phenylindole (DAPI, to view the nuclei) (Sigma) 
followed by washing. Then the coverslips were mounted in aqueous mounting medium 
(Sigma) and observed under Olympus FV500/IX81 inverted confocal microscope. 
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Results 
PRRSV inhibits type I IFN induction. PRRSV has been found to inhibit IFN induction 
(1, 99, 123). In order to confirm and characterize this feature of PRRSV in a well-known 
model, we used our well characterized, infectious clone-derived PRRS virus strain, FL12 
(92, 202) corresponding to a highly virulent North American PRRSV strain (NVSL # 95-
7895). The FL12 virus strain has been extensively used in our laboratory for studies on 
virulence and immune response in infected animals (6, 38, 92, 202). The FL12 strain was 
used at a multiplicity of infection (moi) of 1.0 to infect macrophages derived from 
monocytes isolated from peripheral blood mononuclear cells of healthy pigs. 
Transmissible gastroenteritis virus (TGEV), a well-known inducer of type I IFN was used 
as a positive control for type I IFN induction. As shown in Fig. 1, very little or no IFN-α 
(Fig. 2.1A) or IFN-β mRNA (Fig. 2.1B) were detected in the cells infected with PRRSV 
whereas TGEV infection showed strong induction of IFN-α and IFN-β mRNA in the 
same type of cells  at both 9 and 18 h post infection (PI). This observation was confirmed 
at the protein levels by measuring porcine IFN-α in infected cell culture supernatants by 
ELISA (Fig. 2.1C).  Productive PRRSV infection in these cells was confirmed by 
immunofluorescence conducted at 24 h PI using monoclonal antibody SDOW-17, which 
is specific for PRRSV nucleocapsid protein (data not shown). Similar differences in the 
type I IFN induction were observed between PRRSV and TGEV infections in pulmonary 
alveolar macrophages, obtained from lung lavage of adult animals (data not shown). 
Several of the PRRSV nsps exhibit strong to moderate inhibition of IFN-β promoter 
activation. Viruses have been known to code for proteins that antagonize type I IFN 
response (19). It has been hypothesized that the poor induction of type I IFN by PRRSV 
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may be an active pathogenic process triggered by the virus when infecting the host (1). 
To investigate the role of PRRS viral proteins in active IFN antagonism, we focused on 
nsps of PRRSV. Nsps comprise almost 80% of the PRRSV genome coding capacity.  All 
the PRRSV nsps, except nsp6 (a very short peptide of 16 amino acids long) derived from 
viral genome (FL12 strain), were cloned as N-terminal tagged fusion protein in a 
mammalian expression vector and verified for expression by transient transfection and 
immunofluorescence in HeLa cells. We were able to obtain suitable expression levels for 
10 nsps. We failed to achieve high level expression for nsp3, which may be due to its 
instability when expressed alone, as it has been most often reported to be part of 
polyprotein complex consisting of other nsps in case of equine arteritis virus (EAV), the 
prototypic family member of Arteriviridae(148). Each of these nsp constructs were co-
transfected into HeLa cells along with IRF3 and human IFN-β-CAT constructs, and CAT 
assays were performed. As shown in Fig. 2A, IFN-β promoter activation by IRF3 was 
suppressed to varying degrees by nsp1, nsp2, nsp4 and nsp11. Nsp1 exhibited the 
strongest inhibitory effect, followed by others (Fig. 2.2A).  Bovine herpes virus protein 
bICP0 was used as a positive control which is known to inhibit IFN-β promoter induction 
by IRF3 (155). This result suggested that several of the PRRSV nsps are capable of 
suppressing IFN-β promoter activation. To confirm this inhibition of IFN-β promoter 
activation, we co-transfected increasing concentrations of each of the corresponding nsp 
plasmids into HeLa cells using the same assay. Fig. 2.2B shows the dose-dependent 
inhibition of IFN-β promoter activity with increasing concentrations of nsps (Fig. 2.2B 
bottom panel).  
42 
 
PRRSV nsp1 and nsp11 inhibit IRF3-mediated gene induction. Viral nucleic acids 
are detected by the host innate immune system using toll-like receptors (TLR) and RIG-
like receptors (RLR). One such unique nucleic acid is double stranded RNA (dsRNA) – a 
common byproduct or intermediate in viral genome replication. In mammals, Toll-like 
Receptor 3 (TLR3), Retinoic acid inducible gene I (RIG-I) and melanoma differentiation-
associated gene-5 (MDA5) are the three known sensors of dsRNA. Engagement of TLR3 
or RLR with dsRNA induces signaling cascades leading to the activation of multiple 
transcription factors such as NF-κB and IRF3. These activated transcription factors 
induce expression of a set of cytokine genes, among which are type I interferons (IFN) – 
the hallmark of the anti-viral response. Interferons signal via cell surface receptors and 
regulate many genes (Interferon stimulated genes, ISG) which sensitize cells for detection 
of invading pathogens, inhibit protein synthesis and limit viral replication (160). We used 
dsRNA mediated TLR3 activation and IFN induction as a model system to understand 
the mechanism of IFN antagonism by PRRSV nsps. We decided to focus on nsp1 and 
nsp11 since they consistently exhibited the strong inhibition property (Fig. 2.2B). Nsp1 is 
proteolytically processed during the infection by its own papain-like protease domain into 
nsp1α and nsp1β. Therefore, the three proteins (nsp1α, nsp1β and nsp11) were tested for 
their IFN antagonistic activity using an ISG56-Luciferase reporter assay. Unlike a 
complex promoter such as IFN-β, the ISG56 promoter has a simpler structure, and can be 
activated by IRF3/IRF7. HEK293 cells stably expressing human TLR3 (HEK293-TLR3), 
were used in order to focus on the TLR3-IRF3 arm of the dsRNA signaling pathway. 
These cells were co-transfected with the nsp expression constructs ISG56-Luciferase and 
Renilla-Luciferase vectors. At 40 h after transfection, cells were stimulated with dsRNA 
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for 6 h followed by Luciferase assay. As expected, all the three proteins showed 
significant downregulation of dsRNA mediated ISG56 promoter activation compared to 
an empty vector control (Fig. 2.3A). 
For a more direct confirmation of the inhibition of dsRNA signaling by these 
proteins, we established HEK293-TLR3 cell lines stably expressing these three PRRSV 
nsps. Upon treatment with dsRNA, these cell lines induced none or very low levels of 
endogenous ISG56 as compared to the empty vector-expressing cells (Fig. 2.3B, C, and 
D). A different dsRNA responsive cell line, HT1080 (human fibrosarcomacell line) 
stably expressing these viral proteins, also showed similar results upon dsRNA treatment 
(data not shown). This indicates that the inhibitory effect observed is independent of the 
cell line being used. Taken together, our results from two different assays suggest that 
PRRSV nsp1α, nsp1β, and nsp11 are involved in inhibition of IRF3-mediated IFN 
signaling. 
PRRSV nsp1β inhibits NF-κB mediated gene induction. In addition to IRF3, TLR3 
signaling pathway also activates NF-κB. The next series of experiments were directed to 
investigate the effect of these nsps on NF-κBmediated gene induction by dsRNA. Cells 
were co-transfected with nsps along with 5X-NF-κB-Luciferase and Renilla luciferase 
reporters. Upon dsRNA treatment, the empty vector-transfected cells showed strong 
induction of Luciferase activity as compared to the untreated cells. Expression of nsp1β 
and nsp11 down regulated the induction of Luciferase activity to the level of untreated 
control (Fig. 2.4A). Interestingly, nsp1α expression did not have significant negative 
effect on NF-κB promoter activity. This suggests differential inhibition of nsp1α 
compared to nsp1β and nsp11. To confirm the negative effect of nsp1β on NF-
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κBsignaling, we assessed the induction of endogenous IL-8 mRNA, a cytokine whose 
expression is principally driven by NF-κB. In accordance with the reporter assay result, 
IL-8 mRNA induction upon dsRNA treatment was significantly reduced in HEK293-
TLR3 cells stably expressing nsp1β to empty vector control cells (Fig. 2.4B). 
TRIF or IKKε do not rescue nsp1β mediated inhibition of IRF3 activation. Besides 
TLR3, cytoplasmic dsRNA is sensed by DExD/H box RNA helicases: RIG-I and MDA5 
(81). A number of RNA viruses induce signaling through dsRNA receptor RIG-I (106). 
Having established that PRRSV nsp1β inhibits TLR3 mediated IRF3 and NF-κB 
signaling, we investigated the effect of nsp1β on RIG-I signaling pathways. We took 
advantage of expressing the N-terminal CARD domain of RIG-I, which constitutively 
activates the RIG-I signaling pathway (53), and tested the effect of nsp1β.  As shown in 
Fig. 2.5A the constitutively active RIG-I, when co-expressed with ISG56-Luciferase, 
induced strong Luciferase activity compared to vector control. However, in presence of 
nsp1β the induction is completely inhibited showing that in addition to TLR3 pathway, 
nsp1β also inhibits RIG-I mediated signaling pathway.  
Often times a very similar approach is used to identify the step/s of the signaling 
pathway that is being inhibited (111). We used expression constructs for TRIF and IKKε, 
two major components of TLR3 signaling pathway, to examine if the nsp1β mediated 
inhibition could be rescued. Our results show that IRF3 activity was induced by 
transfection of TRIF (Fig. 2.5B) and IKKε (Fig. 2.5C) in an ISG56-Luciferase reporter 
assay. Presence of nsp1β significantly down regulated the ISG-56 promoter activation 
induced by these molecules. These results indicate that part of the inhibitory activity of 
nsp1β affect downstream signaling of IRF3 kinases, probably by directly affecting IRF3. 
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Exogenous expression of TRIF could not recover activation of a NF-κB dependent 
promoter in presence of nsp1β either (data not shown). 
Nsp1β inhibits dsRNA induced IRF3 phosphorylation and nuclear translocation. In 
the resting state, IRF3 shuttles between the cytoplasm and the nucleus. Activation by 
dsRNA causes its phosphorylation and translocation to the nucleus (220). The binding 
and recruitment of IRF3 on ISRE promoters is stabilized by CBP/p300 which prevents its 
export from the nucleus. To investigate the mechanism of nsp1β mediated inhibition of 
IRF3 activation, we assayed several hallmark steps of IRF3 activation process, such as 
IRF3 phosphorylation (on Ser396) and nuclear translocation upon dsRNA treatment.  As 
expected dsRNA treatment induced a marked increase in the level of phosphorylated 
IRF3 in the control cells. However, in nsp1β expressing cells IRF3 phosphorylation was 
reduced to the basal level (Fig. 2.6A). IRF3 nuclear translocation was similarly affected 
by nsp1β expression. As shown in Fig. 2.6B, the level of IRF3 present in the nuclear 
fraction increased upon dsRNA treatment. However, in presence of nsp1β IRF3 failed to 
translocate to the nucleus. This was consistent with the previous result showing the 
reduction of IRF3 phosphrylation in presence of nsp1β. This phenomenon was further 
verified by visualization of the sub-cellular location of IRF3 by indirect 
immunofluorescence. HEK293-TLR3 cells transfected with empty vector showed 
efficient IRF3 nuclear translocation 2 h post dsRNA treatment but in the presence of 
nsp1β, most of the IRF3 was retained in the cytoplasm (Fig. 2.6C) in a manner similar to 
empty vector transfected cells without dsRNA treatment (top left panel). These results 
suggest that nsp1β inhibits dsRNA-mediated phosphorylation of IRF3 and its nuclear 
translocation.  
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Nsp1β inhibits Sendai virus induced IFN-β promoter activation. To establish the 
innate immune evasion property of nsp1β in a physiological context we tested Sendai 
virus (SeV) mediated ISG56 induction in nsp1β expressing cells. The innate immune 
response against SeV infection is primarily mediated by RIG-I (106). We tested SeV 
mediated ISG56 induction in nsp1β expressing cells. HEK293-TLR3 cells stably 
expressing nsp1β or empty vector transfected control cells were either mock infected or 
infected with sendai virus (40 HA unit/ml) for 8 h. As shown in Fig. 2.7A, presence of 
nsp1β significantly inhibited SeV mediated ISG56 induction compared to control cells. 
Finally, to replicate the effect of nsp1β on porcine IFN-β induction, we used porcine 
monocytic cell line 3D4/31. This myelomonocytic cell line has been recently 
characterized to support PRRSV replication and infectious virus production upon 
transfection with PRRSV genomic RNA but lacks the necessary receptor in order to 
enable spread of virus from cell to cell (77). The 3D4/31 cells were transfected by 
electroporation with porcine IFN-β-luciferase reporter and nsp1 or nsp1β. SeV infection 
of vector transfected cells showed induction of porcine IFN-β-luciferase activity. 
However, in presence of nsp1 or nsp1β porcine IFN-β-luciferase activity was inhibited in 
a dose dependent manner (Fig. 2.7B). This result confirms our findings that nsp1β plays a 
crucial role in innate immune evasion function of PRRSV in a physiologically relevant 
environment.  
Discussion 
Viruses have developed a number of mechanisms to subvert or prevent IFN induction and 
response (19). In case of PRRSV, both North American and European PRRSV strains 
have been shown to be poor inducers of IFN in vitro and in vivo. Infection of PAMs with 
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the North American prototype PRRSV VR-2332 significantly reduced their ability to 
produce type I IFN (123, 124). Furthermore, absence of IFN-α production in TGEV 
infected swine alveolar macrophages, which had been previously infected with PRRSV, 
implicates an active inhibition of IFN production by PRRSV. In summary, all the studies 
are consistent with the fact that PRRSV exerts an active suppression of type I IFN 
response. In agreement with these, we have shown here that PRRSV infection of 
monocytes-derived macrophage showed inhibition of IFN-α and IFN-β production both 
at mRNA and protein level. Our data show that five PRRSV nsps – the nsp1α, nsp1β, 
nsp2, nsp4, and nsp11 have roles in IFN antagonism and inhibit activation of IFN-β 
promoter.  
In this study we used TLR3 and RIG-I mediated dsRNA signaling pathways as 
model systems to understand the mechanism of innate immune evasion by PRRSV. 
nsp1α, nsp1β and nsp11, when stably expressed in HEK293-TLR3 cells, were able to 
inhibit up-regulation of endogenous ISG56 by dsRNA. Moreover stable expression of 
nsp1β inhibited endogenous ISG56 induction by SeV. Investigation of IRF3 
phosphorylation status after dsRNA stimulation showed nsp1β inhibits IRF3 (Ser396) 
phosphorylation and subsequent nuclear translocation. Although, the biochemical nature 
of this inhibition by PRRSV nsp1β remains to be characterized, there are several 
mechanisms by which different viruses have been shown to inhibit IRF3 activation. 
Certain Paramyxoviral V proteins interact with IKKε/TBK1 and function as competitive 
inhibitor for IRF3 phosphorylation (111). The W protein of Nipah virus specifically 
interacts with karyopherin α3 and α4 through its nuclear localization signal (NLS) and 
prevents IRF3 translocation (166). It has been reported that nsp2 of EAV, the prototypic 
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member of Arteriviridae family, antagonizes host innate immune response by 
deconjugating ubiquitin and ISG15 from their cellular substrates (54). Therefore, it is 
possible that nsp1β a member of cysteine protease family which include most 
deubiquitinases, might  also employ a similar strategy of deconjugating important 
ubiquitin modifications of IRF3 or RIG-I (17). All these possible mechanisms of 
inhibition of dsRNA signaling by nsp1β are currently under investigation.  
Nsp1β and nsp11 expression also inhibited transcription from a NF-κB responsive 
promoter but nsp1α expression has no inhibitory effect. The suppressive role of nsp1β in 
NF-κB-mediated signaling was further evident from the low level of IL-8 induction in 
dsRNA treated HEK293-TLR3 cells stably expressing nsp1β. This is in contradiction 
with a previous report which found PRRSV infection of MARC-145 cells and alveolar 
macrophages resulting in activation of NF-κB pathway through degradation of IκB (97). 
The disagreement might be due to the fact that the NF-κB activation in that study was 
assayed at a late phase of virus infection (24-48 h after virus infection). The activation of 
NF-κB is an immediate early event that occurs within minutes after exposure to a 
stimulus and results in a strong transcriptional stimulation of several cytokines (72). 
Considering that PRRSV replication cycle in macrophages is completed by 12 h this 
effect may be secondary effect of virus infection. Inhibition of NF-κB pathway by 
PRRSV nsps, especially during early infection phase, would help the virus not only to 
subvert the host innate immune response but also to produce enough progeny virus before 
being released by apoptosis as proposed by others (34).  
PRRSV nsp1 contributes two accessory proteinases nsp1α and nsp1β for the 
processing of replicase polyprotein. Nsp1α and nsp1β both possess two papain like 
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cysteine protease (PCP) domains – PCPα and PCPβ, which mediate the release of nsp1α 
and nsp1β from the polyproteins (44). Previous reverse genetics experiments showed that 
PCPα activity is essential for sub-genomic mRNA synthesis but dispensable for genome 
replication. However, mutation of active site residues of PCPβ resulted in no genome 
replication and failure in virus recovery after electroporation of in vitro transcribed RNA, 
underscoring its important role (90). Whether nsp1β active site residues (Cys, His) are 
involved in its IFN antagonistic activity in the context of whole virus infection remains to 
be investigated. However, it may not be feasible to structurally separate proteolytic 
function of nsp1β from its IFN antagonistic function because of the general 
multifunctional nature of viral proteins. This multifunctional nature of nsp1 has been 
already established in EAV and it has been found that structural integrity of nsp1 is 
essential for transcription (198, 201). In such case, given the essential function of PRRSV 
nsp1β in virus viability, it may not be possible to recover by reverse genetics a 
replication-capable virus which lacks anti-IFN activity.  
The inadequate immunological response to PRRSV infection is underscored by 
the fact that infected animal exhibits prolonged viremia, persistent infection and 
continuous virus shedding. The poor type-I IFN production at the site of PRRSV 
infection (e.g. lungs) has long been considered as the root cause behind defective or 
suboptimal initiation and elaboration of antigen-specific adaptive immune response.  
Influenza virus carrying truncated non-structural 1 (NS1) protein, which counteracts the 
host type I IFN response, is highly attenuated in mice, swine, and chicken models (151, 
183).  Another important example of correlation between anti-IFN activity and virulence 
is Ebola virus VP35 protein, which inhibits IRF3 activation. Single amino acid mutation 
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(R312A) of VP35 protein, which compromises its ability to inhibit IRF3 activation, 
renders the virus highly attenuated in mice (67). It is possible that the strong anti-IFN 
activity of the nsps of PRRSV may have a direct effect in the paradoxical immune 
response observed in PRRSV infection and would explain the inability of the host to clear 
PRRSV. Such important immune-modulatory effect of these nsps may be also the basis 
for the pathogenesis and virulence of this virus. On the other hand, Pestiviruses, which 
include classical swine fever virus (CSFV) and bovine viral diarrhea virus (BVDV) have 
been shown to induce proteasomal degradation of IRF3 by the viral autoproteaseNpro, 
which subsequently inhibits IFN α/β production (9, 59). A recent investigation into the 
correlation between the ability of CSFV for IRF3 degradation and viral virulence found 
that impairment of the IFN antagonistic activity did not give rise to an attenuated virus 
(154). The authors implicate that the inhibition of type I IFN may have a role in longer 
persistence of the virus in pigs. Previous results from our laboratory indicated that viral 
nsp3-8 might play a major role in PRRSV virulence (92). Taken together with our studies 
reported here, it suggests that the pathogenesis of PRRSV may be a complex summation 
of several major effectors contributing to the overall pathogenesis of PRRSV. The nsp1β 
acts as a suppressor of innate immune response, and nsp3-8 determines the virulence and 
invasive capacity, which helps the virus to translocate and cross placenta and infect 
fetuses. Highly pathogenic viruses like SARS-CoV, Ebola viruses encode multiple 
proteins targeting different steps in the IFN signaling. This not only ensures complete 
inhibition of interferon response, but also provides a fail-safe mechanism for the virus in 
case a single protein became dysfunctional. Our current findings that five nsps of PRRSV 
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are involved in IFN antagonism, nevertheless of variable ability, point towards PRRSV‟s 
pathogenic nature.  
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TABLE 2.1. Primers used to generate individual nsp expressing plasmids 
 
Primer          Sequence (5’-3’)a Genomic 
position
b
 
nsp1F ATATATCTCGAGATGTCTGGGATACTTGATCGG 192-212 
nsp1αR ATATATGCGGCCGCTTAAAAGTCTTCAGGCTTA 694-710 
nsp1βF ATATATGCTAGCATGTACCCATACGATGTTCCAGATTACGCT 
GGAGCAACTCATGTGC 
651-666 
nsp1R ATATATGCGGCCGCTTAACCGTACCATTTGTGACTGC 1321-
1340 
nsp2F ATATATACGCGTGCTGGAAAGAGAGCAAGGAA 1341-
1360 
nsp2R ATATATGCGGCCGCTTAGCCCAGTAACCTGCCAAGA 4261-
4280 
nsp3F ATATATCTCGAGGGGGCACGCTACATCTGGC 4281-
4299 
nsp3R ATATATGCGGCCGCTTACTCAAGAAGGGACCCAAGC 5599-
5618 
nsp4F ATATCTCGAGATGGGCGCTTTCAGAACTC 5619-
5634 
nsp4R TATATCTAGATCATTCCAGTTCGGGTTTG 6214-
6230 
nsp5F ATATATCTCGAGGGAGGCCTCTCCACCGTC 6231-
6248 
nsp5R ATATATGCGGCCGCTTACTCGGCAAAGTATCGC 6724-
6740 
nsp7F ATATATCTCGAGTCGCTGACTGGTGCCCTC 6788-
6806 
nsp7R ATATATGCGGCCGCTTATTCCCATTGGTTTTTTTTGCTC 7543-
7565 
nsp8F ATATATCTCGAGGCTGCGAAGCTTTCCGTG 7566-
7583 
nsp8R ATATATGCGGCCGCTTACTTAGTCAGGCCCTGGA 7665-
7683 
nsp9F ATATATCTCGAGGGAGCAGTGTTTAAACTGCTAGC 7684-
7706 
nsp9R ATATATGCGGCCGCTTACTCATGATTGGATCTGAGTTTTTC 9595-
9619 
nsp10F ATATATCTCGAGGGGAAGAAGTCCAGAATGTG 9620-
9639 
nsp10R ATATATGCGGCCGCTTATTCCAGATCTGCACAAATG 10923-
10942 
nsp11F ATATCTCGAGATGTCGAGCTCCCCGCTC 10946-
10960 
nsp11R TATATCTAGATCATTCAAGTTGAAAATAGGC 11593-
11611 
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nsp12F ATATATCTCGAGGGCCGCCATTTCACCTGGTA 11612-
11631 
nsp12R ATATATGCGGCCGCTTATCAATTCAGGCCTAAAGTTGGTTC 12049-
12073 
 
a
Restriction enzyme site used for cloning are underlined. The N-terminal hemagglutinin 
(HA) tag in the nsp1βF primer is indicated in bold. 
b
Genomic positions for the primers are based on GenBank accession number AY545985 
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Fig. 2.1.Inhibition of type I interferon production after PRRSV infection. Porcine 
monocyte derived macrophages were mock infected or infected with PRRSV (FL-12) or 
TGEV at a multiplicity of infection of 1. Supernatants and cells were collected after 9 and 
18 h post infection respectively. Total RNA isolated from cells was reverse transcribed 
and real time PCR was done for detection of porcine IFN-α (A), IFN-β (B) mRNA. The 
mRNA copy numbers were calculated after normalization with β-actin copy number and 
expressed in percentage (%) relative to mock control. Bars show average of mRNA copy 
numbers ± SEM from three independent experiments using cells isolated from three 
different pigs. (C) Supernatants from same experiments were used to detect secreted IFN-
α by ELISA. Quantified recombinant porcine IFN-α was used as a standard, and IFN-α 
levels were calculated based upon a standard curve. 
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Fig.2.2.Specific PRRSV proteins are involved in downregulation of IFN-β promoter. 
(A) Hela cells were co transfected with pIFN-β-CAT plasmid (1 μg), IRF3 expression 
plasmid (0.5 μg) and the viral non-structural protein expression plasmids (1 μg) or bovine 
herpes virus-1 protein bICP0. Empty vector was added to the transfection mixture to keep 
the total DNA amount constant. Cell extracts collected at 40 h post transfection were 
analyzed for CAT activity as described in Materials and Methods. Value of CAT activity 
in presence of empty vector was set at 100% and that of viral proteins were normalized 
accordingly. (B) Increasing amounts of indicated nsp coding plasmids were transfected 
and CAT activities were measured as mentioned earlier. Bars represent mean ± SEM 
from three independent experiments. The bottom panels show increasing levels of 
individual nsp expression upon transfection (Actin was used as loading control).  
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Fig.2.3. Inhibition of IRF3 mediated gene induction by PRRSV proteins. (A) HEK-
293TLR3 cells were co-transfected with indicated viral nsp expression plasmids (1 μg) or 
empty vector, ISG56-Luciferase plasmid (0.4 μg), and pRLTK (0.01 μg). At 40 h post 
transfection cells were treated with 10 µg/ml dsRNA or PBS for 6 h and assayed for 
Luciferase activity. Bars represent average fold induction ± SEM for Luciferase activities 
compared to PBS treated vector control. The panel below the bar graph shows the 
expression of respective nsps. The asterisk (*) at nsp1 lane indicates the detection of 
proteolytically processed nsp1 to nsp1α which carries the N-terminal FLAG tag. 
HEK293-TLR3 cells stably expressing nsp1α (B), nsp1β(C) and nsp11 (D)(lanes 4-6), 
were stimulated with indicated amount of dsRNA for 6 h and ISG56 level was measured 
by immunoblotting and compared to empty vector transfected, puromycin resistant 
control cells (lanes 1-3). Expressions of nsps were detected by probing with anti-
FLAG/HA antibody. 
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Fig.2.4. Inhibition of NF-κB mediated gene induction by PRRSV proteins. (A) 
HEK293-TLR3 cells were co-transfected with indicated viral nsp expression plasmids or 
empty vector (1 μg), 5X NF-κB-Luciferase plasmid (0.5 μg), and pRLTK (0.025 μg). At 
40 h post transfection cells were treated with dsRNA for 6 h and assayed for Luciferase 
activity. Fold induction of average Luciferase activity compared to untreated vector 
control from a representative experiment is shown. The immunoblot panel indicates 
expression of individual nsps in the luciferase assay. (B) IL-8 mRNA levels were 
measured by real time PCR in HEK293-TLR3 cells stably expressing nsp1β or vector 
control cells with or without dsRNA treatment. The mRNA copy numbers were 
calculated after normalizing with RPL32 (internal control) copy number and expressed as 
percentage (%) relative to uninduced vector control.  
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Fig.2.5. Nsp1β inhibits IRF3 signaling by acting downstream of IRF3 kinases. 
HEK293-TLR3 cells were co-transfected with ISG56-Luciferase plasmid, nsp1β 
expression plasmids or empty vector. IRF3 signaling pathway was induced by including 
in the transfection (A) constitutively active RIG-I, (B) TRIF and (C) IKKε.  Cells were 
lysed 40 h post transfection and assayed for Luciferase activity. Bars indicate mean fold 
induction ± SEM of Luciferase activity compared to vector control from three 
independent experiments.  
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Fig.2.6. nsp1β inhibits dsRNA induced IRF3 phosphorylation and nuclear 
translocation. (A) HEK293-TLR3 cells stably expressing nsp1β or vector transfected 
cells (vector) were either mock treated or treated with dsRNA for 2hr. Phosphorylated 
IRF3 (pIRF3) and total IRF3 levels were measured by immunoblotting. (B) Nuclear 
fractions (N.P) from HEK293-TLR3 cells stably expressing nsp1β either mock treated or 
treated with dsRNA were blotted for IRF3. DRBP76 and tubulin are markers for nuclear 
and cytoplasmic fractions respectively. WCE represents whole cell extract. (C) IRF3 sub 
cellular localization was determined by confocal microscopy in HEK-293TLR3 cells 
stably transfected with empty vector (vector) or nsp1β after dsRNA stimulation. For this 
purpose cells were either treated or left untreated with 100 μg/ml of dsRNA for 2 h 
followed by immunofluorescence for endogenous IRF3 (green) and nsp1β (red) with 
rabbit anti-IRF3 and mouse anti-HA antibody as indicated on the top of the panel. 
Position of nucleus is indicated by DAPI (blue) staining in the merge image. 
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Fig.2.7. Nsp1 and nsp1β inhibit Sendai virus induced porcine IFN-β promoter 
activation and human ISG56 induction. (A) HEK293-TLR3 cells stably transfected 
with empty vector (vector) or nsp1β were either mock infected or infected with sendai 
virus (40 HA unit/ml) for 8 h. Endogenous ISG56 levels were detected by 
immunoblotting. nsp1β protein was detected by anti-HA antibody. (B) Porcine monocytic 
cells (3D4/31 cell line) were co-transfected with increasing concentration of nsp1/nsp1β 
expression plasmids or empty vector (vector) along with porcine IFN-β-luciferase 
plasmid (0.4 μg) and pRLTK (0.01 μg). 40 h after the transfection cells were either mock 
infected or infected with 80 HA unit/ml of Sendai virus for 8 h and assayed for luciferase 
activity. Bars indicate average fold induction of luciferase activities ± SEM compared to 
uninfected vector control cells. The bottom panel shows immunoblot for the level of each 
nsp expression in respective transfection. The asterisk (*) indicates detection of N-
terminally FLAG tagged nsp1α, the cleavage product of nsp1.  
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CHAPTER III 
 
 
Identification of amino acids important for anti-IFN activity of porcine 
reproductive and respiratory syndrome virus non-structural protein 1  
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Abstract 
Certain non-structural proteins (nsps) of porcine reproductive and respiratory syndrome 
virus (PRRSV) suppress host type I interferon (IFN) production and signaling. The IFN-
antagonism exhibited by PRRSV nsp1α and nsp1β (proteolytic product of nsp1) is 
particularly strong. The objective of the present work is to map the domains or residues 
of nsp1α and nsp1β, which mediate this anti-IFN activity. By performing alanine-
scanning mutagenesis, we have identified several stretches of amino acids in nsp1α and 
nsp1β that when substituted by alanine showed significant relief of IFN-suppression. 
Single amino acid alanine substitution of such stretches in nsp1α allowed us to further 
map individual amino acids that are responsible for IFN-antagonism. Three recombinant 
viruses with mutant nsp1α and nsp1β were recovered by reverse genetics. One of these 
mutant viruses with mutation in nsp1β (16-5A) was further characterized. The 16-5A 
mutant virus was attenuated for growth in vitro and induced significantly higher amount 
of type I IFN transcripts in infected macrophages. In infected pigs, the 16-5A virus 
exhibited reduced growth at early times after infection but quickly regained wild type 
growth properties. Sequencing of the nsp1β region from recovered virus showed that the 
introduced mutations were unstable and the revertant nsp1β showed IFN-suppression 
similar to the wild type nsp1β. This indicates a strong selection pressure towards 
maintaining the IFN-inhibitory property of virus for successful propagation in pigs. 
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Introduction 
Porcine reproductive and respiratory syndrome (PRRS) is a significant animal 
disease affecting swine herds in all pork-producing countries. Two major clinical 
manifestations of the disease are late term reproductive failure in pregnant sows and 
respiratory distress in young piglets as well as growing pigs. A comprehensive study by 
Neumann et al, has estimated the annual economic loss by PRRS to the US swine 
industry to be $560 billion (132). The recent large-scale outbreak of “high fever” disease 
in China in 2006 with unusually high mortality rate further adds to the significance of this 
swine pathogen (197). The etiological agent of the disease is PRRS virus (PRRSV), an 
enveloped positive sense single stranded RNA virus whose genome is ~15 Kb. PRRSV 
belongs to the family Arteriviridae which, along with Coronaviridae and Roniviridae 
families, form the order Nidovirales (24). Other members of Arteriviridae families 
include equine arteritis virus (EAV), lactate dehydrogenase elevating virus (LDV) and 
simian hemorrhagic fever virus (SHFV). The viral genome encodes 10 open reading 
frames (ORFs)- ORF1a, ORF1b, ORF2a, ORF2b, ORF3, ORF4, ORF5a, ORF5, ORF6 
and ORF7. The ORF1a and ORF1b are translated to form polyproteins, which are 
processed by viral proteases to form 14 different non-structural proteins (nsps) (49, 175). 
Several of the nsps have been identified as integral members of viral replication and 
transcription machinery. Furthermore, the nsps are also likely to regulate viral 
pathogenesis through their involvement in modulation of host innate immune response. 
The type 1 interferon (IFN) constitutes a major player of the host innate immune 
response system. Viral replication intermediates like double stranded RNA (dsRNA) are 
sensed by cytoplasmic (RIG-I like helicases) as well as endosomal (Toll-like receptor 3, 
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TLR3) sensors which trigger a complex signaling cascade (19, 82). These signaling 
events culminate in activation of several transcription factors include interferon 
regulatory factor 3 (IRF3), nuclear factor kappa B (NF-κB) and activating transcription 
factor-2 (ATF-2). These transcription factors coordinately drive expression of type 1 IFN 
genes. Once IFN-beta is secreted, it binds to the IFN receptors on the cell surface and 
initiates the Janus kinase (JAK) - signal transducers and activators of the transcription 
(STAT) signaling pathway, which leads to synthesis of IFN-stimulated genes (ISGs). 
These ISGs then establish the antiviral state. During the course of evolution, viruses have 
developed numerous strategies to counteract IFN production and signaling pathways to 
ensure their survival in nature (214). Infection with PRRSV results in poor type 1 IFN 
production both in in vitro infected macrophages and infected pigs (1, 99). This low level 
of IFN induction is a process of active suppression by virus since infection with a strong 
IFN-inducer transmissible gastroenteritis coronavirus (TGEV) after PRRSV infection 
could not elicit detectable IFN production (1). The nsps of PRRSV inhibit IFN-dependent 
transcription. Earlier, we reported that five different nsps (nsp1α, nsp1β, nsp2, nsp4 and 
nsp11) can inhibit IFN-β gene transcription (16). The nsp1α and nsp1β protein suppress 
both IRF3 and NF-κB mediated IFN gene induction (16, 29, 180). Both proteins also 
target the JAK/STAT pathway and inhibit IFN signaling (29, 140). PRRSV nsp2 
interferes with NF-κB signaling by deubiquitinating the ubiquitinated IκBα molecule 
which is important for NF-κB activation (188). 
After being exposed to PRRSV, the animals develop viremia, which lasts for a 
month, but virus can still be detected in certain secondary lymphoid tissue up to 5 months 
after infection (3, 226). The level of various proinflammatory cytokines, other important 
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components of host innate immune response besides IFN, are low compared to those 
induced by several other respiratory swine pathogens (210, 211). The subsequent 
development of effector molecules of adaptive immune response e.g. neutralizing 
antibodies, antigen-specific T-cells are delayed (109). The initial suboptimal innate 
response is hypothesized for the delayed and defective development of adaptive immune 
response (88, 126). Thus, a PRRSV that does not efficiently suppress type 1 IFN 
induction is predicted to stimulate a strong adaptive immune response culminating in the 
rapid clearance of PRSSV.  
The objective in this study was to map the domains/residues of PRRSV nsp1α and 
nsp1β that are responsible for inhibiting IRF3 mediated gene induction. Using alanine-
scanning mutagenesis, we have identified such residues in both proteins. Next, we 
recovered PRRSV strains with mutations in the nsp1α or nsp1β proteins. Characterization 
of an nsp1β mutant virus (16-5A) demonstrated that the virus is attenuated for growth 
and induces higher level of type 1 IFN in vitro. However, the mutation was unstable in 
vivo and the revertant virus quickly regained the ability to suppress IFN production in 
infected pigs. 
Materials and methods 
Cells and viruses- HEK293-TLR3 (Invivogen), MARC-145 (obtained from Dr. Will 
Laegreid, USMARC, USDA/ARS) (85), cells were maintained in DMEM containing 10 
% fetal bovine serum and 50 μg/ml of gentamicin (Sigma). Porcine monocyte derived 
macrophages were prepared from peripheral blood mononuclear cells as described 
previously (110). Briefly, mononuclear cells were isolated from blood of donor pigs by 
Ficoll density centrifugation using Lymphocyte separation medium (Mediatech). These 
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cells were allowed to attach to a glass petridish for one day followed by washing with 
PBS to enrich the monocytes.  The attached monocytes were cultured in RPMI 1640 
medium supplemented with 10% BVDV-free fetal bovine serum in presence of 
macrophage colony stimulating factor  (5 ng/ml) (Sigma) for 7 days in order to induce 
their differentiation into macrophages. These monocyte-derived macrophages were then 
harvested by cell dissociation buffer (Gibco) and seeded with RPMI 1640 and 10% FBS 
for virus infection.  
Infectious clone derived genotype II PRRSV strain FL12 was propagated in 
MARC-145 cells to prepare the virus stocks for this study (202). The various mutant 
viruses were also propagated in MARC-145 cells upon recovery. Viruses from passage 3 
(P3) were used for most in vitro experiments as well as for animal inoculation. Sendai 
virus (Cantell strain) was obtained from Charles River Laboratories and was used at 50 
haemagglutinating unit/ml concentration for infection of MARC-145 cells. 
Plasmids and antibodies- The pIHA-FLAG-nsp1α, pIHA-FLAG-nsp1β, pISG56-luc, 
pFLAG-IKKε, and pIHA-HA-nsp1β plasmids have been described earlier (16, 68, 185). 
The Nipah virus W and the different importin-α coding plasmids are generous gifts from 
Dr. Christopher Basler, Mount Sinai medical school (166). The nsp1β block deletion 
mutants were prepared by overlap extension PCR method as described earlier (75). The 
different alanine substitution mutants were prepared by site-directed mutagenesis by 
megaprimer PCR method using a standard technique as described  elsewhere (158). The 
primers used for these mutants are listed in table 1. 
Antibodies used in this study and their sources are as follows- SDOW 17 (anti-
PRRSV N monoclonal antibody) (131) was purchased from National Veterinary Services 
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Laboratories (NVSL, Ames, IA). The mouse anti-β-Actin (Sc-47778), anti-HA agarose 
(Sc-7392AC) were obtained from Santa Cruz Biotech. The anti-Flag M2 (F3165) and 
rabbit anti-FLAG (F7425) were products of Sigma Aldrich. Secondary antibodies 
conjugated to HRP were purchased from Kirkegaard and Perry Ltd (KPL) including goat 
anti-mouse (074-1807) and goat anti-rabbit (214-1516) antibodies. PRRSV nsp1 antibody 
was developed by immunizing rabbit with the protein and could detect both nsp1α and 
nsp1β. The anti-ISG56 and anti-nsp2/3 antibody were generous gifts from Dr. Saumendra 
Sarkar, U Pittsburg and Dr. Eric J. Snijder, LUMC, The Netherlands respectively (90).  
Reporter assays- ISG56-luciferase reporter assays were performed as described earlier 
with small modifications (16). HEK293-TLR3 cells were transfected with 0.4 μg of 
ISG56-luciferase reporter plasmid and 20 ng of pRL-TK (Promega) along with indicated 
protein expression vectors using TransIT (Mirus Bio) as per manufacturer‟s protocol. 
Twenty four hours post transfection the media was replaced with fresh media. At 40 h 
post transfection, cells were either treated with 5 μg/ml of poly (I): poly (C) (GE Health 
Care) or PBS for 6 h and luciferase assays were performed using Dual Luciferase assay 
kit from Promega. Then the firefly luciferase activities were expressed as percentages 
with respect to control after normalizing with renilla luciferase activities (empty vector 
transfected and dsRNA stimulated cells, were normalized to 100 %). 
IFN and viral RNA real-time PCR- For IFN real-time PCR, total RNA was isolated 
from virus infected/mock infected monocyte derived macrophages using Trizol 
(Invitrogen) reagent and was treated with DNase before cDNA synthesis. Then 1µg of 
RNA was reverse transcribed using oligo-dT primer and the M-MLV reverse 
transcription kit (Invitrogen) as per manufacturer‟s recommendation. Next the cDNA was 
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used for real-time PCR to quantitate the indicated mRNA copy number in a Smartcycler 
machine (Cepheid) using the Faststart Universal Probe Mastermix (Roche). The cycling 
conditions used were- initial denaturation-95°C/10 minutes, amplification (40 cycles)- 
95°C/30 seconds and 60°C/30 seconds. The swine IFN-α, β and β-actin (internal control) 
real time PCR was performed using a TaqMan probe based method as described earlier 
(16). IFN-α and IFN-β mRNA levels in virus-infected cells were expressed in copy 
numbers relative to mock infected or un-stimulated cells as per the method described 
earlier (184). The IFN mRNA levels were normalized across the experiments using 
porcine β-actin as internal control. For measuring viral RNA copy numbers a single step 
Taqman-based reverse transcription-real time PCR using Hot start-IT Probe one step 
qRT-PCR master mix (Affymetrix) was designed. Viral RNA was isolated using Qiagen 
Viral RNA mini kit (Qiagen) from 140μl of serum from infected pigs following 
manufacturer‟s instruction. The isolated RNA (4μl) was used in the PCR reaction and the 
RNA copy number was calculated using a standard curve generated with in vitro 
transcripts. The probe and primers used were- 3UTR84P (probe)-
TCACCTATTCAATTAGGGCGACCG, 3UTR44F (forward primer)-
ATGTGTGGTGAATGGCACTG and 3UTR141R21 (reverse primer)-
GCATGGTTCTCGCCAATTAAA. The PCR is targeted to the 3‟UTR of type II 
PRRSV. The cycling conditions for this PCR were - reverse transcription-50°C/30 
minutes, initial denaturation -95°C/2 minutes, amplification 45 cycles (95°C/15 seconds 
and 60°C/60 seconds). 
Co-Immunoprecipitation (Co-IP) and Immunoblotting assay- In over-expression 
experiments, the indicated plasmids were transfected into 293TLR3 cells using 
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Lipofectamine2000 (Invitrogen) as per manufacturer‟s protocol. Then, 36 to 48 h after 
transfection, the cells were washed twice with PBS and collected for lysate preparation. 
Lysis was performed in the lysis buffer [20 mM Tris (pH7.5), 150 mM NaCl, 1 mM 
EDTA, 1 mM EGTA, 1% Triton X-100, 2.5mM sodium pyrophosphate, 1 mM β-
glycerophosphate, 1 mM sodium orthovanadate and complete protease inhibitor 
(Roche)]. After clarification at 13,000 RPM for 10 min at 4°C, the lysates were incubated 
with indicated antibodies or antibodies conjugated agarose beads overnight. A 5% lysate 
sample was removed and stored at -80°C to be used later as whole cell lysate (WCL). The 
antigen-antibody complexes were washed three times in Tris-buffered saline (TBS) and 
subsequently eluted from the beads by boiling in Laemmlli SDS-PAGE loading buffer. 
The eluted proteins were resolved in SDS-PAGE followed by transfer onto 
polyvinylidenedifluoride (PVDF) membrane (Millipore). Then the membranes were 
blocked in blocking buffer (Tris buffered saline containing 5% nonfat dry milk and 0.1% 
Tween 20) for 1 h followed by incubation with indicated primary antibodies. After that, 
membranes were washed and incubated with horseradish peroxidase (HRP)-conjugated 
secondary antibodies. Finally the proteins were visualized with an ECL detection system 
(Pierce). 
In vitro transcription, RNA electroporation and mutant virus recovery- Generation 
of full length PRRSV in vitro transcripts have been described earlier (91, 202). Briefly 
the mutant pFL12 full length plasmids were linearized with AclI restriction enzyme. The 
digested DNA was phenol: chloroform purified and 1µg of DNA was used as template in 
a 20µl in vitro transcription reaction using mMESSAGEmMACHINE ultra T7 kit 
(Ambion) as per manufacturer‟s recommendation. The resulting capped and 
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polyadenylated full length RNA was further purified with phenol: chloroform before 
being used in the electroporation reaction. MARC-145 cells were electroporated as 
described previously (91, 202). After electroporation, cells were seeded in DMEM media 
containing 10% FBS. Cells were regularly checked for development of cytopathic effect 
and virus growth was also confirmed by indirect immunofluorescence using anti-N and 
anti-nsp2/3 antibodies. Upon confirmation of virus growth, supernatants from the plates 
were collected and clarified. This supernatant was labeled as passage „0‟ (P0) and was 
further amplified to prepare stocks for subsequent studies.  
Viral growth kinetics- For multiple step growth curve, monocyte derived macrophages 
were infected at 0.1 multiplicity of infection (moi) with indicated viruses. Then culture 
supernatants were collected at indicated time post viral infection and were stored at -80°C 
until titration. Titrations of the supernatants were performed in MARC-145 cells and 
expressed as tissue culture infectious dose 50 per ml (TCID50/ml) as per Spearman and 
Karber method. To determine the plaque morphology, plaque assay was performed 
following standard procedure. 
Animal experiments- Four to six-week old pigs (n=8) were purchased from a specific 
pathogen-free herd with a certified record of PRRSV absence. Pigs were randomly 
divided into two groups (n=4) and inoculated with 10
5.2
 TCID50/ml (in total of 2 ml 
inoculum) of the FL12 (wt PRRSV) or 16-5A virus. The inoculum was divided equally 
and inoculated through both intramuscular as well as intranasal route. Viremia was 
measured by real-time PCR in sera collected at 3, 7 and 14 days post infection (dpi).  
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Results 
PRRSV nsp1β does not interact with several signaling intermediates of type 1 IFN 
induction pathway. We recently discovered that PRRSV encoded nsp1β inhibits IRF3 
phosphorylation (16). However, the mechanism employed by nsp1β to achieve this effect 
is not understood. We hypothesized that nsp1β might interact with the IRF3 kinases 
(IKKε and TBK1) and affect their phosphorylation ability. Certain paramyxovirus V 
proteins interfere with IRF3 phosphorylation by interacting with IKK and TBK1 (111). 
Possible interactions between nsp1β and IKKε were investigated by co-IP assays in cells 
overexpressing both proteins. We could not detect IKKε in the immune-complex 
precipitated by ansp1β-specific antibody (first lane, Fig.3.1). We also examined whether 
nsp1β interacts with some of the other upstream (relative to IRF3 kinases location) 
signaling intermediates of IFN induction pathway such as TRIF, TRAF3, TRAF6, RIG-I 
but could not find any association (data not shown). We have previously shown that 
nsp1β inhibits IRF3 nuclear translocation (16). Other reports have shown nsp1β also 
inhibits STAT-1/2 (transcription factor for ISG synthesis) nuclear translocation (140). 
This led us to hypothesize that nsp1β might target some common cellular proteins 
involved in nuclear import of these transcription factors. Importin-α (Karyopherin-α) are 
a group of proteins which bind to the nuclear localization signals of cargo proteins and 
transport them into nucleus with help from importin-β (216). We performed co-IP 
experiments of nsp1β with 6 different subtypes of importin-α (α1 to α6) but were unable 
to detect any interaction (Fig.3.1). The expression of importin-α5 was not detected in our 
reaction, so no conclusion can be derived about nsp1β-importin-α5 interaction. As a 
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positive control for the IP reaction, we used Nipah virus W protein that interacts with 
importin-α3, which showed successful pull down (last lane) (166). Altogether our 
observation indicates that nsp1β‟s inhibitory effect on IRF3 phosphorylation and nuclear 
translocation of specific transcription factor is mediated through an unidentified 
mechanism. 
Several amino acid stretches of nsp1β are involved in its IFN-suppression function. 
Previously we demonstrated that PRRSV nsp1β is a potent inhibitor of IFN-β induction 
in response to dsRNA treatment (16). For these current experiments, we wanted to map 
the residues/domains of nsp1β involved in suppressing IFN production. Initially, six 
mutants of nsp1βs, each with 30 aa block deletions, were prepared and their protein 
expressions were compared to wild type (wt) nsp1β. Subsequently, their ability to relieve 
the IFN-suppression was analyzed by ISG56 reporter assay. The ISG56 reporter vector 
contains tandem repeats of IFN-stimulated response element (ISRE) promoter elements 
which can be activated by IRF3/IRF7. As shown in Fig. 3.2A, there is significant 
variation in the level of mutant nsp1β proteins with most deletion mutants expressing 
reduced level of proteins compared to wt nsp1β. To our surprise all mutants completely 
relieve the IFN-inhibitory property of wt nsp1β. This suggests that the 30 aa block 
deletions of nsp1β might result in gross deformations in the protein tertiary structure 
which subsequently led to this non-specific relief of ISG56 promoter inhibition. 
Therefore, we decided to perform alanine-scanning mutagenesis where short amino acid 
stretches (5-7 aa) of wt nsp1β were replaced by alanine. The chance of gross alterations 
in structure by such mutation is lower than block deletions. All three domains of nsp1β 
were targeted in this mutagenesis and most of the residues mutated are well conserved 
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among type II PRRSV strains. The resulting 15 different mutants were then tested for 
protein expression and their ability to suppress IFN-alpha promoter activity.  There were 
wide variations in the expression level of the different mutant nsp1β relative to wt nsp1β, 
with some mutants exhibiting higher levels of protein accumulation, while others 
showing lower levels than wt nsp1β (Fig. 3.2B bottom). The ISG56 reporter assay results 
showed variable degree of alleviation in the IFN-suppression effect, with the highest 
being 60% relief (Fig. 3.2B top). Six different mutant nsp1β (10-6A, 16-5A, 21-7A, 70-
5A, 155-5A and 192-5A) were chosen for further analysis based on two criteria, (a) 
relatively similar/higher protein expression level compared to wt nsp1β and (b) exhibiting 
higher percentage (≥40%) of relief in IFN-inhibition. Taken together, we identified 
several mutant nsp1β located both in the nuclease domain and the PCPβ domain with 
reduced ability to suppress induction of an IRF3 dependent promoter in response to 
dsRNA treatment. 
Nsp1β cysteine protease active site mutant retains the IFN-inhibitory property. The 
cysteine protease activity nsp1β is essential for its proteolytic processing of the nsp1β-
nsp2 junction, which leads to the release of nsp1β from the polyprotein. Several viral 
proteases that down regulate IFN production can degrade certain signaling intermediates 
in the IFN induction pathway (103, 104). To examine whether nsp1β proteolytic activity 
is essential for its IFN-antagonism, we generated mutants of nsp1β with the individual 
protease active sites mutated to alanine (C270A and H339A). When tested for their IFN-
inhibitory property in an ISG56-luc assay, these mutants showed similar or even stronger 
suppression of the ISRE promoter as measured by response to dsRNA stimulation (fig 
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2C). We concluded that the protease active sites of nsp1β were not critical for down 
regulation of IFN induction. 
Identification of residues in PCPα domain of PRRSV nsp1α those are important for 
inhibiting IFN production. After mapping the residues of nsp1β involved in IFN-
antagonism; we repeated the same strategy on the other viral accessory protease nsp1α. 
An initial alanine-scanning mutagenesis of nsp1α encompassing 5 to 7 amino acid 
residues was performed and the mutants were subjected to ISG56 reporter assay. The 
results obtained from this initial study showed that the central PCPα domain is 
responsible for the IFN-inhibitory property but not the N-terminal zinc finger domain or 
C-terminal extension (data not shown). Next we performed shorter alanine substitutions 
(3 to 5 aa) in this PCPα domain. ISG56 reporter assay of these mutants showed that 
mutants involving amino acid residue 89 to 100 are relieved of their IFN-suppression 
property (Fig 3.3A). Certain mutants in the N-terminal zinc finger domain were also 
included for comparison. Next, we decided to identify those individual amino acid 
residues in this region which when mutated would alleviate the IFN down regulation. It is 
possible that, these substitutions might affect correct processing of the nsp1α-nsp1β 
junction by nsp1α protease which is important for virus viability. To ensure correct 
processing of this junction, these single amino acid substitutions were made in the 
background of a full length nsp1 expression plasmid in which the nsp1β protein has been 
rendered inactive for ISG56 promoter inhibition. They were first checked for successful 
cleavage of the nsp1α-nsp1β junction and then subjected to ISG56 reporter assay. As 
shown in Fig 3.3B, four nsp1α mutants (G90S, L91A, N92A and R97A) showed almost 
complete relief of the inhibitory effect. Some single amino acid mutants (Y122A, G125A 
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and C126A) in the c-terminal region were used as negative control. Similarly to nsp1β, 
alanine substitution of nsp1α protease active site residue His146 did not alter its IFN-
suppression ability (Fig.3.3C). Altogether we have identified four specific amino acids of 
nsp1α responsible for its IFN-antagonism. 
Recovery of PRRSV harboring mutant nsp1α and nsp1β. From the alanine-scanning 
mutagenesis experiments described above, we identified several mutant nsp1α (G90S, 
L91A, N92A and R97A) and nsp1β (10-6A, 16-5A, 21-7A, 70-5A, 155-5A and 192-5A) 
proteins which exhibit a reduced ability to suppress IFN induction in response to dsRNA. 
Our next objective was to recover viruses encoding these mutant proteins. We used a 
standard reverse genetics approach to recover these mutant viruses as described earlier 
(91, 202). At 48 h post electroporation of full length infectious RNA, MARC-145 cells 
were immunostained for viral nucleocapsid protein (indicator of sg mRNA transcription) 
as well as viral nsp2/3 protein (indicator of viral replication). Out of the ten different 
mutants we attempted, we were only able to recover three different viruses including the 
nsp1α G90S, nsp1β 16-5A and nsp1β 70-5A. The rest of the viruses showed no signs of 
viral replication and sg RNA synthesis as indicated by absence of nsp2/3 and 
nucleocapsid protein as evaluated by immunofluorescence (data not shown).    
The in vitro characterization of 16-5A mutant virus. First, we compared the in vitro 
growth characteristics of 16-5A mutant virus with that of the parental wt PRRSV strain 
(FL12) in monocyte-derived macrophages. The multistep growth kinetics of both viruses 
were significantly different, with the mutant virus showing more than one log lower titers 
compared to wt virus (Fig.3.4A). Such reduction in titer was evident at most of the time 
points the viruses were assayed. Similar growth attenuation was also observed in the 
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permissive monkey kidney cell line MARC-145 (data not shown). There was no 
difference, however, in the plaque morphology of both viruses (Fig.3.4B). Next we 
compared the various nsps accumulation in 16-5A mutant virus infected MARC-145 cells 
to that of wtFL12 infected cells by immunoblotting. As expected, we observed reduced 
levels of nsp1α, and nsp3, in cells infected with 16-5A (Fig.3.4C). But to our surprise, 
there were low levels of nsp1β in 16-5A infected cells (infected with 1 moi and samples 
collected 12 h post-infection). Such reduction in the level of mutant nsp1β might be a 
result of degradation of the protein that only occurs in the context of PRRSV infection. 
No significant difference on the mutant nsp1β localization was observed when compared 
to wt nsp1β, when overexpressed in Hela cells (Fig.3.4D). Taken together, these studies 
indicated that 16-5A mutant virus was growth attenuated in vitro and exhibited reduced 
nsp1β accumulation during infection of MARC-145 cells. The other recovered mutant 
viruses e.g. nsp1α G90S and nsp1β 70-5A were also attenuated for growth compared to 
wt FL12 virus (Subramniam.S., Osorio F.A., unpublished observation). 
Increased type 1 IFN induction in response to PRRSV 16-5A infection in monocyte-
derived macrophages. After characterizing the in vitro growth phenotype of the 16-5A 
virus, our next objective was to investigate whether this mutant can induce higher levels 
of type 1 IFNs compared to wt virus. To this end, monocyte derived macrophages were 
mock infected or infected with 1 moi of wt PRRSV or 16-5A mutant virus. Total RNA 
was isolated from the cells and porcine IFN-α and IFN-β mRNA copy numbers were 
determined by real-time PCR. Both types of IFNs were induced at significantly higher 
levels in 16-5A virus infected macrophages compared to wt virus at all the three different 
time points tested (Fig.3.5A and 3.5B). Moreover MARC-145 cells infected with 16-5A 
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virus have significantly higher level of ISG56 expression compared to wt virus when 
stimulated with Sendai virus (Fig.3.5C). These indicate that the 16-5A mutant virus has 
reduced ability to suppress IFN induction compared to wt PRRSV. 
The 16-5A mutant virus exhibits delayed growth characteristics and is unstable in 
infected pigs. Our next objective was to perform in vivo characterization of the 16-5A 
mutant virus and compare that to the parental virus (wt FL12). Two groups of young pigs 
(n=4 each) were infected with either wt or mutant virus. The level of viremia was 
measured by calculating viral RNA copy numbers in sera at different times post infection. 
Animals infected with 16-5A virus showed reduced viremia when compared to wt virus 
infected animals during early time post infection (3 dpi) (Fig 3.6A). But at later times e.g. 
5 dpi and 7dpi, the difference between the mutant and the wt virus was minor. Such rapid 
recovery in growth of 16-5A mutant virus led us to hypothesize that the mutant virus 
might have accumulated certain mutations enabling it to attain growth properties similar 
to wt PRSSV. To test this prediction, we sequenced the nsp1β region of virus from serum 
of 16-5A infected animals at 3, 7 and 14 dpi. Confirming our hypothesis, we observed an 
alanine to threonine substitution at amino acid position 18 of nsp1β at 3 dpi in all 16-5A 
infected animals (Fig 3.6B). These animals also accumulated another mutation at 7 dpi, in 
which alanine at position 19 reverted to valine, which is the parental amino acid at that 
position. At 14 dpi, both mutations were still present and no other mutations were 
observed in nsp1β amino acid sequence. This led us to investigate whether the resulting 
revertant nsp1β (nsp1β TV mut) could relieve IFN suppression. An ISG56 luciferase 
assay with the nsp1β TV mut showed that it has similar IFN-suppression ability as wt 
nsp1β and did not offer any relief from suppression unlike 16-5A mutant (Fig.6C). This 
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suggested that the quick growth recovery of the mutant virus was mediated through the 
mutations in the aa 18 and 19 position of nsp1β 16-5A, which led to the recovery of 
nsp1β‟s IFN-suppressive ability. 
Discussion 
PRRSV Nsp1‟s innate immune antagonistic action has attracted considerable 
attention in recent years resulting in research that has enhanced our understanding of the 
biological role of this protein. The known mechanisms of IFN-suppression by nsp1α 
include inhibition of IκB phosphorylation which prevents nuclear translocation of NF-κB 
(180). Nsp1β‟s mode of action includes both inhibition of IRF3 phosphorylation and 
nuclear translocation, as well as inhibition of STAT1/STAT2 nuclear translocation (16, 
29, 140). In addition,  Kim et al. has shown that expression of nsp1 can target CREB-
binding protein (CBP) for proteasomal degradation (87). Though these studies shed light 
on the steps in IFN pathway targeted by nsp1α and nsp1β, we still do not understand the 
mechanism by which this protein inhibits IFN signaling. A common theme emerged from 
the reported antagonistic action of nsp1β is that it interferes with nuclear translocation of 
several transcription factors (16, 140). This led us to investigate whether nsp1β hijacked 
the nuclear import machinery as the protein itself translocates into the nucleus after virus 
infection  and in the process might inhibit translocation of cellular proteins (29). We were 
unable, however, to find any interaction between nsp1β and the cellular importin-α 
proteins, and similar findings have been reported by others (140). Identifying the precise 
mechanism of action of both nsps will be important for mapping the residues involved in 
IFN down regulation.  
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Most of the research performed so far in relation to nsp1‟s anti-IFN activity 
includes protein overexpression. Such overexpression might lead to atypical expression, 
unusual localization of protein leading to artifactual functions. In response to such 
concern, we approached the question of whether nsp1 will act as an IFN-antagonist in the 
context of virus infection. To this end, the traditional method would call for development 
of a virus without the IFN antagonistic property followed by checking the relief in IFN 
suppression. However, since both nsp1α and nsp1β are required for viral sg mRNA 
synthesis and processing of polyprotein (two crucial steps in viral life cycle), it is 
impossible to completely remove them from the viral genome (90). Therefore, we 
performed alanine-scanning mutagenesis to map the residues involved in IFN-
suppression. This approach was predicted to have a better chance of recovering mutant 
viruses that can replicate. We identified several discontinuous stretches of nsp1β as being 
responsible for the inhibition of IRF3 mediated gene induction. It is possible that 
different stretches might target distinct steps in the IFN signaling pathway, a 
circumstance which could not be distinguished by our end point ISG56 luciferase assay. 
Interestingly, none of the alanine mutants could provide complete relief in the 
suppression when expressed individually (Fig.3.2B). This suggests that multiple regions 
of nsp1β are needed for inhibiting IFN production. Since these alanine mutants did not 
cover the whole nsp1β sequence, the presence of a region (not included in our assay) with 
anti-IFN activity cannot be ruled out at this time. Unlike nsp1β, we could more precisely 
locate (at the single amino acid level) the IFN-antagonism in nsp1α. The three nsp1α 
mutants G90S, N91A and L92A which are consecutively located exhibited complete 
relief of inhibition of IRF3 gene induction. All the three amino acids are important for 
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nsp1α homodimer interaction with N91 present on the surface of the protein according 
the newly described nsp1α crystal structure (187). It is therefore possible that nsp1α 
homodimerization may be a requirement for its IFN inhibitory activity. Both nsp1α and 
nsp1β are cysteine proteases and their protease activity is essential for correct processing 
of the viral polyprotein. Mutation of the protease active site residues did not affect their 
anti-IFN function. This observation is in line with the previous findings that both 
proteases are only capable of cis-proteolytic activity (cleaving themselves from the viral 
polyprotein) and once released from the polyprotein, cease at being proteolytically active 
(187, 233). Contrary to this view, Shi et al. have reported that mutation of the nsp1α 
protease active site resulted in loss of its anti-IFN property (170). Such discordance might 
be explained by the use of the nsp1 full length plasmid in the assay, as mutation of the 
cys76 (nsp1α protease active residue) in this construct will prevent the processing of 
mature nsp1α and nsp1β which might be important for IFN inhibition. An alternative 
explanation would be that the amino acids used for this substitution (serine for cysteine 
and tyrosine for histidine) might affect the normal protein structure compared to our 
alanine substitution. 
Our efforts to recover viruses with mutations in nsp1α and nsp1β had limited 
success. We could recover one mutant virus in nsp1α (G90S) and two in nsp1β (16-5A 
and 70-5A) out of ten different constructs. It is possible that these IFN-antagonist 
deficient viruses became susceptible to anti-viral action of IFN that is produced by 
transfection of the in vitro transcript during the virus recovery process. These transcripts 
possess the 5‟ triphosphate group, which is a strong inducer of RIG-I signaling (163). To 
avoid such endogenous IFN induction, we used BHK-21 cells which have impaired RIG-
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I signaling (64). However, when we repeated the transfection experiments in BHK-21 
cells we could only recover the above mentioned same three mutant viruses. There was 
no evidence of genome replication (nsp2/3 immunofluorescence staining) or sg mRNA 
synthesis (nucleocapsid immunofluorescence staining) in the case of any of the seven 
remaining constructs. This suggests that these mutations interfere with some basic 
requirements in viral replication, sg RNA transcription and/or polyprotein processing, the 
latter two being known functions of both nsp1α and nsp1β. 
Several studies have indicated that IFN antagonist knockout viruses present  
severe growth defects in vitro and are promptly cleared in vivo by the host IFN response 
(150). In this report, we have pursued characterization of one of the nsp1β mutant virus 
(16-5A). The virus exhibits slow growth kinetics in monocyte-derived macrophages and 
was able to attain a maximal titer of 10
4
 TCID50/ml. Such growth ability of 16-5A might 
be due to the residual IFN suppression activity of the virus encoded by four other fully 
functional IFN antagonistic nsps previously described. Though we observed similar level 
of nsp1β proteins between wt and 16-5A mutant in plasmid overexpression studies 
(Fig.3.2B), the 16-5A mutant virus expressed lower levels of nsp1β compared to the wt 
virus (Fig.3.4C). Such reduction in nsp1β might be a result of possible instability of the 
mutant protein resulting in its rapid removal, something that did not occur under 
individual overexpression conditions but happened in virus infected cells.   
The 16-5A mutant virus showed delayed growth kinetics in vivo but eventually 
reached titers equivalent to wt PRRSV at 7 dpi. This abnormal in vivo kinetics was due to 
the reversion of the 16-5A mutation, as the revertant nsp1β showed equally effective 
IFN-suppression as wt nsp1β. This gain-of-function mutation most likely contributed to 
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16-5A virus‟ ability to attain wt growth. It is possible that a minor species of virus with 
the mutation(s) has (have) appeared during our routine passage in cell culture (to prepare 
stocks for inoculation). However our sequencing control (standard Sanger sequencing) of 
the inoculant virus did not give any such indication. Nevertheless this indicates a strong 
selective pressure on these residues during growth inside the host. Interestingly, the first 
residue to be replaced is alanine at position 18 by a polar residue (threonine) (at 3 dpi). 
The natural amino acid at this position is lysine, which has been implicated in nsp1β‟s 
nuclease activity. Xue et al (233) have suggested that lysine18 is responsible for 
stabilizing the bound nucleic acid in the positively charged pocket formed in the nuclease 
domain of nsp1β. It should be mentioned that the function of this nuclease domain in 
viral life cycle is not known. It is therefore possible that the presence of a polar residue 
(like threonine) is essential for a functional nuclease activity, which might be important 
for in vivo viral replication. Mutation of lysine18 to alanine alone was not sufficient to 
alleviate nsp1β‟s IFN-suppression ability (in ISG56 luciferase assay), which suggests that 
nuclease activity is probably not important for IRF3 dependent IFN modulation (data not 
shown). It should be noted, however, that a possible role of the nuclease activity in other 
transcription factor mediated IFN induction cannot be excluded. 
In summary, our results confirm the IFN-inhibitory nature of PRRSV nsp1 in the 
context of virus infection. Alanine-scanning mutagenesis identified amino acids 
important for the anti-IFN property of both proteins nsp1α and nsp1β. A mutant virus 
which induces significantly higher level of IFN mRNA in vitro quickly reverted in vivo to 
acquire the IFN-suppression ability. Future studies should then include a more thorough 
scanning of the viral IFN antagonists to identify residues involved in antagonism. This 
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mutation study is especially challenging in case of PRRSV as it should target multiple 
nsps although most of them are essential for viral replicative cycle. Inclusion of an in 
vitro replication-transcription assay along with IFN-related assay will help to segregate 
the IFN-inhibitory domains from replicative domains of the proteins and accelerate the 
finding of successful candidate mutations. There are ample examples of viruses with 
rationally designed modifications to remove the anti-IFN property without alteration in 
their replication potential. Information from such studies can be incorporated to develop 
effective control strategies against PRRSV (235). 
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Table 3.1. Sequences of primers used to prepare the mutant nsp1α and nsp1β plasmids 
Primer name Primer sequence (5’ to 3’) Plasmid 
synthesized 
Nsp1β δ1 for GACTTTTGCCCTTTTGAGGAGGCGAAATTTGAAACTG pIHAflag-
nsp1βδ1 
Nsp1β δ1 rev CAGTTTCAAATTTCGCCTCCTCAAAAGGGCAAAAGTC 
Nsp1β δ2 for CCTCGTGGCGGGGATTCTAAGTTTGTGTTCATGC pIHAflag-
nsp1βδ2 
Nsp1β δ2 rev GCTATGAACACAAACTTAGAATCCCCGCCACGAGG 
Nsp1β δ3 for ACCACGCAGTGGACATGGGTAACTGCTGGTGGCG pIHAflag-
nsp1βδ3 
Nsp1β δ3 rev CGCCACCAGCAGTTACCCATGTCCACTGCGTGGT 
Nsp1β δ4 for GCTAATACTGTCCCTGAAAAGCATGGTGTCGCTGG pIHAflag-
nsp1βδ4 
Nsp1β δ4 rev CCAGCGACACCATGCTTTTCAGGGACAGTATTAGC 
Nsp1β δ5 for CAATTCGGCTATCAAAGGGAGTATTTCTCTGTTAGGG pIHAflag-
nsp1βδ5 
Nsp1β δ5 rev CCCTAACAGAGAAATACTGGGTTTGATAGCCGAATTG 
Nsp1β δ6 for GATGGACCCATTGTCGTAAGGGTAGAGCCCAATAC pIHAflag-
nsp1βδ6 
Nsp1β δ6 rev GTATTGGGCTCTACCCTTACGACAATGGGTCCATC 
Nsp1β 10-6A 
for 
GATATTGGTCATGGCGCCGCCGCCGCTGCAGCCAAAGGGAAAG
TCTCC 
pIHAflag-
nsp1β10-6A 
Nsp1β 16-5A 
rev 
CCGTCATGTATGTGGCCGCCGCTGCCGCCGCCTGGGCCCCTCGT
GGC 
pIHAflag-
nsp1β16-5A 
Nsp1β 21-7A 
rev 
CCAAAGGGAAAGTCTCCGCCGCCGCTGCTGCCGCCGCTGAGGC
GAAATTTGAAAC 
pIHAflag-
nsp1β21-7A 
Nsp1β 32-7A 
rev 
TTGGTTCGCGATCAACTTGGCGGCGGCAGCGGCAGCTGCAAAT
TTCGCCTCATCC 
pIHAflag-
nsp1β32-7A 
Nsp1β 48-6A 
rev 
AGACATGTCCACTGCGGCGGCGGCGGCGGCGGCGATGTGGAGT
TGGTTC 
pIHAflag-
nsp1β48-6A 
Nsp1β 70-5A 
rev 
CAGCCGTGTGGGCAGGCGGCGGCGGCAGCGACACCACTCCCA
GG 
pIHAflag-
nsp1β70-5A 
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Nsp1β 101-5A 
for 
ACTCGCTCCCACT 
GGCCGCTGCCGCCGCAGAAATTCGCCGTGCCA 
pIHAflag-
nsp1β101-5A 
Nsp1β 113-6A 
for 
TCGCCGTGCCAACCAAGCCGCCGCCGCAGCCGCCCATGG 
TGTCGCTGGC 
pIHAflag-
nsp1β113-6A 
Nsp1β 119-5A 
for 
CGGCTATCAAACCAAG 
GCTGCTGCCGCTGCCAAGTACCTACAACGGA 
pIHAflag-
nsp1β119-5A 
Nsp1β 124-4A 
for 
TGG TGTCGCTGGC GCCGCCGCAGCA CGGAGGCTGCAAGC pIHAflag-
nsp1β124-4A 
Nsp1β 136-5A 
for 
AAGCTAATGGTCTCGCAGCAGCCGCTGCTACAGATGGACCCAT
T 
pIHAflag-
nsp1β136-5A 
Nsp1β 142-5A 
for 
GCAGTGACTGATACAGCTGCAGCCGCTGCCGTACAGTATTT 
CTCTGTTA 
pIHAflag-
nsp1β142-5A 
Nsp1β 155-5A 
for 
ATTT CTCTGTTAGG GCCGCCGCCGCCGCC CACTTCAGACTGGC pIHAflag-
nsp1β155-5A 
Nsp1β 175-5A 
for 
CTGG GTTTGAAGAC 
GCCGCCGCAGCAGCCGTAGAGCCCAATACGTC 
pIHAflag-
nsp1β175-5A 
Nsp1β 192-6A 
for 
GTGACA AGGGTGGA GCAGCCGCCGCCGCTGCC AGTCACAA 
ATGGTACGGT 
pIHAflag-
nsp1β192-6A 
 
Nsp1α 20-4A 
rev 
CTGAGACATCGTGTGCAGTAGGCTGCGGCGGCCGCCATAAACA
CCCTGGCAT 
pIHAflag-
nsp1α20-4A 
Nsp1α 32-3A 
rev 
CAGAGGAAGGGCAGCGGCTGCACTGA   
 
pIHAflag-
nsp1α32-3A 
Nsp1α 38-3A 
rev 
CCAAGCTCAGGAACTGCGGCAGCCAGAGGAA 
 
pIHAflag-
nsp1α38-3A 
Nsp1α 41-5A 
rev 
AAAATAGGCCCAGCACTGCAGCGGCAGCAGCTTGGAGATTCAG
AGGAAG 
pIHAflag-
nsp1α41-5A 
Nsp1α 52-3A 
rev 
CCACCGGAGTGGCTCTGCGGCGGCGTAAAATAGGC 
 
pIHAflag-
nsp1α52-3A 
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Nsp1α 55-5A 
rev 
GGGGAATGCACGTGGCAACGTGGCGGCGGCTGCGGCTTCGGGC
CTGTAAAATAGGC 
pIHAflag-
nsp1α55-5A 
Nsp1α 63-5A 
rev 
CGGGGGAGCACTCAACAGCGGCGGCTGCAGCTGGCAACGTCCA
CCGGAG 
pIHAflag-
nsp1α63-5A 
Nsp1α 86-3A 
rev 
CAGGTTTCCACTGGCGGCTGCTGCAATTG pIHAflag-
nsp1α86-3A 
Nsp1α 89-5A 
rev 
CCAATTGCACGAATGACCGCTGCAGCCGCCGCCTTTCAACAAA
GAATGGTGCGG 
pIHAflag-
nsp1α89-5A 
Nsp1α 93-3A 
rev 
GGAAACCTGAACTTTGCAGCAGCAATGGTGCGGG pIHAflag-
nsp1α93-3A 
Nsp1α 97-4A 
rev 
TTCAACAAAGAATGGTGCGGGTCGCAGCTGAGATTTA pIHAflag-
nsp1α97-4A 
Nsp1α G90S 
rev 
GAAAGTTCAGGTTTGAACTGGTCATTCGTGC pIHAflag-
nsp1αG90S 
Nsp1α N91A 
rev 
GACCAGTGGAGCCCTGAACTTTCAAC pIHAflag-
nsp1αN91A 
Nsp1α L92A 
rev 
GACCAGTGGAAACGCGAACTTTCAAC pIHAflag-
nsp1αL92A 
Nsp1α Q95A 
rev 
CCCGCACCATTCTTTGTGCAAAGTTCAGGTTTCCACT pIHAflag-
nsp1αQ95A 
Nsp1α Q96A 
rev 
GCTGCGACCCGCACCATTCTTGCCTGCTTGAAAGTTCAGGTTTC
C 
pIHAflag-
nsp1αQ96A 
Nsp1α R97A 
rev 
GCTGCGACCCGCACCATTGCTTGTTGAAAGTTCAGGTT pIHAflag-
nsp1αR97A 
Nsp1α R100A 
rev 
CAACAAAGAATGGTGGCGGTCGCAGCTGAG pIHAflag-
nsp1αR100A 
Nsp1α Y122A 
rev 
CTACAAGTTGCTGAACGGGGTTGC pIHAflag-
nsp1αY122A 
Nsp1α G125A 
rev 
TTATGAACGGGCTTGCCGCTGGTA pIHAflag-
nsp1αG125A 
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Nsp1α C126A 
rev 
ATGAACGGGGTGCCCGCTGGTACCC pIHAflag-
nsp1αC126A 
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Fig.3.1. PRRSV nsp1β does not interact with IKKε and importin-αs. HEK-293TLR3 
cells were transfected with indicated plasmids (on top). Forty eight hours post 
transfection, cell lysates were immunoprecipitated (IP) with anti-HA antibody and after 
SDS-PAGE separation of the precipitated proteins, the blots were probed (WB) with 
antibodies indicated on the left. A 5% whole cell lysate (WCL) sample was also probed 
similarly to confirm the expression of different protein partners. The identities of various 
protein bands are indicated on the right. The IKKε specific band is indicated with an “*” 
in the WCL panel. 
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Fig.3.2. Mutant nsp1β with reduced ability to antagonize IRF3 mediated gene 
induction. ISG56 luciferase assay was performed with nsp1β block deletion mutant (A), 
nsp1β alanine scanning mutant (B) and nsp1β protease active site mutants (C). HEK-
293TLR3 cells were co-transfected with indicated nsp1β mutant expression plasmids (0.5 
μg) or empty vector (vector), ISG56-Luciferase plasmid (0.4 μg), and pRLTK (0.01 μg). 
At 40 h post transfection cells were treated with 5 µg/ml dsRNA for 6 h and assayed for 
luciferase activity. The panel below the bar graph shows the expression of respective 
mutant nsp1β. Bars represent average (n=3) percentage relief in ISG56 promoter 
suppression ± SEM for luciferase activities compared to vector control (normalized to 
100 %). Actin served as loading control. 
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Fig.3.3. Mutant nsp1α with reduced ability to antagonize IRF3 mediated gene 
induction. ISG56 luciferase assay was performed with nsp1α alanine scanning mutant 
(A), nsp1α single amino acid substitution mutant (B) and nsp1α protease active mutant 
(C). HEK-293TLR3 cells were co-transfected with indicated nsp1α mutant expression 
plasmids (1 μg) or empty vector (vector), ISG56-Luciferase plasmid (0.4 μg), and 
pRLTK (0.01 μg). At 40 h post transfection cells were treated with 5 µg/ml dsRNA for 6 
h and assayed for luciferase activity. The panel below the bar graph shows the expression 
of respective mutant nsp1α. Bars represent average (n=3) percentage relief in ISG56 
promoter suppression ± SEM for luciferase activities compared to vector control 
(normalized to100 %). Actin served as loading control. 
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Fig.3.4. Characterization of 16-5A mutant virus in vitro. (A) Multiple step growth 
kinetics of 16-5A virus in comparison to parental wt virus. Monocyte derived 
macrophages were infected with 0.1 MOI of both viruses and culture supernatant were 
collected at indicated time post infection. They were titrated in MARC-145 cells and 
titers are expressed in Log10TCID50/ml. Error bars indicate SEM values derived from 
three independent experiments. (B) Plaque morphology of 16-5A and wt FL12 virus in 
MARC-145 cells. (C) Viral nsp expression profile. MARC-145 cells were infected with 1 
moi of both viruses (indicated on top) and cells were harvested 12 h post infection (hpi). 
The level of individual nsps (indicated on right) was detected by immunoblotting with 
respective antibodies. (D) Subcellular localization of wt nsp1β and nsp1β 16-5A mutant 
proteins. Hela cells were transfected with indicated protein coding plasmids and 
immunostaining was performed using anti-FLAG antibody to detect Flag-nsp1β (green). 
Proteins detected are indicated inside the panel. Position of nucleus is indicated by DAPI 
(blue) staining in the merge image (right most panels). 
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Fig.3.5. The 16-5A mutant virus induces higher level of type I IFN mRNA. Porcine 
monocyte derived macrophages were mock infected/infected with 1 MOI of 16-5A 
mutant or wt FL12 virus. Total RNA isolated from cells was reverse transcribed and real 
time PCR was done for detection of porcine IFN-α (A), IFN-β (B) mRNA. The mRNA 
copy numbers were calculated after normalization with porcine β-actin copy number and 
expressed relative to mock control. Bars show average of mRNA copy numbers ± SEM 
from two independent experiments. (C)  MARC-145 cells infected with 16-5A/ wt virus 
and 12 hpi were super-infected with sendai virus (SeV) 50 HA (hemagglutinating) 
Units/ml to induce IFN synthesis for another 12 h. ISG56 protein level was detected by 
immunoblotting. The β-actin served as loading control. 
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Fig.3.6. Growth attenuation and instability of 16-5A virus in vivo. (A) The in vivo 
growth property of 16-5A virus. Wt FL12 or 16-5A mutant viruses were inoculated into 
growing pigs and serum was collected at indicated days post infection. After isolation of 
total RNA from serum, 4μl of RNA was used in a single step real-time PCR reaction to 
detect viral RNA copy numbers. The bars represent mean of the viral RNA copy number 
from 4 different animals in each group. Error bars indicate SEM values. (* indicate 
p<0.05 and ns is not significant). (B) Mutations in the nsp1β in 16-5A infected pigs. The 
nsp1β region was amplified by reverse transcription PCR from the serum of 16-5A 
mutant virus infected pigs at indicated days post infection (dpi). The amino acid 
sequences from number 16 to 20 of nsp1β of different dpi were aligned. The 0 dpi 
indicates the inoculated mutant sequence and dot (.) indicates no change in amino acid. 
The wt nsp1β sequence is mentioned in bottom for comparison. (C) ISG56 luciferase 
assay to determine the level of suppression of IRF3 dependent activation by nsp1βwt and 
nsp1β TVmut. Luciferase assay was performed and the results are presented as 
mentioned earlier. 
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CHAPTER IV 
Cellular poly(C) binding protein 1 and 2 interact with porcine 
reproductive and respiratory syndrome virus non-structural protein 1β 
and support viral replication 
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Abstract 
PRRSV infection of swine causes substantial economic losses in the swine industry 
worldwide. Identification of cellular factors involved in PRRSV lifecycle will not only 
enable a better understanding of virus biology but also has the potential for development 
of anti-viral therapeutics. The non-structural protein (nsp)-1 of arteriviruses (including 
PRRSV) has been implicated in viral sub genomic (sg) mRNA transcription. However, 
the mechanism by which nsp1 promotes viral transcription is unknown.  To address the 
role of nsp1, PRRSV nsp1β was used as bait to identify cellular proteins that interact with 
this protein. This analysis revealed that nsp1β interacts with cellular poly (C)-binding 
proteins (PCBPs): PCBP1 and PCBP2. The interactions of PCBP1 and PCBP2 with 
nsp1β were confirmed both in co-immunoprecipitation and in vitro binding assays. The 
PCBPs are nucleic acid binding proteins and are known to regulate both transcriptional 
and post-transcriptional events in cellular and viral productive infection. During PRRSV 
infection, both PCBP1 and PCBP2 re-localize as perinuclear speckles close to viral 
replication-transcription complexes. Moreover recombinant purified PCBP1 and 
PCBP2bind the viral 5‟ untranslated region (UTR). SiRNA-mediated silencing of PCBP1 
and PCBP2 in cells resulted in reduced PRRSV genome replication and transcription 
without any adverse effect on initial polyprotein synthesis. Overall, the results presented 
here point towards an important role for PCBP1 and PCBP2 during PRRSV infection. 
Key words- nsp1β, PCBP1, PCBP2, viral replication. 
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Introduction 
Porcine reproductive and respiratory syndrome virus (PRRSV) is considered to be 
the most significant swine pathogen worldwide. Viral infection leads to late term 
reproductive failure in pregnant sows and respiratory distress in young piglets. A study 
conducted in 2005 estimated the annual loss due to PRRS to the US swine industry to be 
$560 million. PRRSV is a member of family Arteriviridae, which includes equine 
arteritis virus (EAV), lactate dehydrogenase elevating virus (LDV) and simian 
hemorrhagic fever virus (SHFV). Together with Coronaviridae and Roniviridae families, 
Arteriviridae form the order Nidovirales (24). PRRSV contains a (+) sense single-
stranded RNA genome of ~15 Kb in length. The RNA genome is polyadenylated at the 3‟ 
end and possesses a 5‟ cap structure (120). The non-structural proteins (nsps) are encoded 
in the 5‟-proximal two-thirds of the genomic RNA and are synthesized as polyproteins 
from two open reading frames (ORFs): ORF1a and ORF1b. Upon translation, the two 
polyproteins are co- and post-translationally processed by four virus encoded proteolytic 
enzymes i.e. nsp1α, nsp1β, nsp2 and nsp4 to produce 14 different nsps (175, 203). Some 
of these nsps are assembled to form the viral replicase complex and along with host cell 
components, carry out and regulate viral RNA replication, subgenomic (sg) mRNA 
transcription, and translation. The PRRSV structural proteins encoded by the 3‟-proximal 
one third of the genomic RNA are expressed from a set of six nested sg mRNAs through 
a process of discontinuous RNA transcription (138, 162). These sg mRNAs are 
polycistronic except for the last sg mRNA (sg mRNA7), but only the 5‟ proximal ORF is 
translated to generate a structural protein. The sg mRNAs are 3‟ coterminal and also 
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share a common leader sequence at their 5‟ end with genomic RNA, a property unique to 
both Coronaviruses and Arteriviruses (7, 39). 
In the case of Nidoviruses, the genomic RNA acts as a template for viral protein 
synthesis, genome replication [genome length and subgenome length (-) strand 
production] as well as being encapsidated into virions. These processes must be regulated 
by viral and host cell factors for efficient replication of the virus. Identification of such 
factors is challenging, as it needs uncoupling of the tightly linked processes of genome 
replication and transcription. Studies have identified EAV nsp1 and nsp10 as the two 
proteins essential for sg mRNA synthesis but are dispensable for viral genome replication 
(198, 209). A similar role has also been attributed to PRRSV nsp1α, in which mutations 
of the protease active site led to a replication competent but sg mRNA transcription 
incompetent virus (90). The same study also described that a mutation in the nsp1β 
protease active site results in a total loss of RNA replication, presumably because of the 
absence of cleavage of nsp1β-nsp2 junction. More recently, a report by Nedialkovaet al. 
has shown that all three subdomains of EAV nsp1 (zinc finger, PCPα and PCPβ) are 
important for transcription (128). Importantly, this study also demonstrated that the 
PCPβ‟srole during sg mRNA transcription is separate from its protease function. 
Furthermore, nsp1 regulates the relative amount of viral mRNA by controlling the 
accumulation of full length and subgenome length (-) strand templates (128). In addition 
to its role in viral sg mRNA transcription, EAV nsp1 is also involved in polyprotein 
processing and virion biogenesis, which underscores its multifunctional role in the life 
cycle of the virus (198). A similar role can also be predicted for the PRRSV 
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orthologsnsp1α and nsp1β. In addition to their involvement in viral gene expression, both 
subunits of nsp1 are inhibitors of cellular innate immune responses(16, 29, 87, 140, 185). 
While the number of functions attributed to Arterivirus nsp1 is growing rapidly, 
molecular mechanisms of their functions have not been clearly elucidated. Identification 
of cellular proteins that interact with nsp1 will shed light on its various roles. An earlier 
report identified the cellular transcriptional co-activator p100 as an interacting partner 
with EAV nsp1, which inferred this interaction is important for viral sg mRNA synthesis 
(199). In this study, we have identified cellular PCBP1 and PCBP2 as two interaction 
partners for PRRSV nsp1β. PCBPs are a group of RNA/DNA binding proteins initially 
characterized by their high affinity binding to nucleic acid homopolymers (100). Both 
PCBP1 and PCBP2 are involved in RNA metabolism [reviewed in (27, 113)]. At the 
transcriptional level, PCBP1 and PCBP2 participate in cellular and viral RNA 
stabilization and enhancement of transcription. At the post-transcriptional level, they 
have been implicated in the attenuation of mRNA splicing, translational enhancement, 
and translational silencing. We have found that in PRRSV-infected cells, PCBP1/2 re-
localizes to viral replication-transcription complexes (RTCs) and also bind to the PRRSV 
5‟UTR in vitro. Silencing of PCBPs reduced viral genome replication and sg mRNA 
transcription in PRRSV infected cells. Our data suggests that PCBPs cooperate with the 
viral nsps to facilitate viral replication. 
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Materials and methods 
Cells and viruses-293T (ATCC), MARC-145 (obtained from Dr. Will Laegreid, 
USMARC, USDA/ARS) (85) and BHK-21 (ATCC) cells were maintained in DMEM 
containing 10% fetal bovine serum and 50μg/ml of gentamicin (Sigma). The virulent 
North American infectious clone derived PRRSV strain FL12 (202) was propagated and 
titrated in MARC-145 cells to prepare the virus stocks for this study. 
Preparation of green fluorescent FL12 virus- The fluorescent FL12 (FLeGFP) virus 
was produced by engineering an eGFP coding sequence between ORF1b and ORF2 
region of FL12 infectious clone by reverse genetics using a method similar to one 
described earlier (142). Briefly, an oligo containing several restriction enzyme sites and 
PRRSV ORF6 transcription regulatory sequence (TRS) was inserted between ORF1b 
stop and ORF2 start at nt position 12074. The restriction sites can be used to insert any 
gene of interest to the viral genome and this gene’s transcription will be driven by TRS2 
present inside ORF1b. The role of ORF6 TRS (TRS6) is to drive transcription of ORF2a 
and 2b. Initially the cDNA sequence from nt 8887 to nt 12166 were cloned in pCDNA3.1 
vector using standard cloning technique to produce an intermediate plasmid, pCDNA3.1-
3280 for easier manipulation using primer pair- AflIIAsisI for and RsrIIEcoRV rev. Then 
two PCR products (PCR1 and PCR2) were obtained with 28 nt overlap. PCR1 was 
performed with AflIIAsisI for primer and ORF1bXhoI rev primer. PCR2 was performed 
with XhoITRS for and RsrIIEcoRV rev primer. Primer sequences are mentioned in Table 
2.Using PCR1 as template and AflIIAsisI for as forward primer and PCR2 as reverse 
primer the entire cDNA region from nt 8887 to nt 12166 of FL12, which now encompass 
the restriction sites for insertion of gene of interest as well as the TRS6 was amplified. 
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This PCR product was then cloned in pCDNA3.1-3280 vector using AflII and RsrII 
restriction enzyme, giving rise to pCDNA3.1-3280-REsTRS. Then the eGFP cDNA was 
cloned in this pCDNA3.1-3280-REsTRS vector using NotI enzyme. Next this entire 
FL12 genome sequence along with eGFP were subcloned in pFL12 full length cDNA 
clone using AsisI and EcoRV restriction sites resulting in pFLeGFP plasmid. Following 
standard in vitro transcription procedure, the infectious RNA was obtained from this 
cDNA template and used for FLeGFP virus recovery by electroporation into MARC-
145cells as described elsewhere(202). 
Plasmids and antibodies -The human PCBP1 and PCBP2 cDNA sequences were 
amplified from 293T cells by PCR. Briefly, total RNA was isolated from 293T cells and 
cDNA was synthesized using Superscript-III (Invitrogen) reverse transcriptase using 
oligodT primer following manufacturer‟s protocol. The resulting cDNA was used for 
PCR amplification of HA-PCBP1 and HA-PCBP2 using the following pair of primers: 
for PCBP1, HA- NheIPCBP1 for and EcoRIPCBP1 rev primers were used; for PCBP2, 
KpnIPCBP2 for and ECoRIPCBP2 rev primers were used. Amplified PCBP1 was cloned 
in pCDNA3.1 (+) vector (Invitrogen) using NheI and EcoRI site to have a N-terminal 
fused HA-tagged PCBP1 vector (pcDNA3.1-HA-PCBP1). Subsequently this pcDNA3.1-
HA-PCBP1 was utilized for cloning PCBP2 using KpnI and EcoRI restriction sites, 
giving rise to pcDNA3.1-HA-PCBP2. The cloned cDNA sequences were verified by 
sequencing and found to correspond to Genbank no.NM_006196 (human PCBP1) and 
Genbank no.NM_001128913.1 (human PCBP2 transcript variant 6). PCBP1 and PCBP2 
cDNAs were also subcloned in pET28a(+) vector (Novagen) using NheI and EcoRI 
restriction enzymes. These vectors were named pET28-PCBP1 and pET28-PCBP2 and 
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were used for expression of corresponding proteins in bacteria. Construction of Flag-
nsp1β (185) and Flag-nsp9 (16)  has been described earlier. For bacterial expression of 
GST tagged nsp1β protein expression a pET41C (+) nsp1β vector was prepared. First 
nsp1β sequence was amplified from pIHAFlag- nsp1β vector using the primer set- 
EcoRInsp1β for and Nsp1R primer (185). Then using EcoRIand NotI restriction enzymes 
nsp1β cDNA was cloned in pET41C (+) vector (Novagen). For preparation of PRRSV 5‟ 
UTR and 3‟UTR radiolabelled probes cDNA fragments from FL12 infectious clone 
(Genbank accession no. AY545985) corresponding to nt 1 to 191 (5‟UTR) and nt 15263 
to 15413 (3‟UTR) were cloned in pCDNA3.1 (+).The vectors were named as pCDNA3.1 
(+)-5‟UTR and pCDNA3.1 (+)-3‟UTR respectively. For 5‟UTR- 5‟UTRHindIIIfor with 
5‟UTR NcoIrev and for 3‟UTR- 3‟UTR XbaIfor with 3‟UTR XbaIrev primers were used. 
As these cDNAs are located downstream of T7 promoter, corresponding RNAs can be 
produced using T7 polymerase. The 3‟UTR cDNA was also inserted in the pCDNA3.1 (-
) vector to prepare pCDNA3.1 (-)-3‟UTR, and this was used to prepare (-) sense 3‟UTR 
to be used as probe for (+) sense genomic/sg RNA detection by Northern hybridization. 
The cloned cDNAs were confirmed for correct sequences and proper orientation by 
sequencing. The primers used in this study are listed in table 2. 
The antibodies used in this study and their source are as follows: mouse anti-β-
Actin (Sc-47778), normal mouse IgG1 (Sc-3877), goat anti-PCBP1 (Sc-16504), goat 
anti-PCBP2 (Sc-30725) and mouse anti-GFP (Sc-9996) antibodies were obtained from 
Santa Cruz Biotech. Mouse anti-HA (H3663) and rabbit anti-HA (H6908); anti-Flag M2 
(F3165) and rabbit anti-Flag (F7425) were obtained from Sigma Aldrich. Secondary 
antibodies conjugated to HRP were purchased from Kirkegaard and Perry Ltd (KPL) are- 
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goat anti-mouse (074-1807) and goat anti-rabbit (214-1516). PRRSV nsp1 antibody was 
developed by immunizing rabbits with the protein and could detect both nsp1α and 
nsp1β. The anti-nsp2/3 antibody was a generous gift from Dr. Eric J. Snijder, LUMC 
(90). 
Co-Immunoprecipitation (Co-IP) and GST- pull down assay- In over-expression 
experiments indicated plasmids were transfected in 293T cells using Lipofectamine 2000 
(Invitrogen) as per manufacturer‟s protocol. Then 36 to 48 h post transfection cells were 
harvested after two washings in PBS for cell lysate preparation. In experiments involving 
Co-IP in virus infected cells, MARC-145 cells were harvested for lysis at 24 to 48 h post 
infection. Lysis was performed in RWS buffer (Radioimmunoprecipitation assay buffer 
Without SDS) which contains 10 mMTris-HCl, pH 8.0, 150 mMNaCl, 1% Triton X-100, 
1% sodium deoxycholate, and 1x protease inhibitor. After clarification at 13,000 RPM 
for 10 min at 4°C, the lysates were incubated with indicated antibodies overnight. 
Immunoprecipitation involving anti-Flag antibody used the agarose conjugated to anti-
Flag M2 antibody (Sigma). For the rest of the immunoprecipitation experiments, lysates 
were incubated with antibodies for 12-16 h followed by precipitation of the complex 
using protein Asepharose beads (GE biosciences) for 2 h. Where indicated, the clarified 
lysates were treated with a mixture of RNAse A (2.5 U/100μl) and T1 (1U/μl) for 1 h at 
room temperature before IP. The antigen-antibody complexes were washed four times in 
Tris buffered saline and subsequently eluted from the beads by boiling in Laemmlli SDS-
PAGE loading buffer. The eluted proteins along with the 5% of whole cell lysate (WCL) 
were resolved in SDS-PAGE and subjected to immunoblotting as described earlier with 
indicated antibodies (16). For GST-pull down assays, GST or GST-nsp1β proteins 
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expressed in Escherichia Coli (BL21 cells) were first conjugated to glutathione beads 
using manufacturer‟s protocol (GE Biosciences). Conjugated beads were blocked 
overnight with 5% BSA. These blocked beads were washed twice with TIF buffer (20 
mMTris-HCl, pH 8.0, 150 mMNaCl, 1mM MgCl2, 0.1% NP-40, 10% Glycerol, 0.1mM 
DTT and 1X protease inhibitor) and incubated with purified recombinant PCBP1 or 
PCBP2 for 2 h at room temperature. Then the beads were washed at least 6 times with 
TIF buffer followed by elution of bound proteins using SDS-PAGE loading buffer and 
electrophoresis. 
siRNAs, PRRSV full-length in vitro transcript transfection and virus recovery- 
Human PCBP1 and PCBP2 specific SMARTpool siRNAs were purchased from 
Dharmacon . These siRNAs were used at 10nM (MARC-145 cells) or 20nM (BHK-21 
cells) final concentration for transfection. Transfections of siRNAs were performed using 
LipofectamineRNAiMax (Invitrogen) following the reverse transfection protocol as per 
the supplier‟s recommendation. Seventy-two hour post transfection cells were used for 
further experiments as indicated. 
Generation of full-length viral in vitro transcripts has been described earlier (92, 
202). Approximately 5μg of in vitro transcribed RNA was electroporated in 1.25x106 
BHK-21 cells using Ingenio electroporation solution (Mirus Bio) in a BioRad Gene 
Pulser instrument. The electroporation parameters used were voltage-150V, capacitance-
950μF and resistance-∞. Electroporated cells were resupended in DMEM and 10% FBS 
and incubated at 37°C with 5% CO2 for indicated time points before being harvested for 
further assays. 
Bacterial protein production and purification- The pET28-PCBP1and pET28-PCBP2 
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plasmids were transformed in Escherichia Coli (BL21) cells (Novagen). Overnight 
cultures of transformed Escherichia Coli were diluted 1:10 and the culture was allowed 
to grow until the OD550 reached 0.55. At this point protein expression was induced by 
addition of IPTG to a final concentration of 1mM for an additional 3.5 h. Cells were 
harvested by pelleting the culture and the His-tagged PCBP1/2 were purified  from the 
bacterial pellet under native conditions using ProBond purification system (Invitrogen) as 
per the manufacturer‟s recommendation. Purified proteins after being resolved in SDS-
PAGE are stained with Coomassie to check for its purity. 
RNA probe preparation- Uniformly labeled PRRSV 5‟UTR and 3‟UTR radiolabelled 
[α32P] probes were prepared by in vitro transcription with T7 polymerase using T7-
Riboprobe kit (Promega). pCDNA3.1(+)-5‟UTR and pCDNA3.1(+)-3‟UTR were 
digested with NdeI,XhoI and NdeI, ApaI enzyme pairs respectively. The released 5‟UTR 
and 3‟UTR coding sequence along with T7 promoter were purified and used in the in 
vitro transcription reaction. Unlabeled specific competitor RNA probes were made by 
omitting UTP [α32P] from the in vitro transcription reaction mixture. For non-specific 
competitor RNA synthesis a piece of pcDNA3.1 vector DNA was used as template. 
pCDNA3.1(-)-3‟UTR vectors was digested with NdeI and ApaI to release the T7 
promoter-3‟UTR region which was used as template in in vitro transcription reaction to 
prepare (-) sense 3‟UTR (ns3‟UTR) probe. For (-) sense genomic/sg RNA detection a 
longer probe encompassing nt 14896 to nt 15403 was used. PCR was performed with 
T7PNfor and 3UTR141R21rev primers, encompassing the above region of PRRSV FL12 
genome. The resulting PCR product after purification was used as template in in vitro 
transcription reaction to produce (+) sense 3‟UTR (ps3‟UTR) probe. The in 
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vitrotranscribed RNAs were purified by QiagenRNAeasy column followed by a 
Phenol:Chloroform purification and quantitation by spectrophotometer. Amount of 
radiolabel incorporation was determined by scintillation counting. The ns3‟UTR and 
ps3‟UTR probes were used for determining viral genomic/subgenomic and anti-
genomic/-subgenomic RNAs respectively. 
Electrophoretic mobility shift assay (EMSA)- RNA binding reactions and EMSAs 
were performed as described previously with certain modifications (5). The purified 
probes were refolded by melting at 80°C followed by gradual cooling down to room 
temperature. Then 100nM labeled RNA was incubated with indicated amount of purified 
rPCBP1 or rPCBP2 in a RNA binding buffer [5mM HEPES, pH-7.5, 25mM KCl, 2mM 
MgCl2, 0.1mM EDTA, 3.8% glycerol, 2mM DTT, 0.5mg/ml bovine serum albumin, 
0.5mg/ml Heparin, 0.25 mg/ml Escherichia ColitRNA,  8U of RNasin (RNase inhibitor, 
Promega)]. The incubation was conducted for 20 min at 30°C. In case of competition 
EMSAs, rPCBP1 and rPCBP2 were pre-incubated with specific/non-specific competitor 
for 20 min at 30°C before addition of radiolabeled probe and the incubation was 
continued for another 20 min at 30°C. The resulting ribonucleoprotein (RNP) complexes 
were resolved in 5% native polyacrylamide (29:1 Acrylamide: Bisacrylamide)-5% 
glycerol-0.5X Tris-borate EDTA (TBE) gels. The gels were pre-run for 30 min before 
loading of the samples and subsequently run for 4 h. Then the gels were dried and 
visualized by exposing to a phosphorimager screen. 
Viral titration and Real-time PCR for viral RNA quantitation- Virus infected cell 
culture supernatant samples were collected after indicated time post infection and stored 
at -80°C until titration or RNA isolation. Titrations of the supernatants were performed 
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using standard plaque assay procedure in MARC-145 cells. Single-step Taqman-based 
reverse transcription-real time PCR using Hot start-IT Probe one step qRT-PCR master 
mix (Affymetrix, Cleveland, OH) was designed to measure viral RNA copy number 
targeting to 3‟UTR of type II PRRSV in a Cepheid Smartcycler (Sunnydale, CA). Viral 
RNA was isolated using Qiagen Viral RNA mini kit (Qiagen, Valencia, CA) from 140μl 
of culture supernatant following manufacturer‟s instructions. The isolated RNA (4μl) was 
run and the RNA copy number was calculated using a standard curve generated with in 
vitro transcript. 
Viral RNA isolation and detection by Northern hybridization- Total cellular RNA 
from PRRSV infected MARC-145 cells were isolated at indicated time post-infection 
using Trizol reagent (Invitrogen). After spectrophotometric quantification, 5-10μg of total 
RNA were resolved by agarose gel electrophoresis using a glyoxal based buffer 
(NorthernmaxGly, Ambion). Transfer of RNA to nylon membrane and hybridization with 
radiolabeled probe was done using NorthernmaxGly kit (Ambion) as per manufacturer‟s 
recommendation. Hybridized membranes were exposed to phosphorimager screens and 
RNA bands were visualized by scanning the screens in a BioRad scanner. 
Reverse transcription PCR for IFN-β and PCBP2 mRNA- Total RNA was isolated 
from cells using Trizol reagent (Invitrogen). After quantification equal amount of RNA 
was reverse transcribed using oligodT primer using M-MLV reverse transcription kit 
(Invitrogen). The resulting cDNA was used in a PCR reaction to amplify the target gene 
(IFN-β and PCBP2). Primers used are-for IFN-β, hIFNb for and hIFNb rev, for PCBP2, 
KpnIPCBP2for and PC2KH12EcoRI rev. Cellular RPL32 (16) and GAPDH were also 
amplified and serve as internal control. Primer sequences are listed in table 2. 
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Indirect Immunofluorescence-Indirect immunofluorescence and confocal microscopy 
for visualization of sub cellular protein localization were performed as described 
previously (16). For nsp1β-PCBP1/2 and nsp9-PCBP1/2 co-localization studies, anti-Flag 
polyclonal antibody and anti-HA monoclonal antibody were used. For PCBP1/2 re-
localization experiments anti-nsp2/3 polyclonal antibody and anti-HA monoclonal 
antibody were used. Secondary antibodies used were- Alexa-Fluor 568 Donkey anti-
mouse and Alexa-Fluor 488 Goat anti-rabbit. 
Silver staining and Mass spectrometric identification of proteins- The 
immunoprecipitated proteins were resolved in SDS-PAGE and the acrylamide gels were 
stained with silver using a protocol described earlier (25). The stained bands were excised 
and subjected to LC/MS as described before (83). Briefly, gel pieces were digested by 
trypsin and digested peptides were extracted in 5% formic acid / 50% acetonitrile and 
separated using C18 reversed phase LC column (75 micron x 15cm, BEH 130 , 1.7 
micron Waters, Milford, MA). A Q-TOF Ultima tandem mass spectrometer couple with a 
Nanoaquity HPLC system (Waters) with electrospray ionization was used to analyze the 
eluting peptides. The peak lists of MS/MS data were generated using Distiller (Matrix 
Science, London, UK) using charge state recognition and de-isotoping with the other 
default parameters for Q-TOF data. Data base searches of the acquired MS/MS spectra 
were performed using Mascot (Matrix Science, v2.2.0, London, UK).  The NCBI 
database (20100701) was used in the searches. 
Statistical analysis- Statistical analyses were performed using GraphPad Prism software 
(Graphpad software Inc).  Student‟s unpaired t-test was used to compare the viral titers as 
well as viral RNA copy numbers. The p-values are indicated in the figure legend. 
121 
 
Results 
Identification of PRRSV nsp1β-interacting proteins by immunoprecipitation and 
mass spectrometry. In order to detect cellular proteins that potentially associate with 
PRRSV nsp1β inside the cell, we employed an immunoprecipitation (IP)-coupled mass 
spectrometry (MS) approach. A plasmid encoding Flag-tagged nsp1β (Flag-nsp1β) or an 
empty vector encoding only the Flag sequences (Vector) were transfected into 293T cells. 
Subsequently, nsp1β and its associated proteins were affinity purified using anti-Flag M2 
affinity gel from the cell lysates. After elution from the agarose resin, proteins were 
resolved in SDS-PAGE and subsequently the protein bands were visualized by silver 
staining. In addition to the detection of several common bands in both vector and nsp1β 
lanes, at least four specific bands were detected in nsp1β lane (indicated by asterisk *) 
(Fig.4.1). These bands were excised from the gel and after tryptic digestion; the identity 
of the respective co-immunoprcipitated proteins was determined by liquid 
chromatography (LC)-MS. The band migrating just above the IgG-light chain (IgG-L) 
was identified as PRRSV nsp1β (~27KDa) indicating successful immunoprecipitation.  
Several other cellular proteins were identified by LC-MS analysis of the four bands. 
Their identities including number of separate peptides detected in MS analysis as well as 
the MASCOT score are shown in Table 4.1. The present study is focused on two cellular 
proteins detected at ~ 40 KDa ranges (in band 3) - PCBP1 and PCBP2. 
Interaction and co-localization of PCBP1 and PCBP2 with PRRSV nsp1β. Our first 
objective was to confirm the PRRSV nsp1β‟s interaction with cellular PCBP1/2 as 
observed in the MS study. Initially we used Co-IP assays to validate these interactions. 
293T cells were transfected with Flag-nsp1β or empty vector (Flag-EV) along with HA 
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tagged PCBP1 (HA-PCBP1) or HA tagged PCBP2 (HA-PCBP2). IP was performed with 
either a Flag-specific antibody or an isotype control antibody (normal mouse IgG1). The 
immune-complexes were resolved in SDS-PAGE and probed for the presence of 
PCBP1/2 using anti-HA antibody. We successfully detected the presence of HA-
PCBP1/HA-PCBP2 only in the presence of Flag-nsp1β, but not in the presence of Flag-
EV (Fig. 4.2A and 4.2B). Moreover, IP with the isotype control antibody failed to pull 
down HA-PCBP1/2 suggesting that the nsp1β-PCBP1/2 interaction was specific. Another 
approach to validate the potential interaction between two proteins is to check their sub-
cellular localization in cells co-expressing both proteins. To investigate this, we 
expressed nsp1β and PCBP1 or PCBP2 by transfecting respective protein encoding 
plasmids in MARC-145 cells. Figure 4.2C showed strong co-localization of nsp1β with 
PCBP1/2 in cells expressing both proteins. The co-localization is more pronounced inside 
the nucleus, but some level of cytoplasmic localization of both proteins could also be 
observed. So, both the Co-IP and immunofluorescence assays confirmed interaction 
between PRRSV nsp1β and cellular PCBP1/PCBP2. 
We next examined whether similar interactions exist in the context of PRRSV 
infection. For this, we performed Co-IP of virus-infected MARC-145 cell lysates with 
anti-PCBP1 antibody. After SDS-PAGE separation the blot was probed for the presence 
of nsp1β using an antiserum that detects both subunits of PRRSV nsp1 i.e. nsp1α and 
nsp1β. We could detect the presence of nsp1β but not nsp1α in PRRSV-infected MARC-
145cells (Fig.4.2D). A similar approach to detect nsp1β-PCBP2 interaction in virus-
infected cells was unsuccessful, perhaps PCBP2 antibody does not efficiently 
immunoprecipite PCBP2 (data not shown).  
123 
 
Recent crystallographic studies suggested nsp1β to be a nuclease with the 
potential to bind both DNA and RNA (233). Since both PCBP1 and PCBP2 are also 
proteins with strong affinity for RNA and DNA, we tested whether nsp1β-PCBP 
interaction might be mediated through a non-specific RNA bridge between the protein 
partners. To test this prediction, we treated the cell lysate with a mixture of RNase A and 
T1 before conducting the immunoprecipitation. The ribonuclease treatment did not 
eliminate or reduce the nsp1β-PCBP interaction, suggesting that the interaction between 
these proteins was not a result of both proteins interacting with the same RNA molecule 
(Fig.4.2E). 
The above experiments did not exclude the possibility that nsp1β-PCBP1/2 
association might be mediated indirectly through another cellular protein. To determine 
whether the interaction is a direct physical interaction or not, we employed GST-pull 
down assays. Purified PCBP1 and PCBP2 (from recombinant E. coli) were incubated 
with glutathione beads conjugated with GST-nsp1β or GST protein. Presence of GST-
nsp1β but not GST alone in the incubation mixture retained PCBP1 and PCBP2 (Fig. 
4.2F) indicating that the interaction of cellular PCBPs with viral nsp1β is likely due to a 
direct physical interaction. Overall, the above studies strongly suggest that PRRSV nsp1β 
interacts with cellular PCBP1 and PCBP2. 
Relocalization of PCBP1 and PCBP2 to viral replication-transcription complexes 
(RTC) in PRRSV infected MARC-145 cells. Next we explored the cellular localization 
of PCBP1 and PCBP2 in virus infected cells. Several of the commercially available 
PCBP1/2 antibodies did not work well with our indirect immunofluorescence protocol. 
So we used the HA-tagged PCBP1/2 encoding plasmids to overexpress these proteins and 
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observe their location in virus-infected MARC-145 cells by indirect immunofluorescence 
using anti-HA antibody. Since PCBPs are important for other viral replication, we 
specifically used an antibody directed against PRRSV nsp2/3, two viral proteins involved 
in formation of the viral RTC (141, 176). In mock-infected MARC-145 cells, PCBP1/2 
were distributed in the cytoplasm andprominently in the nucleus (Fig. 4.3A and 4.3B, top 
rows). However, in virus infected cells, a subset of the total PCBP1/2 localized to 
punctate structures in the cytoplasm surrounding the nuclear membrane (Fig. 4.3A and 
4.3B, bottom row). Interestingly, the majority of these cellular speckles were in close 
proximity to the viral RTC, as visualized by PRRSV nsp2/3 antibody staining. Similar 
punctate accumulations of PCBP1/2 are known to be the result of binding to nucleic acids 
(30). The relocalization of PCBP1 and PCBP2 in PRRSV infected cells to viral RTC 
suggested that they regulated viral replication and/or transcription. 
Interaction of cellular PCBP1/2 with PRRSV polymerase protein nsp9. The finding 
that PCBP relocalized to viral RTC suggested that both of these proteins are elements of 
the RTC and may associate with other components of the RTC. An important component 
of the viral RTC is nsp9, the PRRSV RNA-dependent RNA polymerase (RdRP). To test 
whether nsp9 colocalize with PCBP1 or PCBP2 in transfected cells, we employed the 
indirect immunofluorescence assay. We observed colocalization of the proteins in cells 
expressing nsp9 and PCBP1 or PCBP2 (Fig. 4.4A). Further confirmation of this 
interaction was provided in co-IP studies in 293T cells expressing Flag-nsp9 or Flag-EV 
and HA-PCBP1 or HA-PCBP2. Using an anti-Flag antibody, we were able to pull down 
PCBP1 and PCBP2 from the Flag-nsp9 transfected cells but not from Flag-EV 
transfected cells (Fig. 4.4B). In the converse experiment, using anti-HA antibody for 
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immunoprecipitation, we could pull down Flag-nsp9. These results indicated that nsp9 
(directly or indirectly) interacts with both of these proteins in transfected cells.  The 
current unavailability of a PRRSV nsp9-specific antibody prevented us from exploring 
this protein interaction in virus-infected cells. Collectively, these studies indicated that 
nsp9, the viral RdRp and a component of the RTC interacted with PCBP1 and PCBP2 
proteins. 
PCBP1 and PCBP2 bind to the PRRSV 5’ UTR. As discussed above, the appearance 
of speckled PCBP1/2 in PRRSV infected cells might be of the result of their association 
with nucleic acids. Most of the earlier studies involving PCBPs‟ interaction with RNA 
have found these proteins bind to 5‟UTR and/or 3‟UTR of viral as well as cellular RNAs 
and these interactions affect transcription, stability, or translation of RNA (113). 
Therefore, we tested whether PCBP1/2 interacted with the PRRSV 5‟UTR or 3‟UTR 
using EMSA. Upon incubation of radiolabeled 5‟UTR of PRRSV genome with 
increasing concentrations of purified PCBP1 or PCBP2 protein, formation of a slow-
migrating ribonucleoprotein (RNP) complexes was readily detected (Fig. 4.5A). The 
complexes formed with both PCBP1 and PCBP2 were similar in their electrophoretic 
mobility. These RNA: protein complexes were specific to the PRRSV 5‟UTR because 
addition of increasing concentrations of a specific competitor RNA (unlabeled 5‟UTR) 
resulted in a dose-dependent reduction in complex formation, whereas a nonspecific 
unlabeled competitor RNA was unable to disrupt the complex formation (Fig. 4.5B). 
Next, when we repeated the EMSA using PRRSV 3‟UTR, we did not observe any 
specific RNP complex formations (Fig. 4.5C). Taken together, these results indicated that 
the cellular PCBP1 and PCBP2 specifically interacted with the viral 5‟UTR. 
126 
 
Reduction of PCBP1 and/or PCBP2 levels inhibited PRRSV growth. The 
observations that PCBPs interacted with the viral nsp1β, RdRp as well as the viral 5‟UTR 
led us to hypothesize that both of these cellular factors play important roles in the viral 
life cycle. The biological consequences of these interactions were first examined by 
determining the extent of growth of PRRSV in cells depleted of these cellular proteins 
using siRNA-mediated silencing of PCBP1 or PCBP2 gene expression. Fig. 4.6A and 
4.6B shows the reduction in PCBP1 and PCBP2 protein levels at 72 h post siRNA 
treatment in MARC-145 cells, respectively. The silencing efficiency of PCBP1 siRNA 
was around 50% while that of PCBP2 was approximately 75%. Silencing of both proteins 
did not show any observable negative effect on cellular health and growth. When the 
PCBP1- or PCBP2-silenced MARC-145 cells were infected with a genotype II PRRSV 
strain FL12, virus yield in the culture supernatants was substantially reduced at 24 h and 
48 h post infection. Depletion of PCBP1 or PCBP2 in these cells led to an average of 
five-fold decrease in virus titers compared to non-targeting scrambled siRNA-treated 
cells at both 24 h and 48 h post infection (Fig. 4.6C). This inhibitory effect on virus yield 
was also observed at lower multiplicity of infection (0.1 moi) and earlier time post-
infection (18 h) (data not shown). When we quantified the viral RNA copy numbers in 
the supernatants of these cells using real-time PCR, we detected a three- to four-fold 
reduction in copy number in PCBP1/PCBP2 silenced MARC-145 cells compared to those 
in scramble siRNA treated cells (Fig. 4.6D). Furthermore, depletion of both proteins 
simultaneously resulted in a greater reduction (~10 fold) in virus yield (Fig. 4.6E). 
Depletion of PCBP1 and/or PCBP2 also led to similar inhibition of growth of Lelystad 
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virus (a genotype I PRRSV strain), suggesting that the modulatory role of PCBPs in 
PRRSV growth are conserved across genotypes (Fig. 4.6F). 
Since PCBP2 is a negative modulator of IFN production (239), it is possible that the 
reduction in PRRSV growth upon PCBP2 knockdown was caused by increased IFN 
production. Therefore, we examined the levels of IFN-β transcripts in MARC-145 cells 
treated with PCBP2 siRNA and infected with PRRSV. Sendai virus (Sev) stimulated 
MARC-145 cells was used as positive control for IFN induction. Results show that IFN-β 
induction was not observed in these cells (Fig. 4.6G), indicating that reduced PRRSV 
growth in PCBP1/2 deficient cells is not a result of increased IFN production. 
PCBP1 and PCBP2 do not affect PRRSV entry, uncoating or translation from the 
viral genomic RNA. The first steps in the PRSSV life cycle are entry and uncoating for 
release of infectious genomic RNA into the cytoplasm, and the subsequent translation of 
the genome. To investigate if PCBPs play any role in PRRSV entry and uncoating, we 
electroporated BHK-21 cells with in vitro transcribed PRRSV full length RNA, so as to 
obviate the need of viral entry and uncoating steps. In these studies, we used BHK-21 
cells as they exhibit significantly higher transfection efficiency compared to MARC-145 
cells. Fig. 4.7A and 4.7B show silencing of PCBP1 and PCBP2 expression by respective 
siRNAs.  In these experiments, messenger RNA levels for PCBP2 were measured instead 
of measuring the proteins, as no suitable antibodies to detect the protein in BHK-21 cells 
were available.  When PCBP1/2 silenced cells were transfected with in vitro transcribed 
full-length PRRSV RNA encoding eGFP, lower levels of eGFP expression was detected 
when compared to scrambled siRNA treated cells even when the requirement for viral 
entry and uncoating are negated (Fig. 4.7C, top row). Similar reduction in the levels of 
128 
 
eGFP was also observed in PCBP1/2-depleted MARC-145 cells infected with the eGFP-
encoding PRRSV (FLeGFP) (Fig. 4.7C. bottom row) suggesting that the viral entry and 
uncoating steps are not adversely affected by depletion of these cellular proteins. These 
results further indicate that subsequent steps in viral life cycle, like genome translation 
and/or viral RNA synthesis, may have been affected by the depletion of PCBP1/2. 
Following viral uncoating, the released viral genome serves as template for 
translation of the nsps from ORF1a and ORF1b, which are required for assembly of 
replication complex and subsequent viral genome replication. Using a polymerase 
defective PRRSV (FL12Pol
-
) genome, we investigated whether PCBP1/2 was required 
for this initial translation event. Due to mutations in the polymerase active site, FL12Pol
- 
virus cannot undergo replication (202) but the initial translation from the input viral RNA 
remains unaffected. Electroporation of FL12Pol
- 
in vitro transcripts yielded similar level 
of nsp1α and nsp1βproteins in both PCBP1/2 specific siRNA treated cells as well as 
scramble siRNA treated cells (Fig. 4.7D), implying that PCBPs were not necessary for 
translation of the input viral genome. Thus, the experiments described in Figure 4.7 
indicated that PCBP1 and PCBP2 were necessary after virus entry and the initial genomic 
RNA translation. 
PCBP1 and PCBP2 affect viral genome replication. To examine whether PCBP1/2 
play any role in viral RNA synthesis, MARC-145 cells, which are depleted of PCBP1/2 
by siRNA treatment, were infected with PRRSV. Examination of PRRSV genomic RNA 
and sg mRNAs levels in cells depleted of PCBP1/2 revealed that the synthesis of the viral 
RNAs was significantly reduced as compared to that in cells not depleted of these 
proteins (Fig. 4.8A). Synthesis of anti-genomic RNA and anti-subgenomic mRNAs was 
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also reduced in PCBP1/2 depleted cells (Fig. 4.8B). In PCBP1 and PCBP2 deficient cells, 
reduced levels of both structural proteins (eGFP, a pseudo-marker for viral replication) 
and non-structural proteins (nsp1α and nsp1β) accumulation was also observed compared 
to a scramble siRNA treated cells (Fig. 4.8C). Reduced levels of other non-structural 
proteins (nsp2 and nsp3) were also observed suggesting that the involvement of PCBP1 
and PCBP2 were not specific to a particular viral protein synthesis (Fig. 4.8D). Taken 
together, these results suggest that silencing of PCBP1 and PCBP2 has a significant 
inhibitory effect on genome replication and sg mRNA synthesis. 
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Discussion 
Nsp1β interaction partners. Because of their limited genome coding capacity, viruses 
depend on host cellular factors to carry out important functions. During the course of 
evolution, each virus has acquired a unique array of multifunctional proteins. The 
arterivirus nsp1 is an example of a viral protein that has multiple functions. Previous 
studies on nsp1 of EAV and PRRSV suggested this protein is a major regulator of the 
viral replicative cycle as well as an inhibitor of host innate immune responses (16, 29, 87, 
140, 198). In this chapter, we have identified several cellular proteins that interact with 
nsp1β.  Additional studies indicated these cellular proteins play important role(s) in the 
viral life cycle. Though this report is focused on PCBPs, our IP-MS results have detected 
several other proteins of interest (Table 1). Specifically several hnRNP proteins e.g. 
hnRNP K, hnRNP A2/B1 were identified thatare important for replication of 
coronaviruses and other viruses (105, 168, 229). Another noteworthy finding was 
identifying the interaction betweennsp1β and the poly (A) binding protein cytoplasmic 4 
(PABP4), which is expressed upon T-cell activation and is involved in RNA stabilization 
and translation (133, 234). It will be interesting to explore the possible involvement of 
these hnRNPs and PABP4 in the context of PRRSV genome replication and transcription. 
A common property among these putative nsp1β-interacting proteins is their inherent 
RNA binding ability. As nsp1β has also been predicted to interact with RNA, these 
cellular proteins and nsp1β might form RNP complexes and regulate certain aspects of 
the virus life cycle (127, 233). 
Nsps and PCBP interactions. The nsp1β-PCBP1/2 interaction was confirmed under 
ectopic expression conditions and in PRRSV-infected cells. Moreover, we observed 
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relocalization of PCBP1/2 to viral RTC upon PRRSV infection of cells as judged by their 
punctate accumulation in perinuclear regions. A recent report concluded that 25% of total 
EAV nsp1 in infected cells is present in the cytoplasmic RTC-containing cellular fraction 
(208). Together with nsp1β‟s presumed role in sg mRNA synthesis, these results 
suggested nsp1β recruits PCBPs to the viral RTCs to stimulate viral RNA synthesis. The 
RNase treatment of the immuneprecipitate did not alter nsp1β-PCBP1/2 interaction. This 
led us to conclude that the above interaction is not a non-specific RNA mediated 
interaction. However it is possible that both interacting partners might interact with a 
specific RNA moiety which in turn protects the RNA from the nuclease action. 
Additionally, nsp1β and PCBP1/2 co-localized to the nucleus (Fig. 4.2C). EAV nsp1 as 
well as both nsp1α and nsp1β of PRRSV localize to the nucleus during early time post-
infection (29, 200). Functional significance of the interaction of these proteins in the 
nucleus is unclear but it is possible that these complexes regulate cellular RNA 
metabolism within the nucleus. 
Two arteriviral proteins nsp2 and nsp3 are implicated in modifying the 
endoplasmic reticulum (ER) membrane to form double membrane vesicles, which are the 
sites for viral genome amplification (176). Since PRRSV nsp2/3 and PCBPs co-localize 
in virus infected cells (Fig 4.4), we attempted to verify this interaction by co-IP 
experiments. Such experiments did not yield clear-cut results suggesting that the 
association was indirect, weak, or transient (data not shown). On the other hand, the 
interaction between the PRRSV nsp9 (the viral RdRP) with PCBP1/2 was readily 
detected when these proteins were expressed ectopically. Demonstration of similar 
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interaction in virus-infected cells will be important for understanding functional 
consequences of this interaction in viral genome replication. 
PCBP-viral nsp-5’UTR ternary complex. Arteriviral 5‟UTR contains cis-acting 
sequences required for genome replication and sg mRNA production (205). The PCBPs 
bind both 5‟UTR and 3‟UTR of cellular as well as other viral genes and affect RNA 
metabolism. Binding of PCBP1 and PCBP2 to the promoter of mouse mu opioid receptor 
and BRCA1 enhances their transcription (89, 194). PCBP2 bind the 3‟UTR of tyrosine 
hydroxylase mRNA and increases mRNA stabilization and translation (232). Previous 
investigations into proteins binding to arteriviral UTR identified four MA104 cell 
proteins that interact with SHFV 3‟UTR of (-) sense genome (this is antisense to viral 
5‟UTR) (78). Though their identity is unknown, the approximate molecular weights of 
those proteins were 103, 86, 55 and 36 kDa. Using gel mobility shift assays we have also 
demonstrated that PCBP1 and PCBP2 could bind to PRRSV (+) 5‟UTR. As the 
molecular masses of PCBPs are ~40 kDa, it is tempting to speculate that one of the 
cellular proteins bound to the SHFV (-) 3‟UTR is PCBP. The 191 nt 5‟UTR of type 2 
PRRSV contains several pyrimidine rich stretches, which are considered possible sites for 
PCBP binding. The 3‟ terminal 15 nt (from nt 177 to nt 191) has strong homology (only 2 
nt difference) with the consensus PCBP binding site of cellular mRNAs (73). 
Interestingly this same region is also part of the leader transcription regulatory sequence 
(TRS-L) hairpin (LTH) structure, which is conserved across arteriviruses and 
coronaviruses (205). The intact LTH structure is critical for EAV replication and sg 
mRNA synthesis. The demonstration of PCBPs‟ interaction with two replicase gene 
products (nsp1β and nsp9) and 5‟UTR of PRRSV suggested the formation of a ternary 
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RNP complex (5‟UTR-PCBPs-viral nsps). Our effort to purify the nsp1β protein without 
its nuclease activity has not been successful to include this protein in an in vitro binding 
assay with PRRSV 5‟UTR and PCBP to show ternary complex formation.  At this point, 
we speculate that this putative ternary complex might be important for viral genome 
replication. It would also be interesting to investigate if the PCBP-viral nsps interaction is 
required for PCBP‟s localization to PRRSV 5‟UTR or if these are two mutually exclusive 
events. 
Possible mechanism of regulation of viral replication. Using siRNA mediated 
silencing approaches, we have established the importance of PCBPs for PRRSV genome 
replication/transcription. Although both PCBP1 and PCBP2 are closely related (~90% 
amino acid identity), the results presented here suggested that were involved in 
independent steps of PRRSV replication because simultaneous depletion of both proteins 
led to an additive reduction in viral titer compared to individual depletion by siRNA. 
PCBP1/2 did not affect virus entry, uncoating, or translation from genomic RNA. 
However, genomic and anti-genomic RNA synthesis was reduced in PCBP1/2 deficient 
cells (Fig. 4.8A and 4.8B). How does the binding of a cellular factor(s) to the viral 
5‟UTR influence genome replication, which initiates from the 3‟UTR of viral genome? 
Information from poliovirus replicative cycle offers an interesting paradigm in this 
regard. Binding of PCBP1 and PCBP2 to the 5‟ cloverleaf (CL) structure of poliovirus 
stimulated association of viral polymerase precursor (3CD
pro) with the 5‟CL (56). 
Simultaneously the binding of poly (A) binding protein (PABP) to the 3‟UTR poly (A) 
tail and its interaction with the PCBP2 and 3CD
pro
 leads to genome circularization and 
the initiation of replication (69). The level of 3CD
pro 
is suggested to serve a molecular 
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switch between viral translation and replication. During initial stages of viral life cycle in 
the absence of 3CD
pro
, viral genome translation predominates and PCBPs promote viral 
genome translation. When certain levels of 3CD
pro
 accumulate in infected cells,  
formation of a 5‟CL-PCBP-3CDpro RNP complex occurs resulting in repression of 
genome translation and stimulation of genome replication. Such genome circularization 
issuggested as a universal mechanism for (+) strand RNA virus replication including 
coronaviruses (179). We speculate that, in case of PRRSV, the PCBPs might be an 
integral part of the RNP complex that is required for initiation of negative strand RNA 
synthesis. 
The inhibitory effect on sg RNA synthesis upon PCBP1/2 depletion may be the 
result of reduced levels of full-length genome and anti-genome synthesis or due to the 
loss of direct interactions between PCBP1/2 and transcription controlling cis-acting 
elements within the viral genome. Nidoviral sg RNAs are produced through the process 
of discontinuous transcription, and this involve physical interactions between the leader 
TRS (TRS-L) and the body TRSs (TRS-B) that is upstream of each ORF within the viral 
genome. It is also possible that PCBPs are part of an RNP complex that includes TRS-L 
and TRS-B and brings together these distant RNA moieties. Further studies will be 
required to address the interactions of PCBP1/2 with the TRSs and how these interactions 
regulate sg RNA synthesis in PRRSV-infected cells. We also observed lower level of 
viral protein synthesis in the absence of PCBP1/2; but this might be a secondary effect of 
reduced levels of viral replication, considering that we did not detect any effect on 
translation of input genome by PCBP1/2 silencing. 
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Overall, our findings demonstrated that two cellular factors, PCBP1 and PCBP2 
were important regulators of PRRSV replication. They both specifically interact with the 
viral 5‟UTR and the two viral replicase proteins. Whether PCBPs are also necessary for 
other Arteriviruses requires further investigation. Considering the similarity in their 
replication strategy, these cellular proteins might also be important for other members of 
the Nidovirales order. Sequestration of PCBPs by viral nsps for their utilization in viral 
life cycle provides another example of viral exploitation of host cell machinery. 
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Table 4.1. List of proteins present in four specific bands observed in nsp1β lane as 
identified by Mass spectrometry  
 
a
 Significance threshold of proteins was set at p < 0.05. 
b
Number of peptides sequenced found to be derived from the same proteins. 
 
 
 
 
 
 
 
Band 
no. 
Accession 
no. 
Protein name MASCOT 
score 
a
 
Queries 
matched 
b
 
1 gi|4504715 Poly A binding protein, cytoplasmic 
4 isoform 2 
333 9 
gi|288100 Initation factor 4B 159 3 
gi|3122595 Probable ATP-dependent RNA 
helicase DDX17 
132 3 
gi|187281 M4 protein 95 4 
2 gi|14165437 hnRNP K isoform a 404 14 
gi|5031703 Ras-GTPase-activating protein SH3-
domain-binding protein 
292 5 
gi|306890 Chaperonin (HSP60) 167 6 
gi|4191610 IGF-II mRNA-binding protein 2 118 3 
3 gi|460771 hnRNP-E1 340 9 
gi|14141166 hnRNP-E2 325 9 
gi|190238 Nucleolarphosphoprotein B23 159 3 
gi|4504447 hnRNP A2/B1 isoform A2 127 2 
4 gi|4506707 Ribosomal protein S25 136 3 
gi|5032051 Ribosomal protein S14 127 2 
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Table 4.2 Primers used to prepare various constructs used in this study 
 
 
Primers
a
 Sequences (5‟-3‟) 
HA-NheIPCBP1 for
b
 
 
EcoRIPCBP1 rev 
PC2KH12-EcoRI rev 
KpnIPCBP2 for 
ECoRIPCBP2 rev 
EcoRInsp1β for 
5‟UTR HindIII for 
5‟UTR NcoI rev 
3‟UTR XbaIfor 
3‟UTR XbaIrev 
T7PNfor
c 
AflIIAsisI for 
RsrIIEcoRV rev 
ORF1bXhoI rev 
 
XhoITRS for 
GCCGCTAGCATGTACCCATACGATGTTCCAGATTACGCTGG
TACCGATGCCGGTGTGACTGAAAG 
ATATGAATTCCTAGCTGCACCCCATGCC 
ATATGAATTCTTACTCCAACATGACCACGCAG 
ATATGGTACCGACACCGGTGTGATTGAAGG 
ATATGAATTCCTAGCTGCTCCCCATGCC 
ATATGAATTCTGGCTGACGTCTATGATATTGGTCAT 
ATATAAGCTTATGACGTATAGGTGTTGGCTC 
ATATCCATGGTTAAAGGGTTGGAGAGA 
ATATTCTAGATGGGCTGGCATTCCTTAAGC 
ATATTCTAGAAATTTCGGCCGCATGGTTCTC 
TAATACGACTCACTATAGGAAATAACAACGGCAAGCAGC 
ATATATCTTAAGGCGATCGCTCCACACCTG 
ATATATCGGTCCGTATGATGATATCAACAATGGACACC 
CACGGAACGCGGCCGCACGCGTCTCGAGTTCAATTCAGGCCT
AAAGTTG 
CTCGAGACGCGTGCGGCCGCGTTCCGTGGCAACCCCTTTAAC
CAGAGTTTCAGCGGAACAATGAAATGGGGTCCATGCAAAGC 
 
 
 
a
The restriction enzyme sites are underlined. 
b
The HA-epitope tag is indicated in bold. 
c
The T7 promoter sequence is indicated in bold. 
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Fig.4.1.Identification of PRRSV nsp1β-interacting proteins by IP- MS. Flag-empty 
vector (Vector) and Flag-nsp1β (nsp1β) overexpressing 293T cells were used for 
immunoprecipitation using anti-Flag agarose resins. Eluted proteins from the resins were 
resolved in 12% SDS-PAGE and stained by silver staining method. The prominent bands 
at ~55 KDa and ~25KDa are IgG Heavy (IgG-H) and IgG Light (IgG-L) chains 
respectively and indicated in the figure. The nsp1β band is observed just above the IgG-L 
band in nsp1β lane only. The four bands specific to nsp1β lane are indicated by asterisk 
(*). Relative mobility of molecular mass markers are shown on the left. 
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Fig.4.2. Interaction of PCBP1 and PCBP2 with PRRSV nsp1β.Co-IP of HA-PCBP1 
(A) and HA-PCBP2 (B) with Flag-nsp1β. Indicated plasmids (shown on top) were 
transfected into 293T cells, and at 48 h post transfection, whole cell lysates (WCL) were 
immunoprecipitated with anti-Flag or anti-IgG. After SDS-PAGE separation, blots were 
probed (WB) with antibodies indicated on the left. A 5% WCL sample was also probed 
similarly to confirm the expression of different protein partners. The identities of various 
protein bands are indicated on the right. (C) Colocalization of Flag-nsp1β with HA-
PCBP1 (top) and HA-PCBP2 (bottom) by confocal microscopy. MARC-145 cells 
transfected with the above protein expressing plasmids were subjected to indirect 
immunofluorescence to detect Flag-nsp1β (green) and HA-PCBP1/2 (red) using rabbit 
anti-Flag and mouse anti-HA antibodies respectively. Proteins detected are indicated 
inside the panel. Position of nucleus is indicated by DAPI (blue) staining in the merge 
image (right most panels). (D) Co-IP of PRRSV nsp1β with endogenous PCBP1. 
Mock/virus infected MARC-145 cells were used for IP with anti-PCBP1 antibody and 
probed for proteins with respective antibodies indicated in the left. Identities of various 
bands are shown on right. (E) Effect of RNase treatment on PCBP1/2-nsp1β interaction. 
Extracts of 293T cells overexpressing the different proteins were treated or untreated with 
RNase A and T1 for 1 h and IP followed by WB was done as indicated. Bottom panels 
are ethidium bromide staining of agarose gel run for total RNA present with or without 
RNase treatment. (F) GST-pull down assay. Glutathione beads conjugated to GST or 
GST-nsp1β fusion protein (indicated on top) were incubated with recombinant PCBP1 
(left) or PCBP2 (right). After several washings, proteins were eluted from the beads and 
141 
 
SDS-PAGE was performed. Presence of PCBP1/2 was detected by anti-HA antibody. 
The GST/GST-nsp1β expression was confirmed by anti-GST antibody. 
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Fig.4.3. Sub-cellular localization of PCBP1/2 in PRRSV infected MARC-145 cells. 
MARC-145 cells mock-infected or PRRSV-infected were immunostained for presence of 
PCBP1 (A)  or PCBP2 (B) (red) and PRRSV nsp2/3 (green) using mouse anti-HA 
antibody and rabbit anti-nsp2/3 antibody respectively. The identities of the proteins are 
indicated inside the panels. Nuclei are shown by DAPI (blue) staining in the merge image 
(right most panels). 
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Fig.4.4. Interaction of PCBP1 and PCBP2 with PRRSV nsp9.(A) Co-localization of 
nsp9 with PCBP1 (top) and PCBP2 (bottom) by confocal microscopy. MARC-145 cells 
transfected with Flag-nsp9  and HA-PCBP1 or HA-PCBP2 were used for indirect 
immunofluorescence to detect nsp9 (green)  and PCBP1/2 (red) using rabbit anti-Flag and 
mouse anti-HA antibodies respectively. Proteins detected are indicated inside the panel. 
Nuclei are shown by DAPI (blue) staining in the merge image (right most panels). (B) 
Co-IP of HA-PCBP1 and HA-PCBP2 with Flag-nsp9. Indicated plasmids (shown on top) 
were transfected into 293T cells, and at 48 h post transfection, whole cell extracts were 
immunoprecipitated and blots were probed (WB) with antibodies indicated on the left. A 
5% whole cell lysate (WCL) sample was also probed similarly to show the expression of 
different protein partners. The identities of various protein bands are indicated on the 
right. Actin serves as the loading control. 
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Fig. 4.5. Binding of PRRSV 5’UTR with purified PCBP1/2. (A) Gel mobility shift 
assay-
32
P labeled PRRSV (+) 5‟ UTR probe was incubated with increasing 
concentrations of recombinant purified PCBP1 or PCBP2 (0, 0.5, 0.75, 1 and 1.25 µg in 
lane 1 to 5 of each panel, respectively) in a RNA binding reaction. RNP complexes were 
resolved in 5% non-denaturing PAGE and visualized by exposing the dried gel to 
phosphorimager screens. Positions of the free and bound probes are indicated on right. 
(B) Competition gel mobility shift assay. Radiolabeled PRRSV (+) 5‟UTR probes were 
incubated with 0.75 µg of PCBP1 or PCBP2 in presence/absence of unlabeled 5‟UTR 
probe (Sp. comp.) or an irrelevant probe (Non Sp. comp.). Lane 1 and 7, free probe; lane 
2 and 8, no competitor; lane 3-4 and 9-10, increasing concentration of specific competitor 
(10 fold and 50 fold molar excess); lane 5-6 and 11-12 , increasing concentration of non-
specific competitor (10 fold and 50 fold molar excess). (C) Gel mobility shift assay with 
3‟UTR. Radiolabeled PRRSV (+) 3‟UTR probe was incubated alone or with 1µg of 
PCBP1 or PCBP2 and EMSA was performed as described above. 
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Fig.4.6. Silencing of PCBP1 and PCBP2 reduce viral growth in MARC-145 cell. 
Reduction in PCBP1 (A) and PCBP2 (B) protein levels after siRNA treatment. MARC-
145 cells transfected with the scramble or PCBP1/2 specific siRNAs (final concentration 
is indicated in nM on top) were harvested 72 h post transfection. Endogenous PCBP1 and 
PCBP2 were detected using antibodies directed against these proteins. The blots were 
also probed for β-actin to confirm equal protein loading. (C) MARC-145 cells treated for 
72 h with scramble/PCBP1/PCBP2 specific siRNAs were infected with FL12 virus at 1 
moi. Culture supernatants were harvested at 24 h and 48 h post-infection and viral titers 
were determined by plaque assay. Viral titer in scramble siRNA treatment was 
normalized to 1 and titers in other siRNA treatment samples were indicated as fold 
change in comparison to scramble siRNA treatment. (D) Viral RNA copy numbers were 
measured by Real-time PCR from the 24 h post-infection culture supernatants and 
indicated as fold change in comparison to scramble siRNA treatment. (E) Relative virus 
yield after combined silencing of PCBP1 and PCBP2. Supernatants were collected 18 h 
post-transfection and titers were expressed as mentioned above. (F) Relative virus yield 
after indicated siRNA treatment in case of Lelystad virus infection. Treatments were 
done as explained in panel „C‟ and titers were expressed likewise. (G)The IFN-β mRNA 
and RPL32 mRNA (internal control) were measured by reverse-transcription PCR from 
MARC-145 cells treated with indicated siRNAs (on top) and either mock-infected or 
infected with FLeGFP virus for 18 h. Sendai virus (SeV) stimulated MARC-145 cells 
were used as positive control for IFN induction (last lane). (*** indicates p≤0.001, ** 
indicates p≤0.01 and * indicates p≤0.05) 
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Fig.4.7. PCBP1 and PCBP2 are not important for PRRSV entry and uncoating or 
translation of genomic RNA. Effective silencing of PCBP1 and PCBP2 expression in 
BHK-21 cells. Cells treated with indicated concentration of siRNAs were probed for 
endogenous PCBP1 protein level (A) or PCBP2 mRNA level (B) by immunoblotting and 
reverse-transcription PCR, respectively. (C, top panels) At 72 h post siRNA transfection 
(indicated on top), BHK-21 cells were electroporated with FLeGFP full length RNA. The 
eGFP fluorescence was observed 14 h post-electroporation under inverted fluorescence 
microscope. (C, bottom panels) MARC-145 cells similarly transfected with siRNA were 
infected with 1 MOI of FLeGFP virus. The eGFP fluorescence was recorded 12 h post-
infection. (D) BHK-21 cells silenced with scramble/PCBP1/PCBP2 specific siRNAs as 
above were electroporated with pFL12Pol
-
 full length RNA. At 24 h post electroporation 
cells were harvested and PRRSV nsp1α and nsp1β proteins were detected by 
immunoblotting. Level of β-actin was measured to ensure equal protein loading. The first 
lane shows protein from BHK-21 cells that were neither siRNA treated nor electroporated 
with pFL12Pol
-
 RNA. 
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Fig.4.8. Cellular PCBP1 and PCBP2 are required for efficient PRRSV genome 
replication. (A) After 72 h of siRNA transfection, MARC-145 cells were infected with 
FL12 at 1 MOI. At 12 h post-infection, cells were collected and total RNA was isolated. 
Then 5 μg of total RNA from each treatment was used for northern hybridization with a 
radiolabelled (-) 3‟UTR probe to detect viral genomic and subgenomic mRNAs. (B) 
Similarly anti-subgenomic and -genomic RNA were detected from 10 μg of total RNA 
using a radiolabelled (+) 3‟UTR probe. The 28S rRNA levels in the samples are shown in 
the bottom to confirm equal RNA loading in different lanes. The genomic/anti-genomic 
RNA and the subgenomic/ anti-subgenomic RNAs are identified by number 1 and 
number 2 to 7 respectively. (C) MARC-145 cells treated with siRNA specific to 
scramble/PCBP1/PCBP2 were infected with FLeGFP virus at 1 MOI. Cells were 
harvested 12 h post-infection and viral non-structural proteins (nsp1α and nsp1β) and 
structural protein (eGFP) levels were detected by immunoblotting. (D) Level of nsp2 and 
nsp3 also detected by immunoblotting. Actin served as loading control. 
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General conclusions  
Following more than two decades after its discovery, PRRSV still remains a 
significant threat to the swine population world-wide. Pigs exposed to PRRSV undergo a 
prolonged viremic phase followed by an extended persistence of the virus in lymphoid 
organs. The immune response is protective against reinfection by a homologous strain of 
the virus but the animal can be reinfected with a divergent virus strain. Past researches 
have uncovered interesting details about the immunological interactions between the host 
and PRRSV. However, our failure to achieve a broad protective immune response against 
the virus through active immunization indicates that the understandings of these 
interactions are far from complete. This dissertation is focused on elucidating the role of 
viral non-structural proteins (nsps) in two different contexts: (i) their role in subversion of 
host type I IFN response and (ii) their interaction with cellular factors to facilitate viral 
genome replication. 
The suboptimal nature of type I IFN response in PRRSV infection is well- 
established (1, 16). This poor IFN induction is part of the active immune evasion 
mechanisms employed by PRRSV to prolong its survival in the host. A weak IFN 
response not only ensures an initial unhindered spread of the virus, but also leads to a 
weak and delayed acquired immune response. Most of the viruses exhibiting anti-IFN 
property are known to employ certain viral protein(s) that target IFN response. We have 
focused on PRRSV nsps. The nsps were good candidate for such functions because they 
are produced early in the infection when inhibiting IFN production has the strongest 
impact on modulating the course of infection. A cursory scanning of the different nsps 
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with regard to their ability to inhibit IFN-β transcription found that at least five different 
nsps appeared to be involved (chapter 2). The level of IFN suppression exerted by these 
different nsps varied, with nsp1β being the most effective. Further investigation revealed 
that nsp1β antagonizes both IRF3 and NF-κB mediated gene induction. It specifically 
inhibits IRF3 phosphorylation and nuclear translocation upon dsRNA treatment. Studies 
by others have found that nsp1β also interferes with IFN signaling by preventing 
translocation of STAT-1/STAT-2 to the nucleus (140). Both nsp1α and nsp1β also 
suppress TNF-α promoter activation by inhibiting NF-κB and Sp1 transcription factors 
(185). The finding of five different proteins from a single virus exhibiting IFN inhibition 
although is intriguing but not unique. Garcia-Sastre and colleague (2010) in a recent 
review had listed 170 different IFN antagonists from 93 distinct viruses. Approximately 
50% of these viruses have more than one IFN antagonist and 30% of antagonists target 
multiple steps of the IFN signaling pathway (214). While identification of the dominant 
anti-IFN protein of PRRSV in a virus-infected cell is a challenging task (as most of the 
nsps are required for viral life cycle), nsp1β is a strong contender. Evidence of this comes 
from our alanine-scanning mutagenesis studies described in chapter 3. The 16-5A mutant, 
which offered a relatively modest relief in the IFN-suppression in reporter assays was 
able to induce significantly higher level of IFN transcripts compared to wt virus. This 
mutant virus has the remainder of the IFN antagonists intact. Characterization of the other 
viable nsp1β mutant (70-5A) virus which showed a higher level of relief in reporter 
assays will probably confirm the importance of nsp1β‟s in IFN inhibition. Nonetheless, 
the four remaining IFN antagonists also contribute to the IFN-suppression as described 
by our laboratory and others (16, 169, 188). Those nsps target different steps in the IFN 
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induction pathway relative to those targeted by nsp1β, an observation that points towards 
the importance of ensuring a successful IFN-suppression during a PRRSV infection in 
swine. There is also a strong possibility that these five proteins might act in a temporally 
sequential manner to suppress IFN (nsp1 in the start of cell infection, following the other 
nsps at later time points) so that each protein will have the opportunity to carry out its 
non-IFN antagonistic functions (i.e. in viral replication and transcription). These IFN-
antagonistic nsps have also important roles in vital steps of viral life cycle, most of them 
being required for viral replication and transcription (49). Consequently, segregating their 
IFN-suppression role from their involvement in viral replication is difficult. Evidence for 
this comes from our inability to recover several mutant nsp1α and nsp1β, which were 
suitable candidates inhibiting IFN production. Most of these mutants showed no sign of 
genome replication indicating that the mutated residues are important for this vital 
process. 
Viruses devoid of their IFN antagonists are good candidates for live viral 
vaccines. Their replication competence combined with attenuated growth ensures proper 
priming of the adaptive immune response without the unusual side effects of disease 
development. The NS1 truncated/deleted influenza virus or NS1/NS2 deleted respiratory 
syncytial virus are two good examples of such an approach (150, 191, 224). Whether a 
similar approach will work for PRRSV is not clear. We have tried to test this hypothesis 
with the 16-5A mutant virus, but the reversion of the mutation did not allow us to pursue 
any further experimentation. Future mutational analysis of the nsp1 should include 
smaller deletions rather than substitutions, as the latter have a higher probability of 
reversion. A better understanding of the exact mechanism of IFN antagonism by the nsps 
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will help in narrowing the amino acid residues that should be targeted. In the absence of 
such information, it will be important to ensure that the proposed mutation does not 
interfere with other functions of this viral protein. To achieve this goal, the mutant 
screening process should include assays that will measure the competency of the mutant 
to support viral replication and transcription in vitro along with the standard IFN-
promoter based reporter assays.  
While exploring the possible interaction between nsp1β and components of 
cellular IFN signaling pathway by mass spectrometry, we identified PCBP1 and PCBP2 
as interaction partners. Both proteins are implicated in a range of transcriptional and post-
transcriptional activities. Their interaction with poliovirus replicase allows the virus to 
tightly regulate viral genome replication and translation events as both processes use the 
same genomic RNA as the template (69). Nidovirus polyprotein synthesis, genome 
replication and sg RNA transcription also use the same genomic (+) sense RNA as a 
template. Studies in EAV have suggested that the viral nsp1 maintains the balance 
between replication and transcription (128). Nedialkova et al. recently suggested that 
nsp1 interacts with the body TRS motifs in the (+) strand or their complement in (-) 
strand and attenuate the RdRp complexes at the body TRS motifs (127). This will 
determine whether a given genomic RNA undergoes replication (synthesis of full length 
complementary RNA) or transcription (synthesis of sub genome length complementary 
RNA) (Fig.1.3).  EAV nsp1 also determines the relative abundance of the various (-) 
sense sg mRNA transcripts, which in turn determine the level of various sg mRNAs 
(128). Whether nsp1 alone is sufficient to carry out this function or requires help from 
other viral or cellular proteins is unknown. We have observed that silencing of PCBPs 
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leads to reduced replication as well as transcription without any effect on polyprotein 
synthesis and processing (chapter 4). Collectively, our studies suggest that PCBPs are 
part of a ribonucleoprotein complex together with nsp1, which regulate PRSSV genome 
replication and transcription.  
In conclusion, the present work uncovered two important functions of PRRSV 
nsp1:1) IFN antagonism, and 2) interactions with cellular proteins that are important for 
viral replication. Although these are unrelated functions, their ultimate goal is to ensure 
survival and replication of PRSSV in swine. Since these functions are only a subset of the 
functions of PRRSV nsp1, it seems clear that this protein has multiple functions. Further 
research on nsp1 will reveal additional functions, which will provide a better insight into 
the complex virus host interactions that occur in the host. This information is crucial for 
understanding the basic biology of the virus and may be used for designing better 
therapeutic or prophylactic measures against PRSSV. 
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